id	sid	tid	token	lemma	pos
ajmpe-660	1	1	050815-cr095.docx	050815-cr095.docx	NUM
ajmpe-660	1	2	american	american	PROPN
ajmpe-660	1	3	journal	journal	PROPN
ajmpe-660	1	4	of	of	ADP
ajmpe-660	1	5	medical	medical	ADJ
ajmpe-660	1	6	and	and	CCONJ
ajmpe-660	1	7	physical	physical	ADJ
ajmpe-660	1	8	education	education	PROPN
ajmpe-660	1	9	vol.8	vol.8	PROPN
ajmpe-660	1	10	,	,	PUNCT
ajmpe-660	1	11	issue	issue	NOUN
ajmpe-660	1	12	5	5	NUM
ajmpe-660	1	13	;	;	PUNCT
ajmpe-660	1	14	september	september	PROPN
ajmpe-660	1	15	-	-	PUNCT
ajmpe-660	1	16	october	october	PROPN
ajmpe-660	1	17	2023	2023	NUM
ajmpe-660	1	18	;	;	PUNCT
ajmpe-660	1	19	issn	issn	PROPN
ajmpe-660	1	20	:	:	PUNCT
ajmpe-660	1	21	2994	2994	NUM
ajmpe-660	1	22	-	-	SYM
ajmpe-660	1	23	0524	0524	NUM
ajmpe-660	1	24	impact	impact	NOUN
ajmpe-660	1	25	factor	factor	NOUN
ajmpe-660	1	26	:	:	PUNCT
ajmpe-660	1	27	6.14	6.14	NUM
ajmpe-660	1	28	1252	1252	NUM
ajmpe-660	1	29	columbia	columbia	PROPN
ajmpe-660	1	30	rd	rd	PROPN
ajmpe-660	1	31	nw	nw	PROPN
ajmpe-660	1	32	,	,	PUNCT
ajmpe-660	1	33	washington	washington	PROPN
ajmpe-660	1	34	dc	dc	PROPN
ajmpe-660	1	35	,	,	PUNCT
ajmpe-660	1	36	united	united	PROPN
ajmpe-660	1	37	states	states	PROPN
ajmpe-660	1	38	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	1	39	;	;	PUNCT
ajmpe-660	1	40	mail	mail	NOUN
ajmpe-660	1	41	:	:	PUNCT
ajmpe-660	1	42	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	2	1	10	10	NUM
ajmpe-660	3	1	|	|	ADV
ajmpe-660	3	2	a	a	DET
ajmpe-660	3	3	m	m	NOUN
ajmpe-660	3	4	e	e	NOUN
ajmpe-660	3	5	r	r	NOUN
ajmpe-660	4	1	i	i	NOUN
ajmpe-660	4	2	c	c	VERB
ajmpe-660	4	3	a	a	DET
ajmpe-660	4	4	n	n	NOUN
ajmpe-660	5	1	j	j	NOUN
ajmpe-660	5	2	o	o	X
ajmpe-660	5	3	u	u	NOUN
ajmpe-660	5	4	r	r	NOUN
ajmpe-660	5	5	n	n	NOUN
ajmpe-660	5	6	a	a	DET
ajmpe-660	5	7	l	l	NOUN
ajmpe-660	5	8	o	o	X
ajmpe-660	6	1	f	f	X
ajmpe-660	6	2	m	m	NOUN
ajmpe-660	6	3	e	e	NOUN
ajmpe-660	7	1	d	d	NOUN
ajmpe-660	7	2	i	i	PRON
ajmpe-660	7	3	c	c	VERB
ajmpe-660	7	4	a	a	DET
ajmpe-660	7	5	l	l	NOUN
ajmpe-660	7	6	a	a	X
ajmpe-660	7	7	n	n	NOUN
ajmpe-660	8	1	d	d	NOUN
ajmpe-660	8	2	p	p	NOUN
ajmpe-660	8	3	h	h	NOUN
ajmpe-660	8	4	y	y	NOUN
ajmpe-660	8	5	s	s	VERB
ajmpe-660	9	1	i	i	INTJ
ajmpe-660	9	2	c	c	VERB
ajmpe-660	9	3	a	a	DET
ajmpe-660	9	4	l	l	NOUN
ajmpe-660	9	5	e	e	NOUN
ajmpe-660	9	6	d	d	X
ajmpe-660	9	7	u	u	X
ajmpe-660	9	8	c	c	PROPN
ajmpe-660	10	1	a	a	DET
ajmpe-660	10	2	t	t	NOUN
ajmpe-660	11	1	i	i	PRON
ajmpe-660	11	2	o	o	VERB
ajmpe-660	11	3	n	n	CCONJ
ajmpe-660	11	4	|	|	ADV
ajmpe-660	11	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	11	6	harnessing	harness	VERB
ajmpe-660	11	7	curcumin	curcumin	NOUN
ajmpe-660	11	8	's	's	PART
ajmpe-660	11	9	therapeutic	therapeutic	ADJ
ajmpe-660	11	10	potential	potential	NOUN
ajmpe-660	11	11	in	in	ADP
ajmpe-660	11	12	cancer	cancer	NOUN
ajmpe-660	11	13	treatment	treatment	NOUN
ajmpe-660	11	14	"	"	PUNCT
ajmpe-660	11	15	1dr	1dr	NOUN
ajmpe-660	11	16	.	.	PUNCT
ajmpe-660	12	1	xin	xin	PROPN
ajmpe-660	12	2	li	li	PROPN
ajmpe-660	12	3	and	and	CCONJ
ajmpe-660	12	4	2dr	2dr	ADJ
ajmpe-660	12	5	.	.	PUNCT
ajmpe-660	13	1	wei	wei	PROPN
ajmpe-660	13	2	zhang	zhang	PROPN
ajmpe-660	13	3	1shaanxi	1shaanxi	NUM
ajmpe-660	13	4	university	university	NOUN
ajmpe-660	13	5	of	of	ADP
ajmpe-660	13	6	chinese	chinese	ADJ
ajmpe-660	13	7	medicine	medicine	NOUN
ajmpe-660	13	8	,	,	PUNCT
ajmpe-660	13	9	xianyang	xianyang	PROPN
ajmpe-660	13	10	,	,	PUNCT
ajmpe-660	13	11	shaanxi	shaanxi	PROPN
ajmpe-660	13	12	,	,	PUNCT
ajmpe-660	13	13	712000	712000	NUM
ajmpe-660	13	14	,	,	PUNCT
ajmpe-660	13	15	china	china	PROPN
ajmpe-660	13	16	2nanzheng	2nanzheng	NUM
ajmpe-660	13	17	district	district	NOUN
ajmpe-660	13	18	people	people	NOUN
ajmpe-660	13	19	's	's	PART
ajmpe-660	13	20	hospital	hospital	NOUN
ajmpe-660	13	21	,	,	PUNCT
ajmpe-660	13	22	hanzhong	hanzhong	PROPN
ajmpe-660	13	23	,	,	PUNCT
ajmpe-660	13	24	shaanxi	shaanxi	PROPN
ajmpe-660	13	25	,	,	PUNCT
ajmpe-660	13	26	723100	723100	NUM
ajmpe-660	13	27	,	,	PUNCT
ajmpe-660	13	28	china	china	PROPN
ajmpe-660	13	29	abstract	abstract	NOUN
ajmpe-660	13	30	:	:	PUNCT
ajmpe-660	13	31	curcumin	curcumin	NOUN
ajmpe-660	13	32	,	,	PUNCT
ajmpe-660	13	33	a	a	DET
ajmpe-660	13	34	bioactive	bioactive	NOUN
ajmpe-660	13	35	compound	compound	NOUN
ajmpe-660	13	36	derived	derive	VERB
ajmpe-660	13	37	from	from	ADP
ajmpe-660	13	38	various	various	ADJ
ajmpe-660	13	39	zingiberaceae	zingiberaceae	NOUN
ajmpe-660	13	40	plants	plant	NOUN
ajmpe-660	13	41	,	,	PUNCT
ajmpe-660	13	42	has	have	AUX
ajmpe-660	13	43	garnered	garner	VERB
ajmpe-660	13	44	increasing	increase	VERB
ajmpe-660	13	45	attention	attention	NOUN
ajmpe-660	13	46	for	for	ADP
ajmpe-660	13	47	its	its	PRON
ajmpe-660	13	48	potential	potential	NOUN
ajmpe-660	13	49	in	in	ADP
ajmpe-660	13	50	cancer	cancer	NOUN
ajmpe-660	13	51	therapy	therapy	NOUN
ajmpe-660	13	52	.	.	PUNCT
ajmpe-660	14	1	this	this	DET
ajmpe-660	14	2	review	review	NOUN
ajmpe-660	14	3	explores	explore	VERB
ajmpe-660	14	4	the	the	DET
ajmpe-660	14	5	multifaceted	multifaceted	ADJ
ajmpe-660	14	6	role	role	NOUN
ajmpe-660	14	7	of	of	ADP
ajmpe-660	14	8	curcumin	curcumin	NOUN
ajmpe-660	14	9	in	in	ADP
ajmpe-660	14	10	cancer	cancer	NOUN
ajmpe-660	14	11	treatment	treatment	NOUN
ajmpe-660	14	12	,	,	PUNCT
ajmpe-660	14	13	encompassing	encompass	VERB
ajmpe-660	14	14	its	its	PRON
ajmpe-660	14	15	anti	anti	ADJ
ajmpe-660	14	16	-	-	ADJ
ajmpe-660	14	17	tumor	tumor	ADJ
ajmpe-660	14	18	effects	effect	NOUN
ajmpe-660	14	19	,	,	PUNCT
ajmpe-660	14	20	impact	impact	NOUN
ajmpe-660	14	21	on	on	ADP
ajmpe-660	14	22	apoptosis	apoptosis	NOUN
ajmpe-660	14	23	induction	induction	NOUN
ajmpe-660	14	24	,	,	PUNCT
ajmpe-660	14	25	regulation	regulation	NOUN
ajmpe-660	14	26	of	of	ADP
ajmpe-660	14	27	signaling	signal	VERB
ajmpe-660	14	28	pathways	pathway	NOUN
ajmpe-660	14	29	,	,	PUNCT
ajmpe-660	14	30	anti	anti	ADJ
ajmpe-660	14	31	-	-	ADJ
ajmpe-660	14	32	angiogenic	angiogenic	ADJ
ajmpe-660	14	33	properties	property	NOUN
ajmpe-660	14	34	,	,	PUNCT
ajmpe-660	14	35	and	and	CCONJ
ajmpe-660	14	36	enhanced	enhance	VERB
ajmpe-660	14	37	chemosensitivity	chemosensitivity	NOUN
ajmpe-660	14	38	.	.	PUNCT
ajmpe-660	15	1	beyond	beyond	ADP
ajmpe-660	15	2	its	its	PRON
ajmpe-660	15	3	medicinal	medicinal	ADJ
ajmpe-660	15	4	applications	application	NOUN
ajmpe-660	15	5	,	,	PUNCT
ajmpe-660	15	6	curcuminoids	curcuminoid	NOUN
ajmpe-660	15	7	are	be	AUX
ajmpe-660	15	8	also	also	ADV
ajmpe-660	15	9	utilized	utilize	VERB
ajmpe-660	15	10	as	as	ADP
ajmpe-660	15	11	food	food	NOUN
ajmpe-660	15	12	pigments	pigment	NOUN
ajmpe-660	15	13	,	,	PUNCT
ajmpe-660	15	14	making	make	VERB
ajmpe-660	15	15	curcumin	curcumin	NOUN
ajmpe-660	15	16	a	a	DET
ajmpe-660	15	17	versatile	versatile	ADJ
ajmpe-660	15	18	and	and	CCONJ
ajmpe-660	15	19	cost	cost	NOUN
ajmpe-660	15	20	-	-	PUNCT
ajmpe-660	15	21	effective	effective	ADJ
ajmpe-660	15	22	option	option	NOUN
ajmpe-660	15	23	with	with	ADP
ajmpe-660	15	24	fewer	few	ADJ
ajmpe-660	15	25	adverse	adverse	ADJ
ajmpe-660	15	26	reactions	reaction	NOUN
ajmpe-660	15	27	compared	compare	VERB
ajmpe-660	15	28	to	to	ADP
ajmpe-660	15	29	conventional	conventional	ADJ
ajmpe-660	15	30	western	western	ADJ
ajmpe-660	15	31	medicine	medicine	NOUN
ajmpe-660	15	32	.	.	PUNCT
ajmpe-660	16	1	keywords	keyword	NOUN
ajmpe-660	16	2	:	:	PUNCT
ajmpe-660	16	3	curcumin	curcumin	NOUN
ajmpe-660	16	4	,	,	PUNCT
ajmpe-660	16	5	cancer	cancer	NOUN
ajmpe-660	16	6	therapy	therapy	NOUN
ajmpe-660	16	7	,	,	PUNCT
ajmpe-660	16	8	anti	anti	ADJ
ajmpe-660	16	9	-	-	ADJ
ajmpe-660	16	10	tumor	tumor	ADJ
ajmpe-660	16	11	effects	effect	NOUN
ajmpe-660	16	12	,	,	PUNCT
ajmpe-660	16	13	apoptosis	apoptosis	NOUN
ajmpe-660	16	14	,	,	PUNCT
ajmpe-660	16	15	signaling	signal	VERB
ajmpe-660	16	16	pathways	pathway	NOUN
ajmpe-660	16	17	,	,	PUNCT
ajmpe-660	16	18	angiogenesis	angiogenesis	NOUN
ajmpe-660	16	19	,	,	PUNCT
ajmpe-660	16	20	chemosensitivity	chemosensitivity	NOUN
ajmpe-660	16	21	,	,	PUNCT
ajmpe-660	16	22	traditional	traditional	ADJ
ajmpe-660	16	23	chinese	chinese	ADJ
ajmpe-660	16	24	medicine	medicine	NOUN
ajmpe-660	16	25	,	,	PUNCT
ajmpe-660	16	26	tumor	tumor	NOUN
ajmpe-660	16	27	microenvironment	microenvironment	NOUN
ajmpe-660	16	28	.	.	PUNCT
ajmpe-660	17	1	introduction	introduction	NOUN
ajmpe-660	17	2	curcumincuma	curcumincuma	PROPN
ajmpe-660	17	3	longa	longa	PROPN
ajmpe-660	17	4	is	be	AUX
ajmpe-660	17	5	a	a	DET
ajmpe-660	17	6	curcumincuma	curcumincuma	ADJ
ajmpe-660	17	7	genus	genus	NOUN
ajmpe-660	17	8	of	of	ADP
ajmpe-660	17	9	zingiberaceae	zingiberaceae	PROPN
ajmpe-660	17	10	.	.	PUNCT
ajmpe-660	18	1	it	it	PRON
ajmpe-660	18	2	grows	grow	VERB
ajmpe-660	18	3	widely	widely	ADV
ajmpe-660	18	4	in	in	ADP
ajmpe-660	18	5	southwest	southwest	NOUN
ajmpe-660	18	6	of	of	ADP
ajmpe-660	18	7	china[1	china[1	NOUN
ajmpe-660	18	8	]	]	X
ajmpe-660	18	9	.	.	PUNCT
ajmpe-660	19	1	the	the	DET
ajmpe-660	19	2	earliest	early	ADJ
ajmpe-660	19	3	recorded	record	VERB
ajmpe-660	19	4	medicine	medicine	NOUN
ajmpe-660	19	5	of	of	ADP
ajmpe-660	19	6	curcumincuma	curcumincuma	PROPN
ajmpe-660	19	7	longa	longa	PROPN
ajmpe-660	19	8	in	in	ADP
ajmpe-660	19	9	our	our	PRON
ajmpe-660	19	10	country	country	NOUN
ajmpe-660	19	11	's	's	PART
ajmpe-660	19	12	tang	tang	NOUN
ajmpe-660	19	13	bencao	bencao	NOUN
ajmpe-660	19	14	(	(	PUNCT
ajmpe-660	19	15	materia	materia	PROPN
ajmpe-660	19	16	medica	medica	PROPN
ajmpe-660	19	17	of	of	ADP
ajmpe-660	19	18	the	the	DET
ajmpe-660	19	19	tang	tang	PROPN
ajmpe-660	19	20	dynasty	dynasty	PROPN
ajmpe-660	19	21	)	)	PUNCT
ajmpe-660	19	22	was	be	AUX
ajmpe-660	19	23	warm	warm	ADJ
ajmpe-660	19	24	in	in	ADP
ajmpe-660	19	25	nature	nature	NOUN
ajmpe-660	19	26	,	,	PUNCT
ajmpe-660	19	27	bitter	bitter	ADJ
ajmpe-660	19	28	and	and	CCONJ
ajmpe-660	19	29	spicy	spicy	ADJ
ajmpe-660	19	30	in	in	ADP
ajmpe-660	19	31	taste	taste	NOUN
ajmpe-660	19	32	,	,	PUNCT
ajmpe-660	19	33	and	and	CCONJ
ajmpe-660	19	34	returned	return	VERB
ajmpe-660	19	35	to	to	ADP
ajmpe-660	19	36	the	the	DET
ajmpe-660	19	37	spleen	spleen	NOUN
ajmpe-660	19	38	and	and	CCONJ
ajmpe-660	19	39	liver	liver	NOUN
ajmpe-660	19	40	meridians	meridian	NOUN
ajmpe-660	19	41	.	.	PUNCT
ajmpe-660	20	1	it	it	PRON
ajmpe-660	20	2	was	be	AUX
ajmpe-660	20	3	said	say	VERB
ajmpe-660	20	4	that	that	SCONJ
ajmpe-660	20	5	"	"	PUNCT
ajmpe-660	20	6	the	the	DET
ajmpe-660	20	7	main	main	ADJ
ajmpe-660	20	8	heart	heart	NOUN
ajmpe-660	20	9	knot	knot	NOUN
ajmpe-660	20	10	accumulation	accumulation	NOUN
ajmpe-660	20	11	,	,	PUNCT
ajmpe-660	20	12	cystic	cystic	ADJ
ajmpe-660	20	13	disease	disease	NOUN
ajmpe-660	20	14	,	,	PUNCT
ajmpe-660	20	15	qi	qi	NOUN
ajmpe-660	20	16	breaking	break	VERB
ajmpe-660	20	17	blood	blood	NOUN
ajmpe-660	20	18	,	,	PUNCT
ajmpe-660	20	19	in	in	ADP
ajmpe-660	20	20	addition	addition	NOUN
ajmpe-660	20	21	to	to	ADP
ajmpe-660	20	22	wind	wind	NOUN
ajmpe-660	20	23	and	and	CCONJ
ajmpe-660	20	24	heat	heat	NOUN
ajmpe-660	20	25	,	,	PUNCT
ajmpe-660	20	26	eliminate	eliminate	VERB
ajmpe-660	20	27	carbunction	carbunction	NOUN
ajmpe-660	20	28	and	and	CCONJ
ajmpe-660	20	29	swelling	swell	VERB
ajmpe-660	20	30	"	"	PUNCT
ajmpe-660	20	31	[	[	X
ajmpe-660	20	32	2	2	NUM
ajmpe-660	20	33	]	]	PUNCT
ajmpe-660	20	34	.	.	PUNCT
ajmpe-660	21	1	curcumin	curcumin	NOUN
ajmpe-660	21	2	is	be	AUX
ajmpe-660	21	3	an	an	DET
ajmpe-660	21	4	active	active	ADJ
ajmpe-660	21	5	compound	compound	NOUN
ajmpe-660	21	6	extracted	extract	VERB
ajmpe-660	21	7	from	from	ADP
ajmpe-660	21	8	the	the	DET
ajmpe-660	21	9	dried	dry	VERB
ajmpe-660	21	10	rhizome	rhizome	NOUN
ajmpe-660	21	11	of	of	ADP
ajmpe-660	21	12	zingiberaceae	zingiberaceae	PROPN
ajmpe-660	21	13	plants	plant	NOUN
ajmpe-660	21	14	such	such	ADJ
ajmpe-660	21	15	as	as	ADP
ajmpe-660	21	16	curcumincuma	curcumincuma	PROPN
ajmpe-660	21	17	longa	longa	NOUN
ajmpe-660	21	18	,	,	PUNCT
ajmpe-660	21	19	zedoary	zedoary	PROPN
ajmpe-660	21	20	turmeric	turmeric	NOUN
ajmpe-660	21	21	,	,	PUNCT
ajmpe-660	21	22	and	and	CCONJ
ajmpe-660	21	23	curcumincuma	curcumincuma	PROPN
ajmpe-660	21	24	vulgare	vulgare	VERB
ajmpe-660	22	1	[	[	X
ajmpe-660	22	2	3	3	NUM
ajmpe-660	22	3	]	]	PUNCT
ajmpe-660	22	4	.	.	PUNCT
ajmpe-660	23	1	the	the	DET
ajmpe-660	23	2	molecular	molecular	ADJ
ajmpe-660	23	3	formula	formula	NOUN
ajmpe-660	23	4	of	of	ADP
ajmpe-660	23	5	curcumin	curcumin	NOUN
ajmpe-660	23	6	was	be	AUX
ajmpe-660	23	7	c21h20o6	c21h20o6	PROPN
ajmpe-660	23	8	and	and	CCONJ
ajmpe-660	23	9	the	the	DET
ajmpe-660	23	10	molecular	molecular	ADJ
ajmpe-660	23	11	weight	weight	NOUN
ajmpe-660	23	12	was	be	AUX
ajmpe-660	23	13	368.4	368.4	NUM
ajmpe-660	23	14	g	g	NOUN
ajmpe-660	23	15	/	/	SYM
ajmpe-660	23	16	mol	mol	NOUN
ajmpe-660	23	17	.	.	PUNCT
ajmpe-660	24	1	the	the	DET
ajmpe-660	24	2	2d	2d	PROPN
ajmpe-660	24	3	and	and	CCONJ
ajmpe-660	24	4	3d	3d	NUM
ajmpe-660	24	5	structures	structure	NOUN
ajmpe-660	24	6	of	of	ADP
ajmpe-660	24	7	curcumin	curcumin	NOUN
ajmpe-660	24	8	were	be	AUX
ajmpe-660	24	9	downloaded	download	VERB
ajmpe-660	24	10	from	from	ADP
ajmpe-660	24	11	pubchem	pubchem	NOUN
ajmpe-660	24	12	website	website	NOUN
ajmpe-660	24	13	.	.	PUNCT
ajmpe-660	25	1	see	see	VERB
ajmpe-660	25	2	figure	figure	NOUN
ajmpe-660	25	3	1	1	NUM
ajmpe-660	25	4	.	.	PUNCT
ajmpe-660	25	5	kuttan	kuttan	PROPN
ajmpe-660	25	6	r	r	NOUN
ajmpe-660	25	7	et	et	NOUN
ajmpe-660	25	8	al	al	PROPN
ajmpe-660	25	9	.	.	PUNCT
ajmpe-660	26	1	[	[	X
ajmpe-660	26	2	4	4	X
ajmpe-660	26	3	]	]	PUNCT
ajmpe-660	26	4	first	first	ADV
ajmpe-660	26	5	proposed	propose	VERB
ajmpe-660	26	6	that	that	SCONJ
ajmpe-660	26	7	curcumin	curcumin	NOUN
ajmpe-660	26	8	could	could	AUX
ajmpe-660	26	9	be	be	AUX
ajmpe-660	26	10	used	use	VERB
ajmpe-660	26	11	in	in	ADP
ajmpe-660	26	12	anti	anti	ADJ
ajmpe-660	26	13	-	-	ADJ
ajmpe-660	26	14	tumor	tumor	ADJ
ajmpe-660	26	15	therapy	therapy	NOUN
ajmpe-660	26	16	in	in	ADP
ajmpe-660	26	17	1985	1985	NUM
ajmpe-660	26	18	.	.	PUNCT
ajmpe-660	27	1	more	more	ADJ
ajmpe-660	27	2	and	and	CCONJ
ajmpe-660	27	3	more	more	ADJ
ajmpe-660	27	4	studies	study	NOUN
ajmpe-660	27	5	have	have	AUX
ajmpe-660	27	6	confirmed	confirm	VERB
ajmpe-660	27	7	that	that	SCONJ
ajmpe-660	27	8	curcumin	curcumin	NOUN
ajmpe-660	27	9	plays	play	VERB
ajmpe-660	27	10	an	an	DET
ajmpe-660	27	11	anti	anti	ADJ
ajmpe-660	27	12	-	-	ADJ
ajmpe-660	27	13	tumor	tumor	ADJ
ajmpe-660	27	14	role	role	NOUN
ajmpe-660	27	15	by	by	ADP
ajmpe-660	27	16	inducing	induce	VERB
ajmpe-660	27	17	tumor	tumor	NOUN
ajmpe-660	27	18	cell	cell	NOUN
ajmpe-660	27	19	apoptosis	apoptosis	NOUN
ajmpe-660	27	20	,	,	PUNCT
ajmpe-660	27	21	regulating	regulate	VERB
ajmpe-660	27	22	tumor	tumor	NOUN
ajmpe-660	27	23	cell	cell	NOUN
ajmpe-660	27	24	growth	growth	NOUN
ajmpe-660	27	25	signal	signal	NOUN
ajmpe-660	27	26	transduction	transduction	NOUN
ajmpe-660	27	27	pathway	pathway	NOUN
ajmpe-660	27	28	,	,	PUNCT
ajmpe-660	27	29	inhibiting	inhibit	VERB
ajmpe-660	27	30	tumor	tumor	NOUN
ajmpe-660	27	31	angiogenesis	angiogenesis	NOUN
ajmpe-660	27	32	and	and	CCONJ
ajmpe-660	27	33	increasing	increase	VERB
ajmpe-660	27	34	the	the	DET
ajmpe-660	27	35	sensitivity	sensitivity	NOUN
ajmpe-660	27	36	of	of	ADP
ajmpe-660	27	37	tumor	tumor	NOUN
ajmpe-660	27	38	cells	cell	NOUN
ajmpe-660	27	39	to	to	PART
ajmpe-660	27	40	chemotherapy	chemotherapy	NOUN
ajmpe-660	27	41	[	[	X
ajmpe-660	27	42	5	5	NUM
ajmpe-660	27	43	-	-	SYM
ajmpe-660	27	44	7	7	NUM
ajmpe-660	27	45	]	]	PUNCT
ajmpe-660	27	46	.	.	PUNCT
ajmpe-660	28	1	in	in	ADP
ajmpe-660	28	2	addition	addition	NOUN
ajmpe-660	28	3	to	to	ADP
ajmpe-660	28	4	medicinal	medicinal	ADJ
ajmpe-660	28	5	use	use	NOUN
ajmpe-660	28	6	,	,	PUNCT
ajmpe-660	28	7	curcuminoids	curcuminoid	NOUN
ajmpe-660	28	8	are	be	AUX
ajmpe-660	28	9	also	also	ADV
ajmpe-660	28	10	used	use	VERB
ajmpe-660	28	11	as	as	ADP
ajmpe-660	28	12	food	food	NOUN
ajmpe-660	28	13	pigments	pigment	NOUN
ajmpe-660	28	14	and	and	CCONJ
ajmpe-660	28	15	are	be	AUX
ajmpe-660	28	16	one	one	NUM
ajmpe-660	28	17	of	of	ADP
ajmpe-660	28	18	the	the	DET
ajmpe-660	28	19	main	main	ADJ
ajmpe-660	28	20	ingredients	ingredient	NOUN
ajmpe-660	28	21	of	of	ADP
ajmpe-660	28	22	curcuminry	curcuminry	NOUN
ajmpe-660	28	23	[	[	X
ajmpe-660	28	24	8	8	NUM
ajmpe-660	28	25	]	]	PUNCT
ajmpe-660	28	26	.	.	PUNCT
ajmpe-660	29	1	compared	compare	VERB
ajmpe-660	29	2	with	with	ADP
ajmpe-660	29	3	western	western	ADJ
ajmpe-660	29	4	medicine	medicine	NOUN
ajmpe-660	29	5	,	,	PUNCT
ajmpe-660	29	6	it	it	PRON
ajmpe-660	29	7	is	be	AUX
ajmpe-660	29	8	cheap	cheap	ADJ
ajmpe-660	29	9	and	and	CCONJ
ajmpe-660	29	10	safe	safe	ADJ
ajmpe-660	29	11	,	,	PUNCT
ajmpe-660	29	12	and	and	CCONJ
ajmpe-660	29	13	has	have	VERB
ajmpe-660	29	14	fewer	few	ADJ
ajmpe-660	29	15	adverse	adverse	ADJ
ajmpe-660	29	16	reactions	reaction	NOUN
ajmpe-660	29	17	.	.	PUNCT
ajmpe-660	30	1	it	it	PRON
ajmpe-660	30	2	has	have	VERB
ajmpe-660	30	3	broad	broad	ADJ
ajmpe-660	30	4	prospects	prospect	NOUN
ajmpe-660	30	5	in	in	ADP
ajmpe-660	30	6	the	the	DET
ajmpe-660	30	7	treatment	treatment	NOUN
ajmpe-660	30	8	and	and	CCONJ
ajmpe-660	30	9	prevention	prevention	NOUN
ajmpe-660	30	10	of	of	ADP
ajmpe-660	30	11	tumor	tumor	NOUN
ajmpe-660	30	12	diseases	disease	NOUN
ajmpe-660	30	13	[	[	X
ajmpe-660	30	14	9	9	NUM
ajmpe-660	30	15	]	]	PUNCT
ajmpe-660	30	16	.	.	PUNCT
ajmpe-660	31	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-660	31	2	american	american	PROPN
ajmpe-660	31	3	journal	journal	PROPN
ajmpe-660	31	4	of	of	ADP
ajmpe-660	31	5	medical	medical	ADJ
ajmpe-660	31	6	and	and	CCONJ
ajmpe-660	31	7	physical	physical	ADJ
ajmpe-660	31	8	education	education	PROPN
ajmpe-660	31	9	vol.8	vol.8	PROPN
ajmpe-660	31	10	,	,	PUNCT
ajmpe-660	31	11	issue	issue	NOUN
ajmpe-660	31	12	5	5	NUM
ajmpe-660	31	13	;	;	PUNCT
ajmpe-660	31	14	september	september	PROPN
ajmpe-660	31	15	-	-	PUNCT
ajmpe-660	31	16	october	october	PROPN
ajmpe-660	31	17	2023	2023	NUM
ajmpe-660	31	18	;	;	PUNCT
ajmpe-660	31	19	issn	issn	PROPN
ajmpe-660	31	20	:	:	PUNCT
ajmpe-660	31	21	2994	2994	NUM
ajmpe-660	31	22	-	-	SYM
ajmpe-660	31	23	0524	0524	NUM
ajmpe-660	31	24	impact	impact	NOUN
ajmpe-660	31	25	factor	factor	NOUN
ajmpe-660	31	26	:	:	PUNCT
ajmpe-660	31	27	6.14	6.14	NUM
ajmpe-660	31	28	1252	1252	NUM
ajmpe-660	31	29	columbia	columbia	PROPN
ajmpe-660	31	30	rd	rd	PROPN
ajmpe-660	31	31	nw	nw	PROPN
ajmpe-660	31	32	,	,	PUNCT
ajmpe-660	31	33	washington	washington	PROPN
ajmpe-660	31	34	dc	dc	PROPN
ajmpe-660	31	35	,	,	PUNCT
ajmpe-660	31	36	united	united	PROPN
ajmpe-660	31	37	states	states	PROPN
ajmpe-660	31	38	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	31	39	;	;	PUNCT
ajmpe-660	31	40	mail	mail	NOUN
ajmpe-660	31	41	:	:	PUNCT
ajmpe-660	31	42	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	32	1	11	11	NUM
ajmpe-660	33	1	|	|	ADV
ajmpe-660	33	2	a	a	DET
ajmpe-660	33	3	m	m	NOUN
ajmpe-660	33	4	e	e	NOUN
ajmpe-660	33	5	r	r	NOUN
ajmpe-660	34	1	i	i	NOUN
ajmpe-660	34	2	c	c	VERB
ajmpe-660	34	3	a	a	DET
ajmpe-660	34	4	n	n	NOUN
ajmpe-660	35	1	j	j	NOUN
ajmpe-660	35	2	o	o	X
ajmpe-660	35	3	u	u	NOUN
ajmpe-660	35	4	r	r	NOUN
ajmpe-660	35	5	n	n	NOUN
ajmpe-660	35	6	a	a	DET
ajmpe-660	35	7	l	l	NOUN
ajmpe-660	35	8	o	o	X
ajmpe-660	36	1	f	f	X
ajmpe-660	36	2	m	m	NOUN
ajmpe-660	36	3	e	e	NOUN
ajmpe-660	37	1	d	d	NOUN
ajmpe-660	37	2	i	i	PRON
ajmpe-660	37	3	c	c	VERB
ajmpe-660	37	4	a	a	DET
ajmpe-660	37	5	l	l	NOUN
ajmpe-660	37	6	a	a	X
ajmpe-660	37	7	n	n	NOUN
ajmpe-660	38	1	d	d	NOUN
ajmpe-660	38	2	p	p	NOUN
ajmpe-660	38	3	h	h	NOUN
ajmpe-660	38	4	y	y	NOUN
ajmpe-660	38	5	s	s	VERB
ajmpe-660	39	1	i	i	INTJ
ajmpe-660	39	2	c	c	VERB
ajmpe-660	39	3	a	a	DET
ajmpe-660	39	4	l	l	NOUN
ajmpe-660	39	5	e	e	NOUN
ajmpe-660	39	6	d	d	X
ajmpe-660	39	7	u	u	X
ajmpe-660	39	8	c	c	PROPN
ajmpe-660	40	1	a	a	DET
ajmpe-660	40	2	t	t	NOUN
ajmpe-660	41	1	i	i	PRON
ajmpe-660	41	2	o	o	VERB
ajmpe-660	41	3	n	n	CCONJ
ajmpe-660	41	4	|	|	ADV
ajmpe-660	41	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-660	41	6	figure	figure	NOUN
ajmpe-660	41	7	1	1	NUM
ajmpe-660	41	8	:	:	PUNCT
ajmpe-660	41	9	2d	2d	NUM
ajmpe-660	41	10	structure	structure	NOUN
ajmpe-660	41	11	of	of	ADP
ajmpe-660	41	12	the	the	DET
ajmpe-660	41	13	curcumin	curcumin	NOUN
ajmpe-660	41	14	compound	compound	NOUN
ajmpe-660	41	15	and	and	CCONJ
ajmpe-660	41	16	3d	3d	NUM
ajmpe-660	41	17	structure	structure	NOUN
ajmpe-660	41	18	of	of	ADP
ajmpe-660	41	19	the	the	DET
ajmpe-660	41	20	curcumin	curcumin	NOUN
ajmpe-660	41	21	compound	compound	NOUN
ajmpe-660	41	22	according	accord	VERB
ajmpe-660	41	23	to	to	ADP
ajmpe-660	41	24	the	the	DET
ajmpe-660	41	25	latest	late	ADJ
ajmpe-660	41	26	global	global	ADJ
ajmpe-660	41	27	cancer	cancer	NOUN
ajmpe-660	41	28	data	datum	NOUN
ajmpe-660	41	29	in	in	ADP
ajmpe-660	41	30	2020	2020	NUM
ajmpe-660	41	31	released	release	VERB
ajmpe-660	41	32	by	by	ADP
ajmpe-660	41	33	the	the	DET
ajmpe-660	41	34	international	international	ADJ
ajmpe-660	41	35	agency	agency	NOUN
ajmpe-660	41	36	for	for	ADP
ajmpe-660	41	37	research	research	NOUN
ajmpe-660	41	38	on	on	ADP
ajmpe-660	41	39	cancer	cancer	NOUN
ajmpe-660	41	40	(	(	PUNCT
ajmpe-660	41	41	iarc	iarc	NOUN
ajmpe-660	41	42	)	)	PUNCT
ajmpe-660	41	43	of	of	ADP
ajmpe-660	41	44	the	the	DET
ajmpe-660	41	45	world	world	PROPN
ajmpe-660	41	46	health	health	PROPN
ajmpe-660	41	47	organization	organization	NOUN
ajmpe-660	41	48	,	,	PUNCT
ajmpe-660	41	49	the	the	DET
ajmpe-660	41	50	number	number	NOUN
ajmpe-660	41	51	of	of	ADP
ajmpe-660	41	52	new	new	ADJ
ajmpe-660	41	53	cancer	cancer	NOUN
ajmpe-660	41	54	cases	case	NOUN
ajmpe-660	41	55	and	and	CCONJ
ajmpe-660	41	56	cancer	cancer	NOUN
ajmpe-660	41	57	deaths	death	NOUN
ajmpe-660	41	58	in	in	ADP
ajmpe-660	41	59	china	china	PROPN
ajmpe-660	41	60	ranks	rank	VERB
ajmpe-660	41	61	first	first	ADV
ajmpe-660	41	62	in	in	ADP
ajmpe-660	41	63	the	the	DET
ajmpe-660	41	64	world	world	NOUN
ajmpe-660	42	1	[	[	X
ajmpe-660	42	2	10	10	NUM
ajmpe-660	42	3	]	]	PUNCT
ajmpe-660	42	4	.	.	PUNCT
ajmpe-660	43	1	tumor	tumor	NOUN
ajmpe-660	43	2	refers	refer	VERB
ajmpe-660	43	3	to	to	ADP
ajmpe-660	43	4	the	the	DET
ajmpe-660	43	5	uncontrolled	uncontrolled	ADJ
ajmpe-660	43	6	growth	growth	NOUN
ajmpe-660	43	7	or	or	CCONJ
ajmpe-660	43	8	even	even	ADV
ajmpe-660	43	9	infinite	infinite	VERB
ajmpe-660	43	10	abnormal	abnormal	ADJ
ajmpe-660	43	11	proliferation	proliferation	NOUN
ajmpe-660	43	12	of	of	ADP
ajmpe-660	43	13	local	local	ADJ
ajmpe-660	43	14	tissues	tissue	NOUN
ajmpe-660	43	15	in	in	ADP
ajmpe-660	43	16	the	the	DET
ajmpe-660	43	17	body	body	NOUN
ajmpe-660	43	18	under	under	ADP
ajmpe-660	43	19	different	different	ADJ
ajmpe-660	43	20	carcinogenic	carcinogenic	ADJ
ajmpe-660	43	21	conditions	condition	NOUN
ajmpe-660	43	22	,	,	PUNCT
ajmpe-660	43	23	which	which	PRON
ajmpe-660	43	24	is	be	AUX
ajmpe-660	43	25	the	the	DET
ajmpe-660	43	26	local	local	ADJ
ajmpe-660	43	27	manifestation	manifestation	NOUN
ajmpe-660	43	28	of	of	ADP
ajmpe-660	43	29	systemic	systemic	ADJ
ajmpe-660	43	30	diseases	disease	NOUN
ajmpe-660	43	31	.	.	PUNCT
ajmpe-660	44	1	traditional	traditional	ADJ
ajmpe-660	44	2	chinese	chinese	ADJ
ajmpe-660	44	3	medicine	medicine	NOUN
ajmpe-660	44	4	(	(	PUNCT
ajmpe-660	44	5	tcm	tcm	PROPN
ajmpe-660	44	6	)	)	PUNCT
ajmpe-660	44	7	is	be	AUX
ajmpe-660	44	8	one	one	NUM
ajmpe-660	44	9	of	of	ADP
ajmpe-660	44	10	the	the	DET
ajmpe-660	44	11	important	important	ADJ
ajmpe-660	44	12	means	mean	NOUN
ajmpe-660	44	13	of	of	ADP
ajmpe-660	44	14	tumor	tumor	NOUN
ajmpe-660	44	15	treatment	treatment	NOUN
ajmpe-660	44	16	in	in	ADP
ajmpe-660	44	17	china	china	PROPN
ajmpe-660	44	18	.	.	PUNCT
ajmpe-660	45	1	its	its	PRON
ajmpe-660	45	2	main	main	ADJ
ajmpe-660	45	3	advantage	advantage	NOUN
ajmpe-660	45	4	lies	lie	VERB
ajmpe-660	45	5	in	in	ADP
ajmpe-660	45	6	improving	improve	VERB
ajmpe-660	45	7	the	the	DET
ajmpe-660	45	8	internal	internal	ADJ
ajmpe-660	45	9	environment	environment	NOUN
ajmpe-660	45	10	of	of	ADP
ajmpe-660	45	11	the	the	DET
ajmpe-660	45	12	body	body	NOUN
ajmpe-660	45	13	,	,	PUNCT
ajmpe-660	45	14	especially	especially	ADV
ajmpe-660	45	15	in	in	ADP
ajmpe-660	45	16	remodeling	remodel	VERB
ajmpe-660	45	17	the	the	DET
ajmpe-660	45	18	tumor	tumor	NOUN
ajmpe-660	45	19	-	-	PUNCT
ajmpe-660	45	20	related	relate	VERB
ajmpe-660	45	21	microenvironment	microenvironment	NOUN
ajmpe-660	45	22	[	[	X
ajmpe-660	45	23	11	11	NUM
ajmpe-660	45	24	]	]	PUNCT
ajmpe-660	45	25	.	.	PUNCT
ajmpe-660	46	1	traditional	traditional	ADJ
ajmpe-660	46	2	chinese	chinese	ADJ
ajmpe-660	46	3	medicine	medicine	NOUN
ajmpe-660	46	4	experts	expert	NOUN
ajmpe-660	46	5	put	put	VERB
ajmpe-660	46	6	forward	forward	ADV
ajmpe-660	46	7	that	that	SCONJ
ajmpe-660	46	8	"	"	PUNCT
ajmpe-660	46	9	when	when	SCONJ
ajmpe-660	46	10	the	the	DET
ajmpe-660	46	11	positive	positive	ADJ
ajmpe-660	46	12	qi	qi	PROPN
ajmpe-660	46	13	is	be	AUX
ajmpe-660	46	14	insufficient	insufficient	ADJ
ajmpe-660	46	15	,	,	PUNCT
ajmpe-660	46	16	the	the	DET
ajmpe-660	46	17	evil	evil	ADJ
ajmpe-660	46	18	qi	qi	PROPN
ajmpe-660	46	19	is	be	AUX
ajmpe-660	46	20	behind	behind	ADP
ajmpe-660	46	21	"	"	PUNCT
ajmpe-660	46	22	,	,	PUNCT
ajmpe-660	46	23	indicating	indicate	VERB
ajmpe-660	46	24	that	that	SCONJ
ajmpe-660	46	25	the	the	DET
ajmpe-660	46	26	basic	basic	ADJ
ajmpe-660	46	27	pathogenesis	pathogenesis	NOUN
ajmpe-660	46	28	of	of	ADP
ajmpe-660	46	29	malignant	malignant	ADJ
ajmpe-660	46	30	tumors	tumor	NOUN
ajmpe-660	46	31	is	be	AUX
ajmpe-660	46	32	a	a	DET
ajmpe-660	46	33	continuous	continuous	ADJ
ajmpe-660	46	34	struggle	struggle	NOUN
ajmpe-660	46	35	between	between	ADP
ajmpe-660	46	36	"	"	PUNCT
ajmpe-660	46	37	positive	positive	ADJ
ajmpe-660	46	38	deficiency	deficiency	NOUN
ajmpe-660	46	39	"	"	PUNCT
ajmpe-660	46	40	and	and	CCONJ
ajmpe-660	46	41	"	"	PUNCT
ajmpe-660	46	42	evil	evil	ADJ
ajmpe-660	46	43	poison	poison	NOUN
ajmpe-660	46	44	"	"	PUNCT
ajmpe-660	47	1	[	[	X
ajmpe-660	47	2	12	12	NUM
ajmpe-660	47	3	]	]	PUNCT
ajmpe-660	47	4	.	.	PUNCT
ajmpe-660	48	1	tcm	tcm	PROPN
ajmpe-660	48	2	improves	improve	VERB
ajmpe-660	48	3	the	the	DET
ajmpe-660	48	4	body	body	NOUN
ajmpe-660	48	5	's	's	PART
ajmpe-660	48	6	immune	immune	ADJ
ajmpe-660	48	7	function	function	NOUN
ajmpe-660	48	8	and	and	CCONJ
ajmpe-660	48	9	inhibits	inhibit	VERB
ajmpe-660	48	10	the	the	DET
ajmpe-660	48	11	proliferation	proliferation	NOUN
ajmpe-660	48	12	and	and	CCONJ
ajmpe-660	48	13	migration	migration	NOUN
ajmpe-660	48	14	of	of	ADP
ajmpe-660	48	15	cancer	cancer	NOUN
ajmpe-660	48	16	cells	cell	NOUN
ajmpe-660	48	17	,	,	PUNCT
ajmpe-660	48	18	thereby	thereby	ADV
ajmpe-660	48	19	reducing	reduce	VERB
ajmpe-660	48	20	the	the	DET
ajmpe-660	48	21	growth	growth	NOUN
ajmpe-660	48	22	,	,	PUNCT
ajmpe-660	48	23	metastasis	metastasis	NOUN
ajmpe-660	48	24	and	and	CCONJ
ajmpe-660	48	25	recurcuminrence	recurcuminrence	NOUN
ajmpe-660	48	26	of	of	ADP
ajmpe-660	48	27	tumor	tumor	NOUN
ajmpe-660	48	28	cells	cell	NOUN
ajmpe-660	48	29	and	and	CCONJ
ajmpe-660	48	30	preventing	prevent	VERB
ajmpe-660	48	31	the	the	DET
ajmpe-660	48	32	occurcuminrence	occurcuminrence	NOUN
ajmpe-660	48	33	of	of	ADP
ajmpe-660	48	34	tumors	tumor	NOUN
ajmpe-660	48	35	[	[	X
ajmpe-660	48	36	13	13	NUM
ajmpe-660	48	37	]	]	PUNCT
ajmpe-660	48	38	.	.	PUNCT
ajmpe-660	49	1	through	through	ADP
ajmpe-660	49	2	a	a	DET
ajmpe-660	49	3	large	large	ADJ
ajmpe-660	49	4	number	number	NOUN
ajmpe-660	49	5	of	of	ADP
ajmpe-660	49	6	literature	literature	NOUN
ajmpe-660	49	7	studies	study	NOUN
ajmpe-660	49	8	,	,	PUNCT
ajmpe-660	49	9	it	it	PRON
ajmpe-660	49	10	has	have	AUX
ajmpe-660	49	11	been	be	AUX
ajmpe-660	49	12	confirmed	confirm	VERB
ajmpe-660	49	13	that	that	SCONJ
ajmpe-660	49	14	curcumin	curcumin	NOUN
ajmpe-660	49	15	is	be	AUX
ajmpe-660	49	16	particularly	particularly	ADV
ajmpe-660	49	17	effective	effective	ADJ
ajmpe-660	49	18	in	in	ADP
ajmpe-660	49	19	the	the	DET
ajmpe-660	49	20	treatment	treatment	NOUN
ajmpe-660	49	21	of	of	ADP
ajmpe-660	49	22	tumors	tumor	NOUN
ajmpe-660	49	23	,	,	PUNCT
ajmpe-660	49	24	which	which	PRON
ajmpe-660	49	25	is	be	AUX
ajmpe-660	49	26	summarized	summarize	VERB
ajmpe-660	49	27	as	as	ADP
ajmpe-660	49	28	follows	follow	VERB
ajmpe-660	49	29	.	.	PUNCT
ajmpe-660	50	1	1	1	X
ajmpe-660	50	2	.	.	X
ajmpe-660	50	3	curcumin	curcumin	NOUN
ajmpe-660	50	4	and	and	CCONJ
ajmpe-660	50	5	nasopharyngeal	nasopharyngeal	ADJ
ajmpe-660	50	6	carcinoma	carcinoma	NOUN
ajmpe-660	50	7	nasopharyngeal	nasopharyngeal	ADJ
ajmpe-660	50	8	carcinoma	carcinoma	NOUN
ajmpe-660	50	9	(	(	PUNCT
ajmpe-660	50	10	npc	npc	NOUN
ajmpe-660	50	11	)	)	PUNCT
ajmpe-660	50	12	is	be	AUX
ajmpe-660	50	13	a	a	DET
ajmpe-660	50	14	malignant	malignant	ADJ
ajmpe-660	50	15	epithelial	epithelial	ADJ
ajmpe-660	50	16	tumor	tumor	NOUN
ajmpe-660	50	17	originating	originate	VERB
ajmpe-660	50	18	from	from	ADP
ajmpe-660	50	19	the	the	DET
ajmpe-660	50	20	nasopharynx	nasopharynx	NOUN
ajmpe-660	50	21	,	,	PUNCT
ajmpe-660	50	22	most	most	ADJ
ajmpe-660	50	23	of	of	ADP
ajmpe-660	50	24	which	which	PRON
ajmpe-660	50	25	is	be	AUX
ajmpe-660	50	26	geographically	geographically	ADV
ajmpe-660	50	27	located	locate	VERB
ajmpe-660	50	28	in	in	ADP
ajmpe-660	50	29	southeast	southeast	PROPN
ajmpe-660	50	30	asia	asia	PROPN
ajmpe-660	50	31	,	,	PUNCT
ajmpe-660	50	32	while	while	SCONJ
ajmpe-660	50	33	china	china	PROPN
ajmpe-660	50	34	is	be	AUX
ajmpe-660	50	35	one	one	NUM
ajmpe-660	50	36	of	of	ADP
ajmpe-660	50	37	the	the	DET
ajmpe-660	50	38	countries	country	NOUN
ajmpe-660	50	39	with	with	ADP
ajmpe-660	50	40	the	the	DET
ajmpe-660	50	41	highest	high	ADJ
ajmpe-660	50	42	incidence	incidence	NOUN
ajmpe-660	50	43	and	and	CCONJ
ajmpe-660	50	44	mortality	mortality	NOUN
ajmpe-660	50	45	.	.	PUNCT
ajmpe-660	51	1	lin	lin	PROPN
ajmpe-660	51	2	et	et	PROPN
ajmpe-660	51	3	al	al	PROPN
ajmpe-660	51	4	.	.	PUNCT
ajmpe-660	52	1	[	[	X
ajmpe-660	52	2	14	14	NUM
ajmpe-660	52	3	]	]	PUNCT
ajmpe-660	52	4	confirmed	confirm	VERB
ajmpe-660	52	5	that	that	SCONJ
ajmpe-660	52	6	curcumin	curcumin	NOUN
ajmpe-660	52	7	can	can	AUX
ajmpe-660	52	8	significantly	significantly	ADV
ajmpe-660	52	9	inhibit	inhibit	VERB
ajmpe-660	52	10	the	the	DET
ajmpe-660	52	11	growth	growth	NOUN
ajmpe-660	52	12	of	of	ADP
ajmpe-660	52	13	human	human	ADJ
ajmpe-660	52	14	poorly	poorly	ADV
ajmpe-660	52	15	differentiated	differentiate	VERB
ajmpe-660	52	16	nasopharyngeal	nasopharyngeal	ADJ
ajmpe-660	52	17	carcinoma	carcinoma	NOUN
ajmpe-660	52	18	cell	cell	NOUN
ajmpe-660	52	19	line	line	NOUN
ajmpe-660	52	20	cne-1	cne-1	NOUN
ajmpe-660	52	21	,	,	PUNCT
ajmpe-660	52	22	and	and	CCONJ
ajmpe-660	52	23	s	s	VERB
ajmpe-660	52	24	phase	phase	NOUN
ajmpe-660	52	25	arrest	arrest	NOUN
ajmpe-660	52	26	prevents	prevent	VERB
ajmpe-660	52	27	cells	cell	NOUN
ajmpe-660	52	28	from	from	ADP
ajmpe-660	52	29	entering	enter	VERB
ajmpe-660	52	30	the	the	DET
ajmpe-660	52	31	next	next	ADJ
ajmpe-660	52	32	proliferation	proliferation	NOUN
ajmpe-660	52	33	cycle	cycle	NOUN
ajmpe-660	52	34	.	.	PUNCT
ajmpe-660	53	1	by	by	ADP
ajmpe-660	53	2	affecting	affect	VERB
ajmpe-660	53	3	the	the	DET
ajmpe-660	53	4	distribution	distribution	NOUN
ajmpe-660	53	5	of	of	ADP
ajmpe-660	53	6	cell	cell	NOUN
ajmpe-660	53	7	cycle	cycle	NOUN
ajmpe-660	53	8	,	,	PUNCT
ajmpe-660	53	9	it	it	PRON
ajmpe-660	53	10	affects	affect	VERB
ajmpe-660	53	11	the	the	DET
ajmpe-660	53	12	metabolism	metabolism	NOUN
ajmpe-660	53	13	and	and	CCONJ
ajmpe-660	53	14	function	function	NOUN
ajmpe-660	53	15	of	of	ADP
ajmpe-660	53	16	cells	cell	NOUN
ajmpe-660	53	17	,	,	PUNCT
ajmpe-660	53	18	so	so	SCONJ
ajmpe-660	53	19	as	as	SCONJ
ajmpe-660	53	20	to	to	PART
ajmpe-660	53	21	achieve	achieve	VERB
ajmpe-660	53	22	the	the	DET
ajmpe-660	53	23	purpose	purpose	NOUN
ajmpe-660	53	24	of	of	ADP
ajmpe-660	53	25	inhibiting	inhibit	VERB
ajmpe-660	53	26	cell	cell	NOUN
ajmpe-660	53	27	proliferation	proliferation	NOUN
ajmpe-660	53	28	.	.	PUNCT
ajmpe-660	54	1	wang	wang	PROPN
ajmpe-660	54	2	et	et	PROPN
ajmpe-660	54	3	al	al	PROPN
ajmpe-660	54	4	.	.	PUNCT
ajmpe-660	55	1	[	[	X
ajmpe-660	55	2	15	15	NUM
ajmpe-660	55	3	]	]	PUNCT
ajmpe-660	55	4	found	find	VERB
ajmpe-660	55	5	that	that	SCONJ
ajmpe-660	55	6	the	the	DET
ajmpe-660	55	7	high	high	ADJ
ajmpe-660	55	8	expression	expression	NOUN
ajmpe-660	55	9	of	of	ADP
ajmpe-660	55	10	pi3k	pi3k	PROPN
ajmpe-660	55	11	and	and	CCONJ
ajmpe-660	55	12	akt	akt	PROPN
ajmpe-660	55	13	phosphorylation	phosphorylation	NOUN
ajmpe-660	55	14	levels	level	NOUN
ajmpe-660	55	15	in	in	ADP
ajmpe-660	55	16	cne-2z	cne-2z	ADJ
ajmpe-660	55	17	cells	cell	NOUN
ajmpe-660	55	18	were	be	AUX
ajmpe-660	55	19	effectively	effectively	ADV
ajmpe-660	55	20	inhibited	inhibit	VERB
ajmpe-660	55	21	after	after	ADP
ajmpe-660	55	22	curcumin	curcumin	NOUN
ajmpe-660	55	23	intervention	intervention	PROPN
ajmpe-660	55	24	,	,	PUNCT
ajmpe-660	55	25	suggesting	suggest	VERB
ajmpe-660	55	26	that	that	SCONJ
ajmpe-660	55	27	inhibition	inhibition	NOUN
ajmpe-660	55	28	of	of	ADP
ajmpe-660	55	29	endogenous	endogenous	ADJ
ajmpe-660	55	30	pi3k	pi3k	PROPN
ajmpe-660	55	31	/	/	SYM
ajmpe-660	55	32	akt	akt	PROPN
ajmpe-660	55	33	pathway	pathway	NOUN
ajmpe-660	55	34	is	be	AUX
ajmpe-660	55	35	one	one	NUM
ajmpe-660	55	36	of	of	ADP
ajmpe-660	55	37	the	the	DET
ajmpe-660	55	38	mechanisms	mechanism	NOUN
ajmpe-660	55	39	of	of	ADP
ajmpe-660	55	40	curcumin	curcumin	NOUN
ajmpe-660	55	41	anti	anti	NOUN
ajmpe-660	55	42	-	-	ADJ
ajmpe-660	55	43	tumor	tumor	NOUN
ajmpe-660	55	44	.	.	PUNCT
ajmpe-660	56	1	tiam1	tiam1	PROPN
ajmpe-660	56	2	is	be	AUX
ajmpe-660	56	3	a	a	DET
ajmpe-660	56	4	gene	gene	NOUN
ajmpe-660	56	5	related	relate	VERB
ajmpe-660	56	6	to	to	ADP
ajmpe-660	56	7	tumor	tumor	NOUN
ajmpe-660	56	8	invasion	invasion	NOUN
ajmpe-660	56	9	and	and	CCONJ
ajmpe-660	56	10	metastasis	metastasis	NOUN
ajmpe-660	56	11	.	.	PUNCT
ajmpe-660	57	1	it	it	PRON
ajmpe-660	57	2	can	can	AUX
ajmpe-660	57	3	specifically	specifically	ADV
ajmpe-660	57	4	activate	activate	VERB
ajmpe-660	57	5	the	the	DET
ajmpe-660	57	6	gtpase	gtpase	NOUN
ajmpe-660	57	7	activity	activity	NOUN
ajmpe-660	57	8	of	of	ADP
ajmpe-660	57	9	rho	rho	ADJ
ajmpe-660	57	10	protein	protein	NOUN
ajmpe-660	57	11	family	family	NOUN
ajmpe-660	57	12	,	,	PUNCT
ajmpe-660	57	13	and	and	CCONJ
ajmpe-660	57	14	its	its	PRON
ajmpe-660	57	15	downstream	downstream	ADJ
ajmpe-660	57	16	effector	effector	NOUN
ajmpe-660	57	17	is	be	AUX
ajmpe-660	57	18	rac1	rac1	PROPN
ajmpe-660	57	19	,	,	PUNCT
ajmpe-660	57	20	an	an	DET
ajmpe-660	57	21	important	important	ADJ
ajmpe-660	57	22	member	member	NOUN
ajmpe-660	57	23	of	of	ADP
ajmpe-660	57	24	rho	rho	ADJ
ajmpe-660	57	25	protein	protein	NOUN
ajmpe-660	57	26	family	family	NOUN
ajmpe-660	57	27	.	.	PUNCT
ajmpe-660	58	1	"	"	PUNCT
ajmpe-660	58	2	cellular	cellular	ADJ
ajmpe-660	58	3	endocytosis	endocytosis	NOUN
ajmpe-660	58	4	and	and	CCONJ
ajmpe-660	58	5	membrane	membrane	NOUN
ajmpe-660	58	6	transport	transport	NOUN
ajmpe-660	58	7	,	,	PUNCT
ajmpe-660	58	8	cell	cell	NOUN
ajmpe-660	58	9	migration	migration	NOUN
ajmpe-660	58	10	,	,	PUNCT
ajmpe-660	58	11	adhesion	adhesion	NOUN
ajmpe-660	58	12	,	,	PUNCT
ajmpe-660	58	13	invasion	invasion	NOUN
ajmpe-660	58	14	,	,	PUNCT
ajmpe-660	58	15	apoptosis	apoptosis	NOUN
ajmpe-660	58	16	,	,	PUNCT
ajmpe-660	58	17	and	and	CCONJ
ajmpe-660	58	18	tumorigenesis	tumorigenesis	NOUN
ajmpe-660	58	19	.	.	PUNCT
ajmpe-660	58	20	"	"	PUNCT
ajmpe-660	59	1	chen	chen	PROPN
ajmpe-660	59	2	et	et	PROPN
ajmpe-660	59	3	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-660	59	4	american	american	PROPN
ajmpe-660	59	5	journal	journal	PROPN
ajmpe-660	59	6	of	of	ADP
ajmpe-660	59	7	medical	medical	ADJ
ajmpe-660	59	8	and	and	CCONJ
ajmpe-660	59	9	physical	physical	ADJ
ajmpe-660	59	10	education	education	PROPN
ajmpe-660	59	11	vol.8	vol.8	PROPN
ajmpe-660	59	12	,	,	PUNCT
ajmpe-660	59	13	issue	issue	NOUN
ajmpe-660	59	14	5	5	NUM
ajmpe-660	59	15	;	;	PUNCT
ajmpe-660	59	16	september	september	PROPN
ajmpe-660	59	17	-	-	PUNCT
ajmpe-660	59	18	october	october	PROPN
ajmpe-660	59	19	2023	2023	NUM
ajmpe-660	59	20	;	;	PUNCT
ajmpe-660	59	21	issn	issn	PROPN
ajmpe-660	59	22	:	:	PUNCT
ajmpe-660	59	23	2994	2994	NUM
ajmpe-660	59	24	-	-	SYM
ajmpe-660	59	25	0524	0524	NUM
ajmpe-660	59	26	impact	impact	NOUN
ajmpe-660	59	27	factor	factor	NOUN
ajmpe-660	59	28	:	:	PUNCT
ajmpe-660	59	29	6.14	6.14	NUM
ajmpe-660	59	30	1252	1252	NUM
ajmpe-660	59	31	columbia	columbia	PROPN
ajmpe-660	59	32	rd	rd	PROPN
ajmpe-660	59	33	nw	nw	PROPN
ajmpe-660	59	34	,	,	PUNCT
ajmpe-660	59	35	washington	washington	PROPN
ajmpe-660	59	36	dc	dc	PROPN
ajmpe-660	59	37	,	,	PUNCT
ajmpe-660	59	38	united	united	PROPN
ajmpe-660	59	39	states	states	PROPN
ajmpe-660	59	40	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	59	41	;	;	PUNCT
ajmpe-660	59	42	mail	mail	NOUN
ajmpe-660	59	43	:	:	PUNCT
ajmpe-660	59	44	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	60	1	12	12	NUM
ajmpe-660	61	1	|	|	ADV
ajmpe-660	61	2	a	a	DET
ajmpe-660	61	3	m	m	NOUN
ajmpe-660	61	4	e	e	NOUN
ajmpe-660	61	5	r	r	NOUN
ajmpe-660	62	1	i	i	NOUN
ajmpe-660	62	2	c	c	VERB
ajmpe-660	62	3	a	a	DET
ajmpe-660	62	4	n	n	NOUN
ajmpe-660	63	1	j	j	NOUN
ajmpe-660	63	2	o	o	X
ajmpe-660	63	3	u	u	NOUN
ajmpe-660	63	4	r	r	NOUN
ajmpe-660	63	5	n	n	NOUN
ajmpe-660	63	6	a	a	DET
ajmpe-660	63	7	l	l	NOUN
ajmpe-660	63	8	o	o	X
ajmpe-660	64	1	f	f	X
ajmpe-660	64	2	m	m	NOUN
ajmpe-660	64	3	e	e	NOUN
ajmpe-660	65	1	d	d	NOUN
ajmpe-660	65	2	i	i	PRON
ajmpe-660	65	3	c	c	VERB
ajmpe-660	65	4	a	a	DET
ajmpe-660	65	5	l	l	NOUN
ajmpe-660	65	6	a	a	X
ajmpe-660	65	7	n	n	NOUN
ajmpe-660	66	1	d	d	NOUN
ajmpe-660	66	2	p	p	NOUN
ajmpe-660	66	3	h	h	NOUN
ajmpe-660	66	4	y	y	NOUN
ajmpe-660	66	5	s	s	VERB
ajmpe-660	67	1	i	i	INTJ
ajmpe-660	67	2	c	c	VERB
ajmpe-660	67	3	a	a	DET
ajmpe-660	67	4	l	l	NOUN
ajmpe-660	67	5	e	e	NOUN
ajmpe-660	67	6	d	d	X
ajmpe-660	67	7	u	u	X
ajmpe-660	67	8	c	c	PROPN
ajmpe-660	68	1	a	a	DET
ajmpe-660	68	2	t	t	NOUN
ajmpe-660	69	1	i	i	PRON
ajmpe-660	69	2	o	o	VERB
ajmpe-660	70	1	n	n	CCONJ
ajmpe-660	70	2	|	|	ADV
ajmpe-660	70	3	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NOUN
ajmpe-660	70	4	al	al	PROPN
ajmpe-660	70	5	.	.	PUNCT
ajmpe-660	71	1	[	[	X
ajmpe-660	71	2	16	16	NUM
ajmpe-660	71	3	]	]	PUNCT
ajmpe-660	71	4	confirmed	confirm	VERB
ajmpe-660	71	5	that	that	SCONJ
ajmpe-660	71	6	tiam1	tiam1	PROPN
ajmpe-660	71	7	was	be	AUX
ajmpe-660	71	8	highly	highly	ADV
ajmpe-660	71	9	expressed	express	VERB
ajmpe-660	71	10	in	in	ADP
ajmpe-660	71	11	nasopharyngeal	nasopharyngeal	ADJ
ajmpe-660	71	12	carcinoma	carcinoma	NOUN
ajmpe-660	71	13	tissues	tissue	NOUN
ajmpe-660	71	14	by	by	ADP
ajmpe-660	71	15	immunohistochemistry	immunohistochemistry	NOUN
ajmpe-660	71	16	,	,	PUNCT
ajmpe-660	71	17	and	and	CCONJ
ajmpe-660	71	18	the	the	DET
ajmpe-660	71	19	expression	expression	NOUN
ajmpe-660	71	20	of	of	ADP
ajmpe-660	71	21	tiam1	tiam1	X
ajmpe-660	71	22	protein	protein	NOUN
ajmpe-660	71	23	was	be	AUX
ajmpe-660	71	24	determined	determine	VERB
ajmpe-660	71	25	by	by	ADP
ajmpe-660	71	26	treating	treat	VERB
ajmpe-660	71	27	nasopharyngeal	nasopharyngeal	ADJ
ajmpe-660	71	28	carcinoma	carcinoma	NOUN
ajmpe-660	71	29	cells	cell	NOUN
ajmpe-660	71	30	with	with	ADP
ajmpe-660	71	31	different	different	ADJ
ajmpe-660	71	32	concentrations	concentration	NOUN
ajmpe-660	71	33	of	of	ADP
ajmpe-660	71	34	curcumin	curcumin	NOUN
ajmpe-660	71	35	.	.	PUNCT
ajmpe-660	72	1	the	the	DET
ajmpe-660	72	2	results	result	NOUN
ajmpe-660	72	3	suggested	suggest	VERB
ajmpe-660	72	4	that	that	SCONJ
ajmpe-660	72	5	with	with	ADP
ajmpe-660	72	6	the	the	DET
ajmpe-660	72	7	increase	increase	NOUN
ajmpe-660	72	8	of	of	ADP
ajmpe-660	72	9	curcumin	curcumin	NOUN
ajmpe-660	72	10	concentration	concentration	NOUN
ajmpe-660	72	11	,	,	PUNCT
ajmpe-660	72	12	the	the	DET
ajmpe-660	72	13	expression	expression	NOUN
ajmpe-660	72	14	of	of	ADP
ajmpe-660	72	15	tiam1	tiam1	PROPN
ajmpe-660	72	16	in	in	ADP
ajmpe-660	72	17	nasopharyngeal	nasopharyngeal	ADJ
ajmpe-660	72	18	carcinoma	carcinoma	NOUN
ajmpe-660	72	19	5	5	NUM
ajmpe-660	72	20	-	-	PUNCT
ajmpe-660	72	21	8f	8f	NOUN
ajmpe-660	72	22	cells	cell	NOUN
ajmpe-660	72	23	decreased	decrease	VERB
ajmpe-660	72	24	.	.	PUNCT
ajmpe-660	73	1	the	the	DET
ajmpe-660	73	2	migration	migration	NOUN
ajmpe-660	73	3	and	and	CCONJ
ajmpe-660	73	4	invasion	invasion	NOUN
ajmpe-660	73	5	of	of	ADP
ajmpe-660	73	6	cells	cell	NOUN
ajmpe-660	73	7	were	be	AUX
ajmpe-660	73	8	inhibited	inhibit	VERB
ajmpe-660	73	9	,	,	PUNCT
ajmpe-660	73	10	further	far	ADV
ajmpe-660	73	11	indicating	indicate	VERB
ajmpe-660	73	12	that	that	SCONJ
ajmpe-660	73	13	curcumin	curcumin	NOUN
ajmpe-660	73	14	may	may	AUX
ajmpe-660	73	15	inhibit	inhibit	VERB
ajmpe-660	73	16	the	the	DET
ajmpe-660	73	17	invasion	invasion	NOUN
ajmpe-660	73	18	of	of	ADP
ajmpe-660	73	19	npc	npc	NOUN
ajmpe-660	73	20	by	by	ADP
ajmpe-660	73	21	inhibiting	inhibit	VERB
ajmpe-660	73	22	the	the	DET
ajmpe-660	73	23	expression	expression	NOUN
ajmpe-660	73	24	of	of	ADP
ajmpe-660	73	25	invasion	invasion	NOUN
ajmpe-660	73	26	related	relate	VERB
ajmpe-660	73	27	gene	gene	NOUN
ajmpe-660	73	28	tiam1	tiam1	NOUN
ajmpe-660	73	29	.	.	PUNCT
ajmpe-660	74	1	2	2	NUM
ajmpe-660	74	2	.	.	X
ajmpe-660	74	3	curcumin	curcumin	NOUN
ajmpe-660	74	4	and	and	CCONJ
ajmpe-660	74	5	lung	lung	NOUN
ajmpe-660	74	6	cancer	cancer	NOUN
ajmpe-660	74	7	lung	lung	NOUN
ajmpe-660	74	8	cancer	cancer	NOUN
ajmpe-660	74	9	is	be	AUX
ajmpe-660	74	10	the	the	DET
ajmpe-660	74	11	second	second	ADJ
ajmpe-660	74	12	most	most	ADV
ajmpe-660	74	13	common	common	ADJ
ajmpe-660	74	14	cancer	cancer	NOUN
ajmpe-660	74	15	in	in	ADP
ajmpe-660	74	16	the	the	DET
ajmpe-660	74	17	world	world	NOUN
ajmpe-660	74	18	with	with	ADP
ajmpe-660	74	19	a	a	DET
ajmpe-660	74	20	high	high	ADJ
ajmpe-660	74	21	mortality	mortality	NOUN
ajmpe-660	74	22	rate	rate	NOUN
ajmpe-660	74	23	.	.	PUNCT
ajmpe-660	75	1	the	the	DET
ajmpe-660	75	2	incidence	incidence	NOUN
ajmpe-660	75	3	of	of	ADP
ajmpe-660	75	4	lung	lung	NOUN
ajmpe-660	75	5	cancer	cancer	NOUN
ajmpe-660	75	6	is	be	AUX
ajmpe-660	75	7	closely	closely	ADV
ajmpe-660	75	8	related	relate	VERB
ajmpe-660	75	9	to	to	ADP
ajmpe-660	75	10	the	the	DET
ajmpe-660	75	11	maturity	maturity	NOUN
ajmpe-660	75	12	of	of	ADP
ajmpe-660	75	13	the	the	DET
ajmpe-660	75	14	tobacco	tobacco	NOUN
ajmpe-660	75	15	epidemic	epidemic	NOUN
ajmpe-660	75	16	[	[	X
ajmpe-660	75	17	10	10	NUM
ajmpe-660	75	18	]	]	PUNCT
ajmpe-660	75	19	.	.	PUNCT
ajmpe-660	76	1	jin	jin	PROPN
ajmpe-660	76	2	et	et	PROPN
ajmpe-660	76	3	al	al	PROPN
ajmpe-660	76	4	.	.	PUNCT
ajmpe-660	77	1	[	[	X
ajmpe-660	77	2	17	17	NUM
ajmpe-660	77	3	]	]	PUNCT
ajmpe-660	77	4	found	find	VERB
ajmpe-660	77	5	that	that	SCONJ
ajmpe-660	77	6	curcumin	curcumin	NOUN
ajmpe-660	77	7	treatment	treatment	NOUN
ajmpe-660	77	8	of	of	ADP
ajmpe-660	77	9	human	human	ADJ
ajmpe-660	77	10	lung	lung	NOUN
ajmpe-660	77	11	adenocarcinoma	adenocarcinoma	NOUN
ajmpe-660	77	12	cell	cell	NOUN
ajmpe-660	77	13	line	line	NOUN
ajmpe-660	77	14	a549	a549	PROPN
ajmpe-660	77	15	could	could	AUX
ajmpe-660	77	16	inhibit	inhibit	VERB
ajmpe-660	77	17	cell	cell	NOUN
ajmpe-660	77	18	proliferation	proliferation	NOUN
ajmpe-660	77	19	,	,	PUNCT
ajmpe-660	77	20	induce	induce	VERB
ajmpe-660	77	21	cell	cell	NOUN
ajmpe-660	77	22	apoptosis	apoptosis	NOUN
ajmpe-660	77	23	and	and	CCONJ
ajmpe-660	77	24	increase	increase	VERB
ajmpe-660	77	25	caspase-3	caspase-3	NUM
ajmpe-660	77	26	activity	activity	NOUN
ajmpe-660	77	27	.	.	PUNCT
ajmpe-660	78	1	further	furth	ADJ
ajmpe-660	78	2	studies	study	NOUN
ajmpe-660	78	3	showed	show	VERB
ajmpe-660	78	4	that	that	SCONJ
ajmpe-660	78	5	curcumin	curcumin	NOUN
ajmpe-660	78	6	inhibited	inhibit	VERB
ajmpe-660	78	7	the	the	DET
ajmpe-660	78	8	proliferation	proliferation	NOUN
ajmpe-660	78	9	and	and	CCONJ
ajmpe-660	78	10	induced	induced	ADJ
ajmpe-660	78	11	apoptosis	apoptosis	NOUN
ajmpe-660	78	12	of	of	ADP
ajmpe-660	78	13	human	human	ADJ
ajmpe-660	78	14	non	non	ADJ
ajmpe-660	78	15	-	-	ADJ
ajmpe-660	78	16	small	small	ADJ
ajmpe-660	78	17	cell	cell	NOUN
ajmpe-660	78	18	lung	lung	NOUN
ajmpe-660	78	19	cancer	cancer	NOUN
ajmpe-660	78	20	cells	cell	NOUN
ajmpe-660	78	21	by	by	ADP
ajmpe-660	78	22	up	up	ADV
ajmpe-660	78	23	-	-	PUNCT
ajmpe-660	78	24	regulating	regulate	VERB
ajmpe-660	78	25	mir-1925p	mir-1925p	NOUN
ajmpe-660	78	26	and	and	CCONJ
ajmpe-660	78	27	inhibiting	inhibit	VERB
ajmpe-660	78	28	pi3k	pi3k	PROPN
ajmpe-660	78	29	/	/	SYM
ajmpe-660	78	30	akt	akt	PROPN
ajmpe-660	78	31	signaling	signal	VERB
ajmpe-660	78	32	pathway	pathway	NOUN
ajmpe-660	78	33	.	.	PUNCT
ajmpe-660	79	1	chen	chen	PROPN
ajmpe-660	79	2	et	et	PROPN
ajmpe-660	79	3	al	al	PROPN
ajmpe-660	79	4	.	.	PUNCT
ajmpe-660	80	1	[	[	X
ajmpe-660	80	2	18	18	NUM
ajmpe-660	80	3	]	]	PUNCT
ajmpe-660	80	4	found	find	VERB
ajmpe-660	80	5	that	that	SCONJ
ajmpe-660	80	6	after	after	ADP
ajmpe-660	80	7	the	the	DET
ajmpe-660	80	8	treatment	treatment	NOUN
ajmpe-660	80	9	of	of	ADP
ajmpe-660	80	10	a549	a549	PROPN
ajmpe-660	80	11	cells	cell	NOUN
ajmpe-660	80	12	with	with	ADP
ajmpe-660	80	13	curcumin	curcumin	NOUN
ajmpe-660	80	14	,	,	PUNCT
ajmpe-660	80	15	the	the	DET
ajmpe-660	80	16	inhibition	inhibition	NOUN
ajmpe-660	80	17	of	of	ADP
ajmpe-660	80	18	cell	cell	NOUN
ajmpe-660	80	19	viability	viability	NOUN
ajmpe-660	80	20	increased	increase	VERB
ajmpe-660	80	21	and	and	CCONJ
ajmpe-660	80	22	the	the	DET
ajmpe-660	80	23	proportion	proportion	NOUN
ajmpe-660	80	24	of	of	ADP
ajmpe-660	80	25	apoptotic	apoptotic	ADJ
ajmpe-660	80	26	cells	cell	NOUN
ajmpe-660	80	27	increased	increase	VERB
ajmpe-660	80	28	gradually	gradually	ADV
ajmpe-660	80	29	with	with	ADP
ajmpe-660	80	30	the	the	DET
ajmpe-660	80	31	increase	increase	NOUN
ajmpe-660	80	32	of	of	ADP
ajmpe-660	80	33	the	the	DET
ajmpe-660	80	34	concentration	concentration	NOUN
ajmpe-660	80	35	,	,	PUNCT
ajmpe-660	80	36	and	and	CCONJ
ajmpe-660	80	37	the	the	DET
ajmpe-660	80	38	inhibition	inhibition	NOUN
ajmpe-660	80	39	of	of	ADP
ajmpe-660	80	40	lung	lung	NOUN
ajmpe-660	80	41	cancer	cancer	NOUN
ajmpe-660	80	42	cells	cell	NOUN
ajmpe-660	80	43	was	be	AUX
ajmpe-660	80	44	achieved	achieve	VERB
ajmpe-660	80	45	by	by	ADP
ajmpe-660	80	46	reducing	reduce	VERB
ajmpe-660	80	47	the	the	DET
ajmpe-660	80	48	akt	akt	NOUN
ajmpe-660	80	49	signaling	signal	VERB
ajmpe-660	80	50	pathway	pathway	NOUN
ajmpe-660	80	51	in	in	ADP
ajmpe-660	80	52	lung	lung	NOUN
ajmpe-660	80	53	cancer	cancer	NOUN
ajmpe-660	80	54	cells	cell	NOUN
ajmpe-660	80	55	.	.	PUNCT
ajmpe-660	81	1	xu	xu	PROPN
ajmpe-660	81	2	et	et	PROPN
ajmpe-660	82	1	al	al	PROPN
ajmpe-660	82	2	.	.	PUNCT
ajmpe-660	83	1	[	[	X
ajmpe-660	83	2	19	19	NUM
ajmpe-660	83	3	]	]	PUNCT
ajmpe-660	83	4	found	find	VERB
ajmpe-660	83	5	that	that	SCONJ
ajmpe-660	83	6	neutrophil	neutrophil	ADJ
ajmpe-660	83	7	elastase	elastase	NOUN
ajmpe-660	83	8	plays	play	VERB
ajmpe-660	83	9	an	an	DET
ajmpe-660	83	10	important	important	ADJ
ajmpe-660	83	11	role	role	NOUN
ajmpe-660	83	12	in	in	ADP
ajmpe-660	83	13	regulating	regulate	VERB
ajmpe-660	83	14	lung	lung	NOUN
ajmpe-660	83	15	tumor	tumor	NOUN
ajmpe-660	83	16	proliferation	proliferation	NOUN
ajmpe-660	83	17	in	in	ADP
ajmpe-660	83	18	the	the	DET
ajmpe-660	83	19	inflammatory	inflammatory	ADJ
ajmpe-660	83	20	microenvironment	microenvironment	NOUN
ajmpe-660	83	21	of	of	ADP
ajmpe-660	83	22	a549	a549	PROPN
ajmpe-660	83	23	cells	cell	NOUN
ajmpe-660	83	24	.	.	PUNCT
ajmpe-660	84	1	curcumin	curcumin	NOUN
ajmpe-660	84	2	can	can	AUX
ajmpe-660	84	3	inhibit	inhibit	VERB
ajmpe-660	84	4	tumor	tumor	NOUN
ajmpe-660	84	5	proliferation	proliferation	NOUN
ajmpe-660	84	6	induced	induce	VERB
ajmpe-660	84	7	by	by	ADP
ajmpe-660	84	8	neutrophil	neutrophil	ADJ
ajmpe-660	84	9	elastase	elastase	NOUN
ajmpe-660	84	10	.	.	PUNCT
ajmpe-660	85	1	curcumin	curcumin	NOUN
ajmpe-660	85	2	can	can	AUX
ajmpe-660	85	3	also	also	ADV
ajmpe-660	85	4	inhibit	inhibit	VERB
ajmpe-660	85	5	the	the	DET
ajmpe-660	85	6	growth	growth	NOUN
ajmpe-660	85	7	of	of	ADP
ajmpe-660	85	8	cancer	cancer	NOUN
ajmpe-660	85	9	cells	cell	NOUN
ajmpe-660	85	10	by	by	ADP
ajmpe-660	85	11	up	up	ADV
ajmpe-660	85	12	-	-	PUNCT
ajmpe-660	85	13	regulating	regulate	VERB
ajmpe-660	85	14	the	the	DET
ajmpe-660	85	15	expression	expression	NOUN
ajmpe-660	85	16	levels	level	NOUN
ajmpe-660	85	17	of	of	ADP
ajmpe-660	85	18	p53	p53	NOUN
ajmpe-660	85	19	and	and	CCONJ
ajmpe-660	85	20	p21	p21	NOUN
ajmpe-660	85	21	genes	gene	NOUN
ajmpe-660	85	22	in	in	ADP
ajmpe-660	85	23	a549	a549	PROPN
ajmpe-660	85	24	cells	cell	NOUN
ajmpe-660	85	25	,	,	PUNCT
ajmpe-660	85	26	down	down	ADV
ajmpe-660	85	27	-	-	PUNCT
ajmpe-660	85	28	regulating	regulate	VERB
ajmpe-660	85	29	the	the	DET
ajmpe-660	85	30	expression	expression	NOUN
ajmpe-660	85	31	levels	level	NOUN
ajmpe-660	85	32	of	of	ADP
ajmpe-660	85	33	pc	pc	NOUN
ajmpe-660	85	34	-	-	PUNCT
ajmpe-660	85	35	na	na	NOUN
ajmpe-660	85	36	and	and	CCONJ
ajmpe-660	85	37	if4e	if4e	ADJ
ajmpe-660	85	38	genes	gene	NOUN
ajmpe-660	85	39	,	,	PUNCT
ajmpe-660	85	40	and	and	CCONJ
ajmpe-660	85	41	initiating	initiate	VERB
ajmpe-660	85	42	the	the	DET
ajmpe-660	85	43	p53	p53	NOUN
ajmpe-660	85	44	/	/	SYM
ajmpe-660	85	45	p21	p21	NOUN
ajmpe-660	85	46	/	/	SYM
ajmpe-660	85	47	pcna/	pcna/	NUM
ajmpe-660	85	48	if4e	if4e	PROPN
ajmpe-660	85	49	signaling	signal	VERB
ajmpe-660	85	50	pathway	pathway	NOUN
ajmpe-660	85	51	[	[	X
ajmpe-660	85	52	20	20	NUM
ajmpe-660	85	53	-	-	SYM
ajmpe-660	85	54	21	21	NUM
ajmpe-660	85	55	]	]	PUNCT
ajmpe-660	85	56	.	.	PUNCT
ajmpe-660	86	1	li	li	PROPN
ajmpe-660	86	2	et	et	PROPN
ajmpe-660	86	3	al	al	PROPN
ajmpe-660	86	4	.	.	PUNCT
ajmpe-660	87	1	[	[	X
ajmpe-660	87	2	22	22	NUM
ajmpe-660	87	3	]	]	PUNCT
ajmpe-660	87	4	found	find	VERB
ajmpe-660	87	5	that	that	SCONJ
ajmpe-660	87	6	when	when	SCONJ
ajmpe-660	87	7	a549	a549	PROPN
ajmpe-660	87	8	cells	cell	NOUN
ajmpe-660	87	9	were	be	AUX
ajmpe-660	87	10	treated	treat	VERB
ajmpe-660	87	11	with	with	ADP
ajmpe-660	87	12	different	different	ADJ
ajmpe-660	87	13	concentrations	concentration	NOUN
ajmpe-660	87	14	of	of	ADP
ajmpe-660	87	15	curcumin	curcumin	NOUN
ajmpe-660	87	16	for	for	ADP
ajmpe-660	87	17	24	24	NUM
ajmpe-660	87	18	h	h	NOUN
ajmpe-660	87	19	,	,	PUNCT
ajmpe-660	87	20	the	the	DET
ajmpe-660	87	21	expression	expression	NOUN
ajmpe-660	87	22	level	level	NOUN
ajmpe-660	87	23	of	of	ADP
ajmpe-660	87	24	mmp-9	mmp-9	NOUN
ajmpe-660	87	25	was	be	AUX
ajmpe-660	87	26	significantly	significantly	ADV
ajmpe-660	87	27	decreased	decrease	VERB
ajmpe-660	87	28	and	and	CCONJ
ajmpe-660	87	29	the	the	DET
ajmpe-660	87	30	level	level	NOUN
ajmpe-660	87	31	of	of	ADP
ajmpe-660	87	32	timp-1	timp-1	NUM
ajmpe-660	87	33	was	be	AUX
ajmpe-660	87	34	significantly	significantly	ADV
ajmpe-660	87	35	increased	increase	VERB
ajmpe-660	87	36	with	with	ADP
ajmpe-660	87	37	the	the	DET
ajmpe-660	87	38	increase	increase	NOUN
ajmpe-660	87	39	of	of	ADP
ajmpe-660	87	40	concentration	concentration	NOUN
ajmpe-660	87	41	.	.	PUNCT
ajmpe-660	88	1	further	further	ADJ
ajmpe-660	88	2	studies	study	NOUN
ajmpe-660	88	3	showed	show	VERB
ajmpe-660	88	4	that	that	SCONJ
ajmpe-660	88	5	curcumin	curcumin	NOUN
ajmpe-660	88	6	inhibited	inhibit	VERB
ajmpe-660	88	7	the	the	DET
ajmpe-660	88	8	expression	expression	NOUN
ajmpe-660	88	9	of	of	ADP
ajmpe-660	88	10	phosphorylated	phosphorylate	VERB
ajmpe-660	88	11	erk1/2	erk1/2	PROPN
ajmpe-660	88	12	(	(	PUNCT
ajmpe-660	88	13	p44/42	p44/42	PROPN
ajmpe-660	88	14	)	)	PUNCT
ajmpe-660	88	15	in	in	ADP
ajmpe-660	88	16	a	a	DET
ajmpe-660	88	17	concentration	concentration	NOUN
ajmpe-660	88	18	-	-	PUNCT
ajmpe-660	88	19	dependent	dependent	ADJ
ajmpe-660	88	20	manner	manner	NOUN
ajmpe-660	88	21	.	.	PUNCT
ajmpe-660	89	1	however	however	ADV
ajmpe-660	89	2	,	,	PUNCT
ajmpe-660	89	3	the	the	DET
ajmpe-660	89	4	expression	expression	NOUN
ajmpe-660	89	5	of	of	ADP
ajmpe-660	89	6	non	non	ADJ
ajmpe-660	89	7	-	-	ADJ
ajmpe-660	89	8	phosphorylated	phosphorylated	ADJ
ajmpe-660	89	9	erk1	erk1	NOUN
ajmpe-660	89	10	did	do	AUX
ajmpe-660	89	11	not	not	PART
ajmpe-660	89	12	change	change	VERB
ajmpe-660	89	13	significantly	significantly	ADV
ajmpe-660	89	14	,	,	PUNCT
ajmpe-660	89	15	indicating	indicate	VERB
ajmpe-660	89	16	that	that	SCONJ
ajmpe-660	89	17	curcumin	curcumin	NOUN
ajmpe-660	89	18	promoted	promote	VERB
ajmpe-660	89	19	the	the	DET
ajmpe-660	89	20	apoptosis	apoptosis	NOUN
ajmpe-660	89	21	of	of	ADP
ajmpe-660	89	22	a549	a549	PROPN
ajmpe-660	89	23	cells	cell	NOUN
ajmpe-660	89	24	by	by	ADP
ajmpe-660	89	25	inhibiting	inhibit	VERB
ajmpe-660	89	26	the	the	DET
ajmpe-660	89	27	phosphorylation	phosphorylation	NOUN
ajmpe-660	89	28	of	of	ADP
ajmpe-660	89	29	erk1/2	erk1/2	NUM
ajmpe-660	89	30	signaling	signal	VERB
ajmpe-660	89	31	pathway	pathway	NOUN
ajmpe-660	89	32	.	.	PUNCT
ajmpe-660	90	1	3	3	X
ajmpe-660	90	2	.	.	X
ajmpe-660	90	3	curcumin	curcumin	NOUN
ajmpe-660	90	4	and	and	CCONJ
ajmpe-660	90	5	gastric	gastric	ADJ
ajmpe-660	90	6	cancer	cancer	NOUN
ajmpe-660	90	7	gastric	gastric	ADJ
ajmpe-660	90	8	cancer	cancer	NOUN
ajmpe-660	90	9	is	be	AUX
ajmpe-660	90	10	a	a	DET
ajmpe-660	90	11	highly	highly	ADV
ajmpe-660	90	12	malignant	malignant	ADJ
ajmpe-660	90	13	tumor	tumor	NOUN
ajmpe-660	90	14	,	,	PUNCT
ajmpe-660	90	15	ranking	rank	VERB
ajmpe-660	90	16	fifth	fifth	ADJ
ajmpe-660	90	17	in	in	ADP
ajmpe-660	90	18	morbidity	morbidity	NOUN
ajmpe-660	90	19	and	and	CCONJ
ajmpe-660	90	20	fourth	fourth	ADJ
ajmpe-660	90	21	in	in	ADP
ajmpe-660	90	22	mortality	mortality	NOUN
ajmpe-660	90	23	in	in	ADP
ajmpe-660	90	24	the	the	DET
ajmpe-660	90	25	world	world	NOUN
ajmpe-660	90	26	[	[	X
ajmpe-660	90	27	10	10	NUM
ajmpe-660	90	28	]	]	PUNCT
ajmpe-660	90	29	.	.	PUNCT
ajmpe-660	91	1	early	early	ADJ
ajmpe-660	91	2	endoscopic	endoscopic	ADJ
ajmpe-660	91	3	radical	radical	ADJ
ajmpe-660	91	4	resection	resection	NOUN
ajmpe-660	91	5	can	can	AUX
ajmpe-660	91	6	curcumine	curcumine	VERB
ajmpe-660	91	7	more	more	ADJ
ajmpe-660	91	8	than	than	ADP
ajmpe-660	91	9	90	90	NUM
ajmpe-660	91	10	%	%	NOUN
ajmpe-660	91	11	of	of	ADP
ajmpe-660	91	12	gastric	gastric	ADJ
ajmpe-660	91	13	cancer	cancer	NOUN
ajmpe-660	91	14	,	,	PUNCT
ajmpe-660	91	15	but	but	CCONJ
ajmpe-660	91	16	chemotherapy	chemotherapy	NOUN
ajmpe-660	91	17	and	and	CCONJ
ajmpe-660	91	18	radiotherapy	radiotherapy	NOUN
ajmpe-660	91	19	are	be	AUX
ajmpe-660	91	20	not	not	PART
ajmpe-660	91	21	effective	effective	ADJ
ajmpe-660	91	22	for	for	ADP
ajmpe-660	91	23	advanced	advanced	ADJ
ajmpe-660	91	24	gastric	gastric	ADJ
ajmpe-660	91	25	cancer	cancer	NOUN
ajmpe-660	91	26	.	.	PUNCT
ajmpe-660	92	1	it	it	PRON
ajmpe-660	92	2	has	have	AUX
ajmpe-660	92	3	been	be	AUX
ajmpe-660	92	4	reported	report	VERB
ajmpe-660	92	5	that	that	SCONJ
ajmpe-660	92	6	curcumin	curcumin	NOUN
ajmpe-660	92	7	can	can	AUX
ajmpe-660	92	8	inhibit	inhibit	VERB
ajmpe-660	92	9	the	the	DET
ajmpe-660	92	10	proliferation	proliferation	NOUN
ajmpe-660	92	11	of	of	ADP
ajmpe-660	92	12	gastric	gastric	ADJ
ajmpe-660	92	13	cancer	cancer	NOUN
ajmpe-660	92	14	cells	cell	NOUN
ajmpe-660	92	15	by	by	ADP
ajmpe-660	92	16	inducing	induce	VERB
ajmpe-660	92	17	apoptosis	apoptosis	NOUN
ajmpe-660	92	18	.	.	PUNCT
ajmpe-660	93	1	in	in	ADP
ajmpe-660	93	2	vitro	vitro	X
ajmpe-660	93	3	,	,	PUNCT
ajmpe-660	93	4	curcumin	curcumin	NOUN
ajmpe-660	93	5	can	can	AUX
ajmpe-660	93	6	induce	induce	VERB
ajmpe-660	93	7	apoptosis	apoptosis	NOUN
ajmpe-660	93	8	of	of	ADP
ajmpe-660	93	9	gastric	gastric	ADJ
ajmpe-660	93	10	cancer	cancer	NOUN
ajmpe-660	93	11	cells	cell	NOUN
ajmpe-660	93	12	by	by	ADP
ajmpe-660	93	13	promoting	promote	VERB
ajmpe-660	93	14	the	the	DET
ajmpe-660	93	15	disintegration	disintegration	NOUN
ajmpe-660	93	16	of	of	ADP
ajmpe-660	93	17	mmp	mmp	PROPN
ajmpe-660	93	18	,	,	PUNCT
ajmpe-660	93	19	and	and	CCONJ
ajmpe-660	93	20	mmp	mmp	PROPN
ajmpe-660	93	21	plays	play	VERB
ajmpe-660	93	22	an	an	DET
ajmpe-660	93	23	important	important	ADJ
ajmpe-660	93	24	role	role	NOUN
ajmpe-660	93	25	in	in	ADP
ajmpe-660	93	26	initiating	initiate	VERB
ajmpe-660	93	27	the	the	DET
ajmpe-660	93	28	mitochondria	mitochondria	NOUN
ajmpe-660	93	29	-	-	PUNCT
ajmpe-660	93	30	dependent	dependent	ADJ
ajmpe-660	93	31	apoptosis	apoptosis	NOUN
ajmpe-660	93	32	pathway	pathway	NOUN
ajmpe-660	94	1	[	[	X
ajmpe-660	94	2	23	23	NUM
ajmpe-660	94	3	]	]	PUNCT
ajmpe-660	94	4	.	.	PUNCT
ajmpe-660	95	1	kruppel	kruppel	PROPN
ajmpe-660	95	2	-	-	PUNCT
ajmpe-660	95	3	like	like	ADJ
ajmpe-660	95	4	factor	factor	NOUN
ajmpe-660	95	5	4(klf4	4(klf4	NUM
ajmpe-660	95	6	)	)	PUNCT
ajmpe-660	95	7	is	be	AUX
ajmpe-660	95	8	a	a	DET
ajmpe-660	95	9	transcription	transcription	NOUN
ajmpe-660	95	10	factor	factor	NOUN
ajmpe-660	95	11	that	that	PRON
ajmpe-660	95	12	plays	play	VERB
ajmpe-660	95	13	an	an	DET
ajmpe-660	95	14	important	important	ADJ
ajmpe-660	95	15	role	role	NOUN
ajmpe-660	95	16	in	in	ADP
ajmpe-660	95	17	cell	cell	NOUN
ajmpe-660	95	18	development	development	NOUN
ajmpe-660	95	19	and	and	CCONJ
ajmpe-660	95	20	progression	progression	NOUN
ajmpe-660	95	21	.	.	PUNCT
ajmpe-660	96	1	curcumin	curcumin	PROPN
ajmpe-660	96	2	combined	combine	VERB
ajmpe-660	96	3	with	with	ADP
ajmpe-660	96	4	klf4	klf4	NOUN
ajmpe-660	96	5	could	could	AUX
ajmpe-660	96	6	block	block	VERB
ajmpe-660	96	7	the	the	DET
ajmpe-660	96	8	cell	cell	NOUN
ajmpe-660	96	9	cycle	cycle	NOUN
ajmpe-660	96	10	of	of	ADP
ajmpe-660	96	11	bgc-823	bgc-823	ADJ
ajmpe-660	96	12	cells	cell	NOUN
ajmpe-660	96	13	in	in	ADP
ajmpe-660	96	14	g1	g1	PROPN
ajmpe-660	96	15	phase	phase	NOUN
ajmpe-660	96	16	.	.	PUNCT
ajmpe-660	97	1	western	western	ADJ
ajmpe-660	97	2	blot	blot	NOUN
ajmpe-660	97	3	showed	show	VERB
ajmpe-660	97	4	that	that	SCONJ
ajmpe-660	97	5	the	the	DET
ajmpe-660	97	6	expression	expression	NOUN
ajmpe-660	97	7	levels	level	NOUN
ajmpe-660	97	8	of	of	ADP
ajmpe-660	97	9	p	p	NOUN
ajmpe-660	97	10	-	-	PUNCT
ajmpe-660	97	11	pi3k	pi3k	NOUN
ajmpe-660	97	12	and	and	CCONJ
ajmpe-660	97	13	cyclind1	cyclind1	NOUN
ajmpe-660	97	14	were	be	AUX
ajmpe-660	97	15	increased	increase	VERB
ajmpe-660	97	16	,	,	PUNCT
ajmpe-660	97	17	and	and	CCONJ
ajmpe-660	97	18	the	the	DET
ajmpe-660	97	19	expression	expression	NOUN
ajmpe-660	97	20	of	of	ADP
ajmpe-660	97	21	p	p	PROPN
ajmpe-660	97	22	-	-	PUNCT
ajmpe-660	97	23	erk	erk	PROPN
ajmpe-660	97	24	was	be	AUX
ajmpe-660	97	25	decreased	decrease	VERB
ajmpe-660	97	26	.	.	PUNCT
ajmpe-660	98	1	these	these	DET
ajmpe-660	98	2	results	result	NOUN
ajmpe-660	98	3	indicated	indicate	VERB
ajmpe-660	98	4	that	that	SCONJ
ajmpe-660	98	5	the	the	DET
ajmpe-660	98	6	combination	combination	NOUN
ajmpe-660	98	7	of	of	ADP
ajmpe-660	98	8	curcumin	curcumin	NOUN
ajmpe-660	98	9	and	and	CCONJ
ajmpe-660	98	10	klf4	klf4	NOUN
ajmpe-660	98	11	could	could	AUX
ajmpe-660	98	12	inhibit	inhibit	VERB
ajmpe-660	98	13	the	the	DET
ajmpe-660	98	14	proliferation	proliferation	NOUN
ajmpe-660	98	15	of	of	ADP
ajmpe-660	98	16	human	human	ADJ
ajmpe-660	98	17	bgc-823	bgc-823	ADJ
ajmpe-660	98	18	cells	cell	NOUN
ajmpe-660	98	19	by	by	ADP
ajmpe-660	98	20	regulating	regulate	VERB
ajmpe-660	98	21	pi3k	pi3k	PROPN
ajmpe-660	98	22	/	/	SYM
ajmpe-660	98	23	akt	akt	PROPN
ajmpe-660	98	24	and	and	CCONJ
ajmpe-660	98	25	erk	erk	PROPN
ajmpe-660	98	26	/	/	SYM
ajmpe-660	98	27	mapk	mapk	PROPN
ajmpe-660	98	28	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-660	98	29	american	american	PROPN
ajmpe-660	98	30	journal	journal	PROPN
ajmpe-660	98	31	of	of	ADP
ajmpe-660	98	32	medical	medical	ADJ
ajmpe-660	98	33	and	and	CCONJ
ajmpe-660	98	34	physical	physical	ADJ
ajmpe-660	98	35	education	education	PROPN
ajmpe-660	98	36	vol.8	vol.8	PROPN
ajmpe-660	98	37	,	,	PUNCT
ajmpe-660	98	38	issue	issue	NOUN
ajmpe-660	98	39	5	5	NUM
ajmpe-660	98	40	;	;	PUNCT
ajmpe-660	98	41	september	september	PROPN
ajmpe-660	98	42	-	-	PUNCT
ajmpe-660	98	43	october	october	PROPN
ajmpe-660	98	44	2023	2023	NUM
ajmpe-660	98	45	;	;	PUNCT
ajmpe-660	98	46	issn	issn	PROPN
ajmpe-660	98	47	:	:	PUNCT
ajmpe-660	98	48	2994	2994	NUM
ajmpe-660	98	49	-	-	SYM
ajmpe-660	98	50	0524	0524	NUM
ajmpe-660	98	51	impact	impact	NOUN
ajmpe-660	98	52	factor	factor	NOUN
ajmpe-660	98	53	:	:	PUNCT
ajmpe-660	98	54	6.14	6.14	NUM
ajmpe-660	98	55	1252	1252	NUM
ajmpe-660	98	56	columbia	columbia	PROPN
ajmpe-660	98	57	rd	rd	PROPN
ajmpe-660	98	58	nw	nw	PROPN
ajmpe-660	98	59	,	,	PUNCT
ajmpe-660	98	60	washington	washington	PROPN
ajmpe-660	98	61	dc	dc	PROPN
ajmpe-660	98	62	,	,	PUNCT
ajmpe-660	98	63	united	united	PROPN
ajmpe-660	98	64	states	states	PROPN
ajmpe-660	98	65	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	98	66	;	;	PUNCT
ajmpe-660	98	67	mail	mail	NOUN
ajmpe-660	98	68	:	:	PUNCT
ajmpe-660	98	69	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	99	1	13	13	NUM
ajmpe-660	100	1	|	|	ADV
ajmpe-660	100	2	a	a	DET
ajmpe-660	100	3	m	m	NOUN
ajmpe-660	100	4	e	e	NOUN
ajmpe-660	100	5	r	r	NOUN
ajmpe-660	101	1	i	i	NOUN
ajmpe-660	101	2	c	c	VERB
ajmpe-660	101	3	a	a	DET
ajmpe-660	101	4	n	n	NOUN
ajmpe-660	102	1	j	j	NOUN
ajmpe-660	102	2	o	o	X
ajmpe-660	102	3	u	u	NOUN
ajmpe-660	102	4	r	r	NOUN
ajmpe-660	102	5	n	n	NOUN
ajmpe-660	102	6	a	a	DET
ajmpe-660	102	7	l	l	NOUN
ajmpe-660	102	8	o	o	X
ajmpe-660	103	1	f	f	X
ajmpe-660	103	2	m	m	NOUN
ajmpe-660	103	3	e	e	NOUN
ajmpe-660	104	1	d	d	NOUN
ajmpe-660	104	2	i	i	PRON
ajmpe-660	104	3	c	c	VERB
ajmpe-660	104	4	a	a	DET
ajmpe-660	104	5	l	l	NOUN
ajmpe-660	104	6	a	a	X
ajmpe-660	104	7	n	n	NOUN
ajmpe-660	105	1	d	d	NOUN
ajmpe-660	105	2	p	p	NOUN
ajmpe-660	105	3	h	h	NOUN
ajmpe-660	105	4	y	y	NOUN
ajmpe-660	105	5	s	s	VERB
ajmpe-660	106	1	i	i	INTJ
ajmpe-660	106	2	c	c	VERB
ajmpe-660	106	3	a	a	DET
ajmpe-660	106	4	l	l	NOUN
ajmpe-660	106	5	e	e	NOUN
ajmpe-660	106	6	d	d	X
ajmpe-660	106	7	u	u	X
ajmpe-660	106	8	c	c	PROPN
ajmpe-660	107	1	a	a	DET
ajmpe-660	107	2	t	t	NOUN
ajmpe-660	108	1	i	i	PRON
ajmpe-660	108	2	o	o	VERB
ajmpe-660	108	3	n	n	CCONJ
ajmpe-660	108	4	|	|	ADV
ajmpe-660	108	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-660	108	6	pathways	pathway	NOUN
ajmpe-660	109	1	[	[	X
ajmpe-660	109	2	24	24	NUM
ajmpe-660	109	3	]	]	PUNCT
ajmpe-660	109	4	.	.	PUNCT
ajmpe-660	110	1	curcumin	curcumin	NOUN
ajmpe-660	110	2	can	can	AUX
ajmpe-660	110	3	inhibit	inhibit	VERB
ajmpe-660	110	4	the	the	DET
ajmpe-660	110	5	proliferation	proliferation	NOUN
ajmpe-660	110	6	and	and	CCONJ
ajmpe-660	110	7	induce	induce	VERB
ajmpe-660	110	8	apoptosis	apoptosis	NOUN
ajmpe-660	110	9	of	of	ADP
ajmpe-660	110	10	gastric	gastric	ADJ
ajmpe-660	110	11	cancer	cancer	NOUN
ajmpe-660	110	12	cells	cell	NOUN
ajmpe-660	110	13	by	by	ADP
ajmpe-660	110	14	inducing	induce	VERB
ajmpe-660	110	15	cell	cell	NOUN
ajmpe-660	110	16	cycle	cycle	NOUN
ajmpe-660	110	17	arrest	arrest	NOUN
ajmpe-660	110	18	in	in	ADP
ajmpe-660	110	19	g2/	g2/	NOUN
ajmpe-660	110	20	m	m	NOUN
ajmpe-660	110	21	phase	phase	NOUN
ajmpe-660	110	22	,	,	PUNCT
ajmpe-660	110	23	down	down	ADV
ajmpe-660	110	24	-	-	PUNCT
ajmpe-660	110	25	regulating	regulate	VERB
ajmpe-660	110	26	the	the	DET
ajmpe-660	110	27	expression	expression	NOUN
ajmpe-660	110	28	of	of	ADP
ajmpe-660	110	29	glycolytic	glycolytic	ADJ
ajmpe-660	110	30	enzymes	enzyme	NOUN
ajmpe-660	110	31	and	and	CCONJ
ajmpe-660	110	32	effectively	effectively	ADV
ajmpe-660	110	33	inhibiting	inhibit	VERB
ajmpe-660	110	34	the	the	DET
ajmpe-660	110	35	mir21	mir21	NOUN
ajmpe-660	110	36	/pten	/pten	NOUN
ajmpe-660	110	37	/	/	SYM
ajmpe-660	110	38	akt	akt	PROPN
ajmpe-660	110	39	molecular	molecular	ADJ
ajmpe-660	110	40	pathway	pathway	NOUN
ajmpe-660	111	1	[	[	X
ajmpe-660	111	2	25	25	NUM
ajmpe-660	111	3	]	]	PUNCT
ajmpe-660	111	4	.	.	PUNCT
ajmpe-660	112	1	curcumin	curcumin	NOUN
ajmpe-660	112	2	induces	induce	VERB
ajmpe-660	112	3	apoptosis	apoptosis	NOUN
ajmpe-660	112	4	of	of	ADP
ajmpe-660	112	5	gastric	gastric	ADJ
ajmpe-660	112	6	cancer	cancer	NOUN
ajmpe-660	112	7	cells	cell	NOUN
ajmpe-660	112	8	in	in	ADP
ajmpe-660	112	9	vitro	vitro	X
ajmpe-660	112	10	and	and	CCONJ
ajmpe-660	112	11	in	in	ADP
ajmpe-660	112	12	vivo	vivo	NOUN
ajmpe-660	112	13	in	in	ADP
ajmpe-660	112	14	conjunction	conjunction	NOUN
ajmpe-660	112	15	with	with	ADP
ajmpe-660	112	16	chemotherapy	chemotherapy	NOUN
ajmpe-660	112	17	drugs	drug	NOUN
ajmpe-660	112	18	such	such	ADJ
ajmpe-660	112	19	as	as	ADP
ajmpe-660	112	20	5	5	NUM
ajmpe-660	112	21	-	-	PUNCT
ajmpe-660	112	22	fluorouracil	fluorouracil	NOUN
ajmpe-660	112	23	and	and	CCONJ
ajmpe-660	112	24	oxaliplatin	oxaliplatin	NOUN
ajmpe-660	112	25	through	through	ADP
ajmpe-660	112	26	bcl	bcl	PROPN
ajmpe-660	112	27	/	/	SYM
ajmpe-660	112	28	baxcaspase8	baxcaspase8	PROPN
ajmpe-660	112	29	,	,	PUNCT
ajmpe-660	112	30	9caspase3	9caspase3	NUM
ajmpe-660	112	31	pathway	pathway	NOUN
ajmpe-660	113	1	[	[	X
ajmpe-660	113	2	26	26	NUM
ajmpe-660	113	3	]	]	PUNCT
ajmpe-660	113	4	.	.	PUNCT
ajmpe-660	114	1	yang	yang	PROPN
ajmpe-660	114	2	et	et	PROPN
ajmpe-660	114	3	al	al	PROPN
ajmpe-660	114	4	.	.	PUNCT
ajmpe-660	115	1	[	[	X
ajmpe-660	115	2	27	27	NUM
ajmpe-660	115	3	]	]	PUNCT
ajmpe-660	115	4	conducted	conduct	VERB
ajmpe-660	115	5	a	a	DET
ajmpe-660	115	6	clinical	clinical	ADJ
ajmpe-660	115	7	study	study	NOUN
ajmpe-660	115	8	on	on	ADP
ajmpe-660	115	9	56	56	NUM
ajmpe-660	115	10	patients	patient	NOUN
ajmpe-660	115	11	with	with	ADP
ajmpe-660	115	12	advanced	advanced	ADJ
ajmpe-660	115	13	gastric	gastric	ADJ
ajmpe-660	115	14	cancer	cancer	NOUN
ajmpe-660	115	15	,	,	PUNCT
ajmpe-660	115	16	and	and	CCONJ
ajmpe-660	115	17	the	the	DET
ajmpe-660	115	18	results	result	NOUN
ajmpe-660	115	19	showed	show	VERB
ajmpe-660	115	20	that	that	SCONJ
ajmpe-660	115	21	curcumin	curcumin	NOUN
ajmpe-660	115	22	adjuvant	adjuvant	ADJ
ajmpe-660	115	23	chemotherapy	chemotherapy	NOUN
ajmpe-660	115	24	drugs	drug	NOUN
ajmpe-660	115	25	could	could	AUX
ajmpe-660	115	26	improve	improve	VERB
ajmpe-660	115	27	the	the	DET
ajmpe-660	115	28	therapeutic	therapeutic	ADJ
ajmpe-660	115	29	effect	effect	NOUN
ajmpe-660	115	30	of	of	ADP
ajmpe-660	115	31	patients	patient	NOUN
ajmpe-660	115	32	with	with	ADP
ajmpe-660	115	33	advanced	advanced	ADJ
ajmpe-660	115	34	gastric	gastric	ADJ
ajmpe-660	115	35	cancer	cancer	NOUN
ajmpe-660	115	36	,	,	PUNCT
ajmpe-660	115	37	reduce	reduce	VERB
ajmpe-660	115	38	the	the	DET
ajmpe-660	115	39	adverse	adverse	ADJ
ajmpe-660	115	40	reactions	reaction	NOUN
ajmpe-660	115	41	of	of	ADP
ajmpe-660	115	42	chemotherapy	chemotherapy	NOUN
ajmpe-660	115	43	,	,	PUNCT
ajmpe-660	115	44	and	and	CCONJ
ajmpe-660	115	45	improve	improve	VERB
ajmpe-660	115	46	the	the	DET
ajmpe-660	115	47	tolerance	tolerance	NOUN
ajmpe-660	115	48	of	of	ADP
ajmpe-660	115	49	patients	patient	NOUN
ajmpe-660	115	50	compared	compare	VERB
ajmpe-660	115	51	with	with	ADP
ajmpe-660	115	52	the	the	DET
ajmpe-660	115	53	chemotherapy	chemotherapy	NOUN
ajmpe-660	115	54	group	group	NOUN
ajmpe-660	115	55	.	.	PUNCT
ajmpe-660	116	1	4	4	X
ajmpe-660	116	2	.	.	X
ajmpe-660	116	3	curcumin	curcumin	NOUN
ajmpe-660	116	4	and	and	CCONJ
ajmpe-660	116	5	liver	liver	NOUN
ajmpe-660	116	6	cancer	cancer	NOUN
ajmpe-660	116	7	liver	liver	NOUN
ajmpe-660	116	8	cancer	cancer	NOUN
ajmpe-660	116	9	ranks	rank	VERB
ajmpe-660	116	10	fifth	fifth	ADJ
ajmpe-660	116	11	in	in	ADP
ajmpe-660	116	12	the	the	DET
ajmpe-660	116	13	global	global	ADJ
ajmpe-660	116	14	incidence	incidence	NOUN
ajmpe-660	116	15	and	and	CCONJ
ajmpe-660	116	16	is	be	AUX
ajmpe-660	116	17	the	the	DET
ajmpe-660	116	18	third	third	ADJ
ajmpe-660	116	19	leading	lead	VERB
ajmpe-660	116	20	cause	cause	NOUN
ajmpe-660	116	21	of	of	ADP
ajmpe-660	116	22	cancer	cancer	NOUN
ajmpe-660	116	23	death	death	NOUN
ajmpe-660	116	24	.	.	PUNCT
ajmpe-660	117	1	in	in	ADP
ajmpe-660	117	2	china	china	PROPN
ajmpe-660	117	3	,	,	PUNCT
ajmpe-660	117	4	the	the	DET
ajmpe-660	117	5	infection	infection	NOUN
ajmpe-660	117	6	rate	rate	NOUN
ajmpe-660	117	7	of	of	ADP
ajmpe-660	117	8	hepatitis	hepatitis	PROPN
ajmpe-660	117	9	b	b	PROPN
ajmpe-660	117	10	virus	virus	NOUN
ajmpe-660	117	11	is	be	AUX
ajmpe-660	117	12	the	the	DET
ajmpe-660	117	13	most	most	ADV
ajmpe-660	117	14	important	important	ADJ
ajmpe-660	117	15	risk	risk	NOUN
ajmpe-660	117	16	factor	factor	NOUN
ajmpe-660	117	17	,	,	PUNCT
ajmpe-660	117	18	and	and	CCONJ
ajmpe-660	117	19	reducing	reduce	VERB
ajmpe-660	117	20	the	the	DET
ajmpe-660	117	21	exposure	exposure	NOUN
ajmpe-660	117	22	to	to	ADP
ajmpe-660	117	23	alcohol	alcohol	NOUN
ajmpe-660	117	24	and	and	CCONJ
ajmpe-660	117	25	aflatoxin	aflatoxin	NOUN
ajmpe-660	117	26	can	can	AUX
ajmpe-660	117	27	reduce	reduce	VERB
ajmpe-660	117	28	the	the	DET
ajmpe-660	117	29	incidence	incidence	NOUN
ajmpe-660	117	30	[	[	X
ajmpe-660	117	31	10	10	NUM
ajmpe-660	117	32	]	]	PUNCT
ajmpe-660	117	33	.	.	PUNCT
ajmpe-660	118	1	the	the	DET
ajmpe-660	118	2	expression	expression	NOUN
ajmpe-660	118	3	of	of	ADP
ajmpe-660	118	4	mirna-29	mirna-29	PROPN
ajmpe-660	118	5	and	and	CCONJ
ajmpe-660	118	6	mirna-30	mirna-30	PROPN
ajmpe-660	118	7	family	family	NOUN
ajmpe-660	118	8	members	member	NOUN
ajmpe-660	118	9	is	be	AUX
ajmpe-660	118	10	elevated	elevate	VERB
ajmpe-660	118	11	in	in	ADP
ajmpe-660	118	12	normal	normal	ADJ
ajmpe-660	118	13	liver	liver	NOUN
ajmpe-660	118	14	and	and	CCONJ
ajmpe-660	118	15	breast	breast	NOUN
ajmpe-660	118	16	cancer	cancer	NOUN
ajmpe-660	118	17	liver	liver	NOUN
ajmpe-660	118	18	metastasis	metastasis	NOUN
ajmpe-660	118	19	models	model	NOUN
ajmpe-660	118	20	,	,	PUNCT
ajmpe-660	118	21	and	and	CCONJ
ajmpe-660	118	22	multiple	multiple	ADJ
ajmpe-660	118	23	members	member	NOUN
ajmpe-660	118	24	of	of	ADP
ajmpe-660	118	25	each	each	DET
ajmpe-660	118	26	mirna	mirna	PROPN
ajmpe-660	118	27	family	family	PROPN
ajmpe-660	118	28	directly	directly	ADV
ajmpe-660	118	29	target	target	VERB
ajmpe-660	118	30	and	and	CCONJ
ajmpe-660	118	31	inhibit	inhibit	VERB
ajmpe-660	118	32	the	the	DET
ajmpe-660	118	33	insulin	insulin	NOUN
ajmpe-660	118	34	-	-	PUNCT
ajmpe-660	118	35	like	like	ADJ
ajmpe-660	118	36	growth	growth	NOUN
ajmpe-660	118	37	factor-1	factor-1	PROPN
ajmpe-660	118	38	(	(	PUNCT
ajmpe-660	118	39	igf-1	igf-1	NOUN
ajmpe-660	118	40	)	)	PUNCT
ajmpe-660	118	41	/igf-1	/igf-1	PUNCT
ajmpe-660	119	1	receptor	receptor	NOUN
ajmpe-660	119	2	(	(	PUNCT
ajmpe-660	119	3	igf-1r	igf-1r	PROPN
ajmpe-660	119	4	)	)	PUNCT
ajmpe-660	119	5	signaling	signal	VERB
ajmpe-660	119	6	axis	axis	NOUN
ajmpe-660	119	7	,	,	PUNCT
ajmpe-660	119	8	which	which	PRON
ajmpe-660	119	9	is	be	AUX
ajmpe-660	119	10	associated	associate	VERB
ajmpe-660	119	11	with	with	ADP
ajmpe-660	119	12	reduced	reduced	ADJ
ajmpe-660	119	13	cancer	cancer	NOUN
ajmpe-660	119	14	progression	progression	NOUN
ajmpe-660	119	15	and	and	CCONJ
ajmpe-660	119	16	metastasis	metastasis	PRON
ajmpe-660	119	17	[	[	X
ajmpe-660	119	18	28	28	NUM
ajmpe-660	119	19	]	]	PUNCT
ajmpe-660	119	20	.	.	PUNCT
ajmpe-660	120	1	chen	chen	PROPN
ajmpe-660	120	2	caiping	caiping	PROPN
ajmpe-660	120	3	et	et	PROPN
ajmpe-660	120	4	al	al	PROPN
ajmpe-660	120	5	.	.	PUNCT
ajmpe-660	121	1	[	[	X
ajmpe-660	121	2	29	29	NUM
ajmpe-660	121	3	]	]	PUNCT
ajmpe-660	121	4	found	find	VERB
ajmpe-660	121	5	that	that	SCONJ
ajmpe-660	121	6	the	the	DET
ajmpe-660	121	7	inhibition	inhibition	NOUN
ajmpe-660	121	8	rate	rate	NOUN
ajmpe-660	121	9	of	of	ADP
ajmpe-660	121	10	hepatocellular	hepatocellular	ADJ
ajmpe-660	121	11	carcinoma	carcinoma	NOUN
ajmpe-660	121	12	hepg2	hepg2	PUNCT
ajmpe-660	121	13	cells	cell	NOUN
ajmpe-660	121	14	was	be	AUX
ajmpe-660	121	15	the	the	DET
ajmpe-660	121	16	best	good	ADJ
ajmpe-660	121	17	after	after	ADP
ajmpe-660	121	18	72	72	NUM
ajmpe-660	121	19	hours	hour	NOUN
ajmpe-660	121	20	of	of	ADP
ajmpe-660	121	21	culture	culture	NOUN
ajmpe-660	121	22	,	,	PUNCT
ajmpe-660	121	23	and	and	CCONJ
ajmpe-660	121	24	curcumin	curcumin	NOUN
ajmpe-660	121	25	may	may	AUX
ajmpe-660	121	26	regulate	regulate	VERB
ajmpe-660	121	27	the	the	DET
ajmpe-660	121	28	biological	biological	ADJ
ajmpe-660	121	29	process	process	NOUN
ajmpe-660	121	30	of	of	ADP
ajmpe-660	121	31	hepatocellular	hepatocellular	ADJ
ajmpe-660	121	32	carcinoma	carcinoma	NOUN
ajmpe-660	121	33	cells	cell	NOUN
ajmpe-660	121	34	by	by	ADP
ajmpe-660	121	35	increasing	increase	VERB
ajmpe-660	121	36	the	the	DET
ajmpe-660	121	37	expression	expression	NOUN
ajmpe-660	121	38	of	of	ADP
ajmpe-660	121	39	mirna-29	mirna-29	PRON
ajmpe-660	121	40	and	and	CCONJ
ajmpe-660	121	41	reducing	reduce	VERB
ajmpe-660	121	42	the	the	DET
ajmpe-660	121	43	expression	expression	NOUN
ajmpe-660	121	44	of	of	ADP
ajmpe-660	121	45	vascular	vascular	ADJ
ajmpe-660	121	46	endothelial	endothelial	ADJ
ajmpe-660	121	47	growth	growth	NOUN
ajmpe-660	121	48	factor	factor	NOUN
ajmpe-660	121	49	(	(	PUNCT
ajmpe-660	121	50	vegf	vegf	PROPN
ajmpe-660	121	51	)	)	PUNCT
ajmpe-660	121	52	.	.	PUNCT
ajmpe-660	122	1	mirna-21	mirna-21	PROPN
ajmpe-660	122	2	-	-	SYM
ajmpe-660	122	3	5	5	NUM
ajmpe-660	122	4	promotes	promote	VERB
ajmpe-660	122	5	the	the	DET
ajmpe-660	122	6	growth	growth	NOUN
ajmpe-660	122	7	,	,	PUNCT
ajmpe-660	122	8	migration	migration	NOUN
ajmpe-660	122	9	and	and	CCONJ
ajmpe-660	122	10	invasion	invasion	NOUN
ajmpe-660	122	11	of	of	ADP
ajmpe-660	122	12	hepatocellular	hepatocellular	ADJ
ajmpe-660	122	13	carcinoma	carcinoma	NOUN
ajmpe-660	122	14	(	(	PUNCT
ajmpe-660	122	15	hcc	hcc	NOUN
ajmpe-660	122	16	)	)	PUNCT
ajmpe-660	122	17	cells	cell	NOUN
ajmpe-660	122	18	by	by	ADP
ajmpe-660	122	19	targeting	target	VERB
ajmpe-660	122	20	downstream	downstream	ADJ
ajmpe-660	122	21	target	target	NOUN
ajmpe-660	122	22	genes	gene	NOUN
ajmpe-660	122	23	,	,	PUNCT
ajmpe-660	122	24	such	such	ADJ
ajmpe-660	122	25	as	as	ADP
ajmpe-660	122	26	faslg	faslg	NOUN
ajmpe-660	122	27	,	,	PUNCT
ajmpe-660	122	28	suppressor	suppressor	NOUN
ajmpe-660	122	29	of	of	ADP
ajmpe-660	122	30	cytokine	cytokine	NOUN
ajmpe-660	122	31	signaling	signal	VERB
ajmpe-660	122	32	6(socs6	6(socs6	NUM
ajmpe-660	122	33	)	)	PUNCT
ajmpe-660	122	34	and	and	CCONJ
ajmpe-660	122	35	kruppel	kruppel	PROPN
ajmpe-660	122	36	-	-	PUNCT
ajmpe-660	122	37	like	like	ADJ
ajmpe-660	122	38	transcription	transcription	NOUN
ajmpe-660	122	39	factor	factor	NOUN
ajmpe-660	122	40	5(klf5	5(klf5	NUM
ajmpe-660	122	41	)	)	PUNCT
ajmpe-660	123	1	[	[	X
ajmpe-660	123	2	30	30	NUM
ajmpe-660	123	3	]	]	PUNCT
ajmpe-660	123	4	.	.	PUNCT
ajmpe-660	124	1	studies	study	NOUN
ajmpe-660	124	2	have	have	AUX
ajmpe-660	124	3	shown	show	VERB
ajmpe-660	124	4	that	that	SCONJ
ajmpe-660	124	5	curcumin	curcumin	NOUN
ajmpe-660	124	6	can	can	AUX
ajmpe-660	124	7	down	down	ADV
ajmpe-660	124	8	-	-	PUNCT
ajmpe-660	124	9	regulate	regulate	VERB
ajmpe-660	124	10	the	the	DET
ajmpe-660	124	11	expression	expression	NOUN
ajmpe-660	124	12	of	of	ADP
ajmpe-660	124	13	mirna-21	mirna-21	PROPN
ajmpe-660	124	14	,	,	PUNCT
ajmpe-660	124	15	up	up	ADV
ajmpe-660	124	16	-	-	PUNCT
ajmpe-660	124	17	regulate	regulate	VERB
ajmpe-660	124	18	the	the	DET
ajmpe-660	124	19	expression	expression	NOUN
ajmpe-660	124	20	of	of	ADP
ajmpe-660	124	21	timp3	timp3	PROPN
ajmpe-660	124	22	,	,	PUNCT
ajmpe-660	124	23	and	and	CCONJ
ajmpe-660	124	24	inhibit	inhibit	VERB
ajmpe-660	124	25	the	the	DET
ajmpe-660	124	26	transforming	transform	VERB
ajmpe-660	124	27	growth	growth	NOUN
ajmpe-660	124	28	factor	factor	NOUN
ajmpe-660	124	29	β1(tgf	β1(tgf	NOUN
ajmpe-660	124	30	-	-	PUNCT
ajmpe-660	124	31	β1)/recombinant	β1)/recombinant	NOUN
ajmpe-660	124	32	smad	smad	PROPN
ajmpe-660	124	33	family	family	NOUN
ajmpe-660	124	34	member	member	NOUN
ajmpe-660	124	35	3(smad3	3(smad3	NOUN
ajmpe-660	124	36	)	)	PUNCT
ajmpe-660	124	37	signaling	signal	VERB
ajmpe-660	124	38	pathway	pathway	NOUN
ajmpe-660	124	39	,	,	PUNCT
ajmpe-660	124	40	thereby	thereby	ADV
ajmpe-660	124	41	inhibiting	inhibit	VERB
ajmpe-660	124	42	the	the	DET
ajmpe-660	124	43	proliferation	proliferation	NOUN
ajmpe-660	124	44	of	of	ADP
ajmpe-660	124	45	hepg2	hepg2	NOUN
ajmpe-660	124	46	and	and	CCONJ
ajmpe-660	124	47	hcc	hcc	PROPN
ajmpe-660	124	48	lm3	lm3	PROPN
ajmpe-660	124	49	cells	cell	NOUN
ajmpe-660	124	50	[	[	X
ajmpe-660	124	51	31	31	NUM
ajmpe-660	124	52	]	]	PUNCT
ajmpe-660	124	53	.	.	PUNCT
ajmpe-660	125	1	in	in	ADP
ajmpe-660	125	2	addition	addition	NOUN
ajmpe-660	125	3	,	,	PUNCT
ajmpe-660	125	4	curcumin	curcumin	NOUN
ajmpe-660	125	5	can	can	AUX
ajmpe-660	125	6	also	also	ADV
ajmpe-660	125	7	reduce	reduce	VERB
ajmpe-660	125	8	the	the	DET
ajmpe-660	125	9	expression	expression	NOUN
ajmpe-660	125	10	of	of	ADP
ajmpe-660	125	11	mirna-21	mirna-21	PROPN
ajmpe-660	125	12	-	-	PUNCT
ajmpe-660	125	13	5p	5p	NOUN
ajmpe-660	125	14	and	and	CCONJ
ajmpe-660	125	15	increase	increase	VERB
ajmpe-660	125	16	sox6	sox6	NOUN
ajmpe-660	125	17	expression	expression	NOUN
ajmpe-660	125	18	to	to	PART
ajmpe-660	125	19	inhibit	inhibit	VERB
ajmpe-660	125	20	the	the	DET
ajmpe-660	125	21	proliferation	proliferation	NOUN
ajmpe-660	125	22	,	,	PUNCT
ajmpe-660	125	23	migration	migration	NOUN
ajmpe-660	125	24	and	and	CCONJ
ajmpe-660	125	25	invasion	invasion	NOUN
ajmpe-660	125	26	of	of	ADP
ajmpe-660	125	27	hcc	hcc	PROPN
ajmpe-660	125	28	cells	cell	NOUN
ajmpe-660	125	29	[	[	X
ajmpe-660	125	30	32	32	NUM
ajmpe-660	125	31	]	]	PUNCT
ajmpe-660	125	32	.	.	PUNCT
ajmpe-660	126	1	5	5	X
ajmpe-660	126	2	.	.	X
ajmpe-660	126	3	curcumin	curcumin	NOUN
ajmpe-660	126	4	and	and	CCONJ
ajmpe-660	126	5	colorectal	colorectal	ADJ
ajmpe-660	126	6	cancer	cancer	NOUN
ajmpe-660	126	7	the	the	DET
ajmpe-660	126	8	incidence	incidence	NOUN
ajmpe-660	126	9	of	of	ADP
ajmpe-660	126	10	colorectal	colorectal	ADJ
ajmpe-660	126	11	cancer	cancer	NOUN
ajmpe-660	126	12	is	be	AUX
ajmpe-660	126	13	the	the	DET
ajmpe-660	126	14	third	third	ADJ
ajmpe-660	126	15	in	in	ADP
ajmpe-660	126	16	the	the	DET
ajmpe-660	126	17	world	world	NOUN
ajmpe-660	126	18	,	,	PUNCT
ajmpe-660	126	19	and	and	CCONJ
ajmpe-660	126	20	the	the	DET
ajmpe-660	126	21	mortality	mortality	NOUN
ajmpe-660	126	22	rate	rate	NOUN
ajmpe-660	126	23	is	be	AUX
ajmpe-660	126	24	the	the	DET
ajmpe-660	126	25	second	second	ADJ
ajmpe-660	126	26	due	due	ADP
ajmpe-660	126	27	to	to	ADP
ajmpe-660	126	28	its	its	PRON
ajmpe-660	126	29	insidious	insidious	ADJ
ajmpe-660	126	30	early	early	ADJ
ajmpe-660	126	31	stage	stage	NOUN
ajmpe-660	126	32	,	,	PUNCT
ajmpe-660	126	33	easy	easy	ADJ
ajmpe-660	126	34	recurcuminrence	recurcuminrence	NOUN
ajmpe-660	126	35	and	and	CCONJ
ajmpe-660	126	36	metastasis	metastasis	NOUN
ajmpe-660	126	37	in	in	ADP
ajmpe-660	126	38	the	the	DET
ajmpe-660	126	39	late	late	ADJ
ajmpe-660	126	40	stage	stage	NOUN
ajmpe-660	126	41	[	[	X
ajmpe-660	126	42	10	10	NUM
ajmpe-660	126	43	]	]	PUNCT
ajmpe-660	126	44	.	.	PUNCT
ajmpe-660	127	1	fang	fang	PROPN
ajmpe-660	127	2	li	li	PROPN
ajmpe-660	128	1	[	[	X
ajmpe-660	128	2	33	33	NUM
ajmpe-660	128	3	]	]	PUNCT
ajmpe-660	128	4	et	et	PROPN
ajmpe-660	128	5	al	al	PROPN
ajmpe-660	128	6	.	.	PROPN
ajmpe-660	128	7	found	find	VERB
ajmpe-660	128	8	that	that	SCONJ
ajmpe-660	128	9	curcumin	curcumin	NOUN
ajmpe-660	128	10	could	could	AUX
ajmpe-660	128	11	inhibit	inhibit	VERB
ajmpe-660	128	12	the	the	DET
ajmpe-660	128	13	expression	expression	NOUN
ajmpe-660	128	14	of	of	ADP
ajmpe-660	128	15	cyclin	cyclin	NOUN
ajmpe-660	128	16	d1	d1	PROPN
ajmpe-660	128	17	in	in	ADP
ajmpe-660	128	18	human	human	ADJ
ajmpe-660	128	19	colon	colon	NOUN
ajmpe-660	128	20	cancer	cancer	NOUN
ajmpe-660	128	21	ht-29	ht-29	CCONJ
ajmpe-660	128	22	cells	cell	NOUN
ajmpe-660	128	23	in	in	ADP
ajmpe-660	128	24	a	a	DET
ajmpe-660	128	25	dose	dose	NOUN
ajmpe-660	128	26	and	and	CCONJ
ajmpe-660	128	27	time	time	NOUN
ajmpe-660	128	28	-	-	PUNCT
ajmpe-660	128	29	dependent	dependent	ADJ
ajmpe-660	128	30	manner	manner	NOUN
ajmpe-660	128	31	.	.	PUNCT
ajmpe-660	129	1	in	in	ADP
ajmpe-660	129	2	addition	addition	NOUN
ajmpe-660	129	3	,	,	PUNCT
ajmpe-660	129	4	curcumin	curcumin	NOUN
ajmpe-660	129	5	inhibited	inhibit	VERB
ajmpe-660	129	6	the	the	DET
ajmpe-660	129	7	activation	activation	NOUN
ajmpe-660	129	8	of	of	ADP
ajmpe-660	129	9	activator	activator	NOUN
ajmpe-660	129	10	protein-1	protein-1	PROPN
ajmpe-660	129	11	(	(	PUNCT
ajmpe-660	129	12	ap-1	ap-1	ADV
ajmpe-660	129	13	)	)	PUNCT
ajmpe-660	129	14	in	in	ADP
ajmpe-660	129	15	colon	colon	NOUN
ajmpe-660	129	16	cancer	cancer	NOUN
ajmpe-660	129	17	cells	cell	NOUN
ajmpe-660	129	18	,	,	PUNCT
ajmpe-660	129	19	resulting	result	VERB
ajmpe-660	129	20	in	in	ADP
ajmpe-660	129	21	the	the	DET
ajmpe-660	129	22	overexpression	overexpression	NOUN
ajmpe-660	129	23	of	of	ADP
ajmpe-660	129	24	mir-21	mir-21	PROPN
ajmpe-660	129	25	gene	gene	NOUN
ajmpe-660	129	26	binding	bind	VERB
ajmpe-660	129	27	to	to	ADP
ajmpe-660	129	28	the	the	DET
ajmpe-660	129	29	mir-21	mir-21	PROPN
ajmpe-660	129	30	promoter	promoter	NOUN
ajmpe-660	129	31	.	.	PUNCT
ajmpe-660	130	1	under	under	ADP
ajmpe-660	130	2	the	the	DET
ajmpe-660	130	3	regulation	regulation	NOUN
ajmpe-660	130	4	of	of	ADP
ajmpe-660	130	5	mir-21	mir-21	PROPN
ajmpe-660	130	6	,	,	PUNCT
ajmpe-660	130	7	colon	colon	NOUN
ajmpe-660	130	8	cancer	cancer	NOUN
ajmpe-660	130	9	cell	cell	NOUN
ajmpe-660	130	10	cycle	cycle	NOUN
ajmpe-660	130	11	was	be	AUX
ajmpe-660	130	12	arrested	arrest	VERB
ajmpe-660	130	13	in	in	ADP
ajmpe-660	130	14	g2	g2	PROPN
ajmpe-660	130	15	/	/	SYM
ajmpe-660	130	16	m	m	PROPN
ajmpe-660	130	17	phase	phase	NOUN
ajmpe-660	130	18	.	.	PUNCT
ajmpe-660	131	1	thereby	thereby	ADV
ajmpe-660	131	2	inhibiting	inhibit	VERB
ajmpe-660	131	3	the	the	DET
ajmpe-660	131	4	abnormal	abnormal	ADJ
ajmpe-660	131	5	and	and	CCONJ
ajmpe-660	131	6	rapid	rapid	ADJ
ajmpe-660	131	7	proliferation	proliferation	NOUN
ajmpe-660	131	8	of	of	ADP
ajmpe-660	131	9	tumor	tumor	NOUN
ajmpe-660	131	10	cells	cell	NOUN
ajmpe-660	131	11	.in	.in	PUNCT
ajmpe-660	131	12	the	the	DET
ajmpe-660	131	13	study	study	NOUN
ajmpe-660	131	14	of	of	ADP
ajmpe-660	131	15	curcumin	curcumin	NOUN
ajmpe-660	131	16	-	-	PUNCT
ajmpe-660	131	17	induced	induce	VERB
ajmpe-660	131	18	apoptosis	apoptosis	NOUN
ajmpe-660	131	19	of	of	ADP
ajmpe-660	131	20	tumor	tumor	NOUN
ajmpe-660	131	21	cells	cell	NOUN
ajmpe-660	131	22	,	,	PUNCT
ajmpe-660	131	23	curcumin	curcumin	NOUN
ajmpe-660	131	24	can	can	AUX
ajmpe-660	131	25	effectively	effectively	ADV
ajmpe-660	131	26	disturb	disturb	VERB
ajmpe-660	131	27	the	the	DET
ajmpe-660	131	28	balance	balance	NOUN
ajmpe-660	131	29	of	of	ADP
ajmpe-660	131	30	mitochondrial	mitochondrial	ADJ
ajmpe-660	131	31	membrane	membrane	NOUN
ajmpe-660	131	32	potential	potential	NOUN
ajmpe-660	131	33	,	,	PUNCT
ajmpe-660	131	34	enhance	enhance	VERB
ajmpe-660	131	35	the	the	DET
ajmpe-660	131	36	inhibition	inhibition	NOUN
ajmpe-660	131	37	of	of	ADP
ajmpe-660	131	38	bcl	bcl	PROPN
ajmpe-660	131	39	-	-	PROPN
ajmpe-660	131	40	xl	xl	PROPN
ajmpe-660	131	41	protein	protein	NOUN
ajmpe-660	131	42	,	,	PUNCT
ajmpe-660	131	43	and	and	CCONJ
ajmpe-660	131	44	regulate	regulate	VERB
ajmpe-660	131	45	cell	cell	NOUN
ajmpe-660	131	46	apoptosis	apoptosis	NOUN
ajmpe-660	131	47	[	[	X
ajmpe-660	131	48	34	34	NUM
ajmpe-660	131	49	]	]	PUNCT
ajmpe-660	131	50	.	.	PUNCT
ajmpe-660	132	1	luo	luo	PROPN
ajmpe-660	132	2	qiang	qiang	PROPN
ajmpe-660	133	1	[	[	X
ajmpe-660	133	2	35	35	NUM
ajmpe-660	133	3	]	]	PUNCT
ajmpe-660	133	4	treated	treat	VERB
ajmpe-660	133	5	human	human	ADJ
ajmpe-660	133	6	colon	colon	NOUN
ajmpe-660	133	7	cancer	cancer	NOUN
ajmpe-660	133	8	sw620	sw620	ADJ
ajmpe-660	133	9	cells	cell	NOUN
ajmpe-660	133	10	cultured	culture	VERB
ajmpe-660	133	11	in	in	ADP
ajmpe-660	133	12	vitro	vitro	X
ajmpe-660	133	13	with	with	ADP
ajmpe-660	133	14	different	different	ADJ
ajmpe-660	133	15	concentrations	concentration	NOUN
ajmpe-660	133	16	of	of	ADP
ajmpe-660	133	17	curcumin	curcumin	NOUN
ajmpe-660	133	18	for	for	ADP
ajmpe-660	133	19	24	24	NUM
ajmpe-660	133	20	h	h	NOUN
ajmpe-660	133	21	,	,	PUNCT
ajmpe-660	133	22	and	and	CCONJ
ajmpe-660	133	23	found	find	VERB
ajmpe-660	133	24	that	that	SCONJ
ajmpe-660	133	25	the	the	DET
ajmpe-660	133	26	proliferation	proliferation	NOUN
ajmpe-660	133	27	ability	ability	NOUN
ajmpe-660	133	28	of	of	ADP
ajmpe-660	133	29	tumor	tumor	NOUN
ajmpe-660	133	30	cells	cell	NOUN
ajmpe-660	133	31	was	be	AUX
ajmpe-660	133	32	significantly	significantly	ADV
ajmpe-660	133	33	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-660	133	34	american	american	PROPN
ajmpe-660	133	35	journal	journal	PROPN
ajmpe-660	133	36	of	of	ADP
ajmpe-660	133	37	medical	medical	ADJ
ajmpe-660	133	38	and	and	CCONJ
ajmpe-660	133	39	physical	physical	ADJ
ajmpe-660	133	40	education	education	PROPN
ajmpe-660	133	41	vol.8	vol.8	PROPN
ajmpe-660	133	42	,	,	PUNCT
ajmpe-660	133	43	issue	issue	NOUN
ajmpe-660	133	44	5	5	NUM
ajmpe-660	133	45	;	;	PUNCT
ajmpe-660	133	46	september	september	PROPN
ajmpe-660	133	47	-	-	PUNCT
ajmpe-660	133	48	october	october	PROPN
ajmpe-660	133	49	2023	2023	NUM
ajmpe-660	133	50	;	;	PUNCT
ajmpe-660	133	51	issn	issn	PROPN
ajmpe-660	133	52	:	:	PUNCT
ajmpe-660	133	53	2994	2994	NUM
ajmpe-660	133	54	-	-	SYM
ajmpe-660	133	55	0524	0524	NUM
ajmpe-660	133	56	impact	impact	NOUN
ajmpe-660	133	57	factor	factor	NOUN
ajmpe-660	133	58	:	:	PUNCT
ajmpe-660	133	59	6.14	6.14	NUM
ajmpe-660	133	60	1252	1252	NUM
ajmpe-660	133	61	columbia	columbia	PROPN
ajmpe-660	133	62	rd	rd	PROPN
ajmpe-660	133	63	nw	nw	PROPN
ajmpe-660	133	64	,	,	PUNCT
ajmpe-660	133	65	washington	washington	PROPN
ajmpe-660	133	66	dc	dc	PROPN
ajmpe-660	133	67	,	,	PUNCT
ajmpe-660	133	68	united	united	PROPN
ajmpe-660	133	69	states	states	PROPN
ajmpe-660	133	70	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	133	71	;	;	PUNCT
ajmpe-660	133	72	mail	mail	NOUN
ajmpe-660	133	73	:	:	PUNCT
ajmpe-660	133	74	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	134	1	14	14	NUM
ajmpe-660	135	1	|	|	ADV
ajmpe-660	135	2	a	a	DET
ajmpe-660	135	3	m	m	NOUN
ajmpe-660	135	4	e	e	NOUN
ajmpe-660	135	5	r	r	NOUN
ajmpe-660	136	1	i	i	NOUN
ajmpe-660	136	2	c	c	VERB
ajmpe-660	136	3	a	a	DET
ajmpe-660	136	4	n	n	NOUN
ajmpe-660	137	1	j	j	NOUN
ajmpe-660	137	2	o	o	X
ajmpe-660	137	3	u	u	NOUN
ajmpe-660	137	4	r	r	NOUN
ajmpe-660	137	5	n	n	NOUN
ajmpe-660	137	6	a	a	DET
ajmpe-660	137	7	l	l	NOUN
ajmpe-660	137	8	o	o	X
ajmpe-660	138	1	f	f	X
ajmpe-660	138	2	m	m	NOUN
ajmpe-660	138	3	e	e	NOUN
ajmpe-660	139	1	d	d	NOUN
ajmpe-660	139	2	i	i	PRON
ajmpe-660	139	3	c	c	VERB
ajmpe-660	139	4	a	a	DET
ajmpe-660	139	5	l	l	NOUN
ajmpe-660	139	6	a	a	X
ajmpe-660	139	7	n	n	NOUN
ajmpe-660	140	1	d	d	NOUN
ajmpe-660	140	2	p	p	NOUN
ajmpe-660	140	3	h	h	NOUN
ajmpe-660	140	4	y	y	NOUN
ajmpe-660	140	5	s	s	VERB
ajmpe-660	141	1	i	i	INTJ
ajmpe-660	141	2	c	c	VERB
ajmpe-660	141	3	a	a	DET
ajmpe-660	141	4	l	l	NOUN
ajmpe-660	141	5	e	e	NOUN
ajmpe-660	141	6	d	d	X
ajmpe-660	141	7	u	u	X
ajmpe-660	141	8	c	c	PROPN
ajmpe-660	142	1	a	a	DET
ajmpe-660	142	2	t	t	NOUN
ajmpe-660	143	1	i	i	PRON
ajmpe-660	143	2	o	o	VERB
ajmpe-660	143	3	n	n	CCONJ
ajmpe-660	143	4	|	|	ADV
ajmpe-660	143	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-660	143	6	inhibited	inhibit	VERB
ajmpe-660	143	7	in	in	ADP
ajmpe-660	143	8	a	a	DET
ajmpe-660	143	9	dose	dose	NOUN
ajmpe-660	143	10	-	-	PUNCT
ajmpe-660	143	11	dependent	dependent	ADJ
ajmpe-660	143	12	manner	manner	NOUN
ajmpe-660	143	13	.	.	PUNCT
ajmpe-660	144	1	at	at	ADP
ajmpe-660	144	2	the	the	DET
ajmpe-660	144	3	same	same	ADJ
ajmpe-660	144	4	time	time	NOUN
ajmpe-660	144	5	,	,	PUNCT
ajmpe-660	144	6	sw620	sw620	ADJ
ajmpe-660	144	7	cells	cell	NOUN
ajmpe-660	144	8	were	be	AUX
ajmpe-660	144	9	regulated	regulate	VERB
ajmpe-660	144	10	by	by	ADP
ajmpe-660	144	11	bcl-2	bcl-2	NOUN
ajmpe-660	144	12	signaling	signal	VERB
ajmpe-660	144	13	pathway	pathway	NOUN
ajmpe-660	144	14	and	and	CCONJ
ajmpe-660	144	15	underwent	underwent	ADJ
ajmpe-660	144	16	apoptosis	apoptosis	NOUN
ajmpe-660	144	17	.	.	PUNCT
ajmpe-660	145	1	curcumin	curcumin	PROPN
ajmpe-660	145	2	was	be	AUX
ajmpe-660	145	3	applied	apply	VERB
ajmpe-660	145	4	to	to	ADP
ajmpe-660	145	5	colon	colon	NOUN
ajmpe-660	145	6	cancer	cancer	NOUN
ajmpe-660	145	7	sw480	sw480	PROPN
ajmpe-660	145	8	cells	cell	NOUN
ajmpe-660	145	9	cultured	cultured	ADJ
ajmpe-660	145	10	in	in	ADP
ajmpe-660	145	11	vitro	vitro	X
ajmpe-660	145	12	.	.	PUNCT
ajmpe-660	146	1	rt	rt	PROPN
ajmpe-660	146	2	-	-	PUNCT
ajmpe-660	146	3	qp	qp	PROPN
ajmpe-660	146	4	cr	cr	PROPN
ajmpe-660	146	5	and	and	CCONJ
ajmpe-660	146	6	western	western	ADJ
ajmpe-660	146	7	blot	blot	NOUN
ajmpe-660	146	8	experiments	experiment	NOUN
ajmpe-660	146	9	showed	show	VERB
ajmpe-660	146	10	that	that	SCONJ
ajmpe-660	146	11	curcumin	curcumin	NOUN
ajmpe-660	146	12	could	could	AUX
ajmpe-660	146	13	regulate	regulate	VERB
ajmpe-660	146	14	the	the	DET
ajmpe-660	146	15	apoptosis	apoptosis	NOUN
ajmpe-660	146	16	of	of	ADP
ajmpe-660	146	17	colon	colon	NOUN
ajmpe-660	146	18	cancer	cancer	NOUN
ajmpe-660	146	19	sw480	sw480	PROPN
ajmpe-660	146	20	cells	cell	NOUN
ajmpe-660	146	21	by	by	ADP
ajmpe-660	146	22	recruiting	recruit	VERB
ajmpe-660	146	23	fas	fas	NOUN
ajmpe-660	146	24	death	death	NOUN
ajmpe-660	146	25	receptor	receptor	NOUN
ajmpe-660	146	26	and	and	CCONJ
ajmpe-660	146	27	activating	activate	VERB
ajmpe-660	146	28	downstream	downstream	ADJ
ajmpe-660	146	29	signals	signal	NOUN
ajmpe-660	146	30	of	of	ADP
ajmpe-660	146	31	death	death	NOUN
ajmpe-660	146	32	receptor	receptor	NOUN
ajmpe-660	146	33	pathway	pathway	NOUN
ajmpe-660	147	1	[	[	X
ajmpe-660	147	2	36	36	NUM
ajmpe-660	147	3	]	]	PUNCT
ajmpe-660	147	4	.	.	PUNCT
ajmpe-660	148	1	zhang	zhang	PROPN
ajmpe-660	148	2	et	et	PROPN
ajmpe-660	148	3	al	al	PROPN
ajmpe-660	148	4	.	.	PUNCT
ajmpe-660	149	1	[	[	X
ajmpe-660	149	2	37	37	NUM
ajmpe-660	149	3	]	]	PUNCT
ajmpe-660	149	4	found	find	VERB
ajmpe-660	149	5	that	that	SCONJ
ajmpe-660	149	6	curcumin	curcumin	NOUN
ajmpe-660	149	7	significantly	significantly	ADV
ajmpe-660	149	8	inhibited	inhibit	VERB
ajmpe-660	149	9	the	the	DET
ajmpe-660	149	10	proliferation	proliferation	NOUN
ajmpe-660	149	11	of	of	ADP
ajmpe-660	149	12	colon	colon	NOUN
ajmpe-660	149	13	cancer	cancer	NOUN
ajmpe-660	149	14	sw620	sw620	ADJ
ajmpe-660	149	15	cells	cell	NOUN
ajmpe-660	149	16	and	and	CCONJ
ajmpe-660	149	17	upregulated	upregulate	VERB
ajmpe-660	149	18	the	the	DET
ajmpe-660	149	19	expression	expression	NOUN
ajmpe-660	149	20	of	of	ADP
ajmpe-660	149	21	nkd2	nkd2	PROPN
ajmpe-660	149	22	in	in	ADP
ajmpe-660	149	23	colorectal	colorectal	ADJ
ajmpe-660	149	24	cancer	cancer	NOUN
ajmpe-660	149	25	cells	cell	NOUN
ajmpe-660	149	26	and	and	CCONJ
ajmpe-660	149	27	xenografts	xenograft	NOUN
ajmpe-660	149	28	,	,	PUNCT
ajmpe-660	149	29	leading	lead	VERB
ajmpe-660	149	30	to	to	ADP
ajmpe-660	149	31	the	the	DET
ajmpe-660	149	32	downregulation	downregulation	NOUN
ajmpe-660	149	33	of	of	ADP
ajmpe-660	149	34	key	key	ADJ
ajmpe-660	149	35	markers	marker	NOUN
ajmpe-660	149	36	in	in	ADP
ajmpe-660	149	37	wnt	wnt	NOUN
ajmpe-660	149	38	signaling	signal	VERB
ajmpe-660	149	39	.	.	PUNCT
ajmpe-660	150	1	in	in	ADP
ajmpe-660	150	2	addition	addition	NOUN
ajmpe-660	150	3	,	,	PUNCT
ajmpe-660	150	4	curcumin	curcumin	NOUN
ajmpe-660	150	5	inhibited	inhibit	VERB
ajmpe-660	150	6	the	the	DET
ajmpe-660	150	7	progression	progression	NOUN
ajmpe-660	150	8	of	of	ADP
ajmpe-660	150	9	epithelialmesenchymal	epithelialmesenchymal	ADJ
ajmpe-660	150	10	transition	transition	NOUN
ajmpe-660	150	11	(	(	PUNCT
ajmpe-660	150	12	etm	etm	PROPN
ajmpe-660	150	13	)	)	PUNCT
ajmpe-660	150	14	through	through	ADP
ajmpe-660	150	15	the	the	DET
ajmpe-660	150	16	overexpression	overexpression	NOUN
ajmpe-660	150	17	of	of	ADP
ajmpe-660	150	18	e	e	NOUN
ajmpe-660	150	19	-	-	NOUN
ajmpe-660	150	20	cadherin	cadherin	NOUN
ajmpe-660	150	21	and	and	CCONJ
ajmpe-660	150	22	the	the	DET
ajmpe-660	150	23	down	down	ADJ
ajmpe-660	150	24	-	-	PUNCT
ajmpe-660	150	25	regulation	regulation	NOUN
ajmpe-660	150	26	of	of	ADP
ajmpe-660	150	27	vimentin	vimentin	NOUN
ajmpe-660	150	28	.	.	PUNCT
ajmpe-660	151	1	6	6	NUM
ajmpe-660	151	2	.	.	X
ajmpe-660	151	3	curcumin	curcumin	NOUN
ajmpe-660	151	4	and	and	CCONJ
ajmpe-660	151	5	gynecologic	gynecologic	ADJ
ajmpe-660	151	6	tumors	tumor	NOUN
ajmpe-660	151	7	6.1	6.1	NUM
ajmpe-660	151	8	.	.	PUNCT
ajmpe-660	152	1	ovarian	ovarian	ADJ
ajmpe-660	152	2	cancer	cancer	NOUN
ajmpe-660	152	3	ovarian	ovarian	ADJ
ajmpe-660	152	4	cancer	cancer	NOUN
ajmpe-660	152	5	is	be	AUX
ajmpe-660	152	6	a	a	DET
ajmpe-660	152	7	common	common	ADJ
ajmpe-660	152	8	malignant	malignant	ADJ
ajmpe-660	152	9	tumor	tumor	NOUN
ajmpe-660	152	10	in	in	ADP
ajmpe-660	152	11	the	the	DET
ajmpe-660	152	12	female	female	ADJ
ajmpe-660	152	13	reproductive	reproductive	ADJ
ajmpe-660	152	14	system	system	NOUN
ajmpe-660	152	15	with	with	ADP
ajmpe-660	152	16	high	high	ADJ
ajmpe-660	152	17	mortality	mortality	NOUN
ajmpe-660	152	18	and	and	CCONJ
ajmpe-660	152	19	poor	poor	ADJ
ajmpe-660	152	20	prognosis	prognosis	NOUN
ajmpe-660	152	21	.	.	PUNCT
ajmpe-660	153	1	seo	seo	NOUN
ajmpe-660	153	2	et	et	PROPN
ajmpe-660	153	3	al	al	PROPN
ajmpe-660	153	4	.	.	PUNCT
ajmpe-660	154	1	[	[	X
ajmpe-660	154	2	38	38	NUM
ajmpe-660	154	3	]	]	PUNCT
ajmpe-660	154	4	found	find	VERB
ajmpe-660	154	5	that	that	SCONJ
ajmpe-660	154	6	an	an	DET
ajmpe-660	154	7	abnormal	abnormal	ADJ
ajmpe-660	154	8	increase	increase	NOUN
ajmpe-660	154	9	in	in	ADP
ajmpe-660	154	10	the	the	DET
ajmpe-660	154	11	expression	expression	NOUN
ajmpe-660	154	12	level	level	NOUN
ajmpe-660	154	13	of	of	ADP
ajmpe-660	154	14	muscle	muscle	NOUN
ajmpe-660	154	15	/	/	SYM
ajmpe-660	154	16	endoplasmic	endoplasmic	ADJ
ajmpe-660	154	17	reticulum	reticulum	NOUN
ajmpe-660	154	18	calcium	calcium	NOUN
ajmpe-660	154	19	atpase	atpase	PROPN
ajmpe-660	154	20	(	(	PUNCT
ajmpe-660	154	21	serca	serca	PROPN
ajmpe-660	154	22	)	)	PUNCT
ajmpe-660	154	23	,	,	PUNCT
ajmpe-660	154	24	which	which	PRON
ajmpe-660	154	25	regulates	regulate	VERB
ajmpe-660	154	26	ca	ca	NOUN
ajmpe-660	154	27	(	(	PUNCT
ajmpe-660	154	28	2	2	NUM
ajmpe-660	154	29	+	+	NOUN
ajmpe-660	154	30	)	)	PUNCT
ajmpe-660	154	31	homeostasis	homeostasis	NOUN
ajmpe-660	154	32	,	,	PUNCT
ajmpe-660	154	33	was	be	AUX
ajmpe-660	154	34	observed	observe	VERB
ajmpe-660	154	35	in	in	ADP
ajmpe-660	154	36	ovarian	ovarian	ADJ
ajmpe-660	154	37	cancer	cancer	NOUN
ajmpe-660	154	38	.	.	PUNCT
ajmpe-660	155	1	curcumin	curcumin	NOUN
ajmpe-660	155	2	induced	induce	VERB
ajmpe-660	155	3	apoptosis	apoptosis	NOUN
ajmpe-660	155	4	of	of	ADP
ajmpe-660	155	5	ovarian	ovarian	ADJ
ajmpe-660	155	6	cancer	cancer	NOUN
ajmpe-660	155	7	cells	cell	NOUN
ajmpe-660	155	8	in	in	ADP
ajmpe-660	155	9	a	a	DET
ajmpe-660	155	10	concentration	concentration	NOUN
ajmpe-660	155	11	and	and	CCONJ
ajmpe-660	155	12	time	time	NOUN
ajmpe-660	155	13	-	-	PUNCT
ajmpe-660	155	14	dependent	dependent	ADJ
ajmpe-660	155	15	manner	manner	NOUN
ajmpe-660	155	16	,	,	PUNCT
ajmpe-660	155	17	and	and	CCONJ
ajmpe-660	155	18	the	the	DET
ajmpe-660	155	19	solute	solute	NOUN
ajmpe-660	155	20	ca	can	AUX
ajmpe-660	155	21	(	(	PUNCT
ajmpe-660	155	22	2	2	NUM
ajmpe-660	155	23	+	+	NOUN
ajmpe-660	155	24	)	)	PUNCT
ajmpe-660	155	25	flux	flux	NOUN
ajmpe-660	155	26	in	in	ADP
ajmpe-660	155	27	ovarian	ovarian	ADJ
ajmpe-660	155	28	cancer	cancer	NOUN
ajmpe-660	155	29	cells	cell	NOUN
ajmpe-660	155	30	was	be	AUX
ajmpe-660	155	31	significant	significant	ADJ
ajmpe-660	155	32	(	(	PUNCT
ajmpe-660	155	33	15μm	15μm	ADJ
ajmpe-660	155	34	)	)	PUNCT
ajmpe-660	155	35	.	.	PUNCT
ajmpe-660	156	1	it	it	PRON
ajmpe-660	156	2	was	be	AUX
ajmpe-660	156	3	further	far	ADV
ajmpe-660	156	4	confirmed	confirm	VERB
ajmpe-660	156	5	that	that	SCONJ
ajmpe-660	156	6	inhibition	inhibition	NOUN
ajmpe-660	156	7	of	of	ADP
ajmpe-660	156	8	serca	serca	NOUN
ajmpe-660	156	9	activity	activity	NOUN
ajmpe-660	156	10	by	by	ADP
ajmpe-660	156	11	curcumin	curcumin	NOUN
ajmpe-660	156	12	could	could	AUX
ajmpe-660	156	13	disrupt	disrupt	VERB
ajmpe-660	156	14	ca	ca	NOUN
ajmpe-660	156	15	(	(	PUNCT
ajmpe-660	156	16	2	2	NUM
ajmpe-660	156	17	+	+	NOUN
ajmpe-660	156	18	)	)	PUNCT
ajmpe-660	156	19	homeostasis	homeostasis	NOUN
ajmpe-660	156	20	,	,	PUNCT
ajmpe-660	156	21	thereby	thereby	ADV
ajmpe-660	156	22	promoting	promote	VERB
ajmpe-660	156	23	apoptosis	apoptosis	NOUN
ajmpe-660	156	24	of	of	ADP
ajmpe-660	156	25	ovarian	ovarian	ADJ
ajmpe-660	156	26	cancer	cancer	NOUN
ajmpe-660	156	27	cells	cell	NOUN
ajmpe-660	156	28	.	.	PUNCT
ajmpe-660	157	1	liu	liu	PROPN
ajmpe-660	157	2	et	et	PROPN
ajmpe-660	157	3	al	al	PROPN
ajmpe-660	157	4	.	.	PUNCT
ajmpe-660	158	1	[	[	X
ajmpe-660	158	2	39	39	NUM
ajmpe-660	158	3	]	]	PUNCT
ajmpe-660	158	4	found	find	VERB
ajmpe-660	158	5	that	that	SCONJ
ajmpe-660	158	6	curcumin	curcumin	NOUN
ajmpe-660	158	7	significantly	significantly	ADV
ajmpe-660	158	8	reduced	reduce	VERB
ajmpe-660	158	9	cell	cell	NOUN
ajmpe-660	158	10	viability	viability	NOUN
ajmpe-660	158	11	and	and	CCONJ
ajmpe-660	158	12	induced	induce	VERB
ajmpe-660	158	13	apoptotic	apoptotic	ADJ
ajmpe-660	158	14	cell	cell	NOUN
ajmpe-660	158	15	death	death	NOUN
ajmpe-660	158	16	in	in	ADP
ajmpe-660	158	17	human	human	ADJ
ajmpe-660	158	18	ovarian	ovarian	ADJ
ajmpe-660	158	19	cancer	cancer	NOUN
ajmpe-660	158	20	cell	cell	NOUN
ajmpe-660	158	21	lines	line	NOUN
ajmpe-660	158	22	sk	sk	ADP
ajmpe-660	158	23	-	-	PUNCT
ajmpe-660	158	24	ov-3	ov-3	NOUN
ajmpe-660	158	25	and	and	CCONJ
ajmpe-660	158	26	a2780	a2780	ADJ
ajmpe-660	158	27	,	,	PUNCT
ajmpe-660	158	28	and	and	CCONJ
ajmpe-660	158	29	induced	induce	VERB
ajmpe-660	158	30	protective	protective	ADJ
ajmpe-660	158	31	autophagy	autophagy	NOUN
ajmpe-660	158	32	in	in	ADP
ajmpe-660	158	33	human	human	ADJ
ajmpe-660	158	34	ovarian	ovarian	ADJ
ajmpe-660	158	35	cancer	cancer	NOUN
ajmpe-660	158	36	cells	cell	NOUN
ajmpe-660	158	37	by	by	ADP
ajmpe-660	158	38	inhibiting	inhibit	VERB
ajmpe-660	158	39	the	the	DET
ajmpe-660	158	40	akt	akt	PROPN
ajmpe-660	158	41	/	/	SYM
ajmpe-660	158	42	mtor	mtor	PROPN
ajmpe-660	158	43	/	/	SYM
ajmpe-660	158	44	p70s6k	p70s6k	PROPN
ajmpe-660	158	45	pathway	pathway	NOUN
ajmpe-660	158	46	.	.	PUNCT
ajmpe-660	159	1	weir	weir	PROPN
ajmpe-660	159	2	et	et	PROPN
ajmpe-660	159	3	al	al	PROPN
ajmpe-660	159	4	.	.	PUNCT
ajmpe-660	160	1	[	[	X
ajmpe-660	160	2	40	40	NUM
ajmpe-660	160	3	]	]	PUNCT
ajmpe-660	160	4	found	find	VERB
ajmpe-660	160	5	that	that	SCONJ
ajmpe-660	160	6	curcumin	curcumin	NOUN
ajmpe-660	160	7	can	can	AUX
ajmpe-660	160	8	inhibit	inhibit	VERB
ajmpe-660	160	9	the	the	DET
ajmpe-660	160	10	proliferation	proliferation	NOUN
ajmpe-660	160	11	of	of	ADP
ajmpe-660	160	12	cisplatin	cisplatin	NOUN
ajmpe-660	160	13	-	-	PUNCT
ajmpe-660	160	14	resistant	resistant	ADJ
ajmpe-660	160	15	(	(	PUNCT
ajmpe-660	160	16	cr	cr	NOUN
ajmpe-660	160	17	)	)	PUNCT
ajmpe-660	160	18	and	and	CCONJ
ajmpe-660	160	19	sensitive	sensitive	ADJ
ajmpe-660	160	20	(	(	PUNCT
ajmpe-660	160	21	cs	cs	ADJ
ajmpe-660	160	22	)	)	PUNCT
ajmpe-660	160	23	human	human	ADJ
ajmpe-660	160	24	ovarian	ovarian	ADJ
ajmpe-660	160	25	cancer	cancer	NOUN
ajmpe-660	160	26	cells	cell	NOUN
ajmpe-660	160	27	,	,	PUNCT
ajmpe-660	160	28	activate	activate	VERB
ajmpe-660	160	29	caspase-2	caspase-2	NUM
ajmpe-660	160	30	and	and	CCONJ
ajmpe-660	160	31	parp	parp	ADJ
ajmpe-660	160	32	degradation	degradation	NOUN
ajmpe-660	160	33	to	to	PART
ajmpe-660	160	34	enhance	enhance	VERB
ajmpe-660	160	35	p53	p53	NOUN
ajmpe-660	160	36	phosphorylation	phosphorylation	NOUN
ajmpe-660	160	37	and	and	CCONJ
ajmpe-660	160	38	apoptosis	apoptosis	NOUN
ajmpe-660	160	39	,	,	PUNCT
ajmpe-660	160	40	thereby	thereby	ADV
ajmpe-660	160	41	inducing	induce	VERB
ajmpe-660	160	42	g	g	NOUN
ajmpe-660	160	43	(	(	PUNCT
ajmpe-660	160	44	3	3	NUM
ajmpe-660	160	45	)	)	PUNCT
ajmpe-660	160	46	/m	/m	PUNCT
ajmpe-660	160	47	phase	phase	NOUN
ajmpe-660	160	48	cell	cell	NOUN
ajmpe-660	160	49	cycle	cycle	NOUN
ajmpe-660	160	50	arrest	arrest	NOUN
ajmpe-660	160	51	in	in	ADP
ajmpe-660	160	52	cr	cr	NOUN
ajmpe-660	160	53	cells	cell	NOUN
ajmpe-660	160	54	.	.	PUNCT
ajmpe-660	161	1	6.2	6.2	NUM
ajmpe-660	161	2	.	.	PUNCT
ajmpe-660	162	1	cervical	cervical	ADJ
ajmpe-660	162	2	cancer	cancer	NOUN
ajmpe-660	162	3	cervical	cervical	ADJ
ajmpe-660	162	4	cancer	cancer	NOUN
ajmpe-660	162	5	is	be	AUX
ajmpe-660	162	6	the	the	DET
ajmpe-660	162	7	fourth	fourth	ADJ
ajmpe-660	162	8	most	most	ADV
ajmpe-660	162	9	commonly	commonly	ADV
ajmpe-660	162	10	diagnosed	diagnose	VERB
ajmpe-660	162	11	cancer	cancer	NOUN
ajmpe-660	162	12	and	and	CCONJ
ajmpe-660	162	13	the	the	DET
ajmpe-660	162	14	fourth	fourth	ADJ
ajmpe-660	162	15	leading	leading	ADJ
ajmpe-660	162	16	cause	cause	NOUN
ajmpe-660	162	17	of	of	ADP
ajmpe-660	162	18	cancer	cancer	NOUN
ajmpe-660	162	19	death	death	NOUN
ajmpe-660	162	20	in	in	ADP
ajmpe-660	162	21	women	woman	NOUN
ajmpe-660	162	22	[	[	X
ajmpe-660	162	23	10	10	NUM
ajmpe-660	162	24	]	]	PUNCT
ajmpe-660	162	25	.	.	PUNCT
ajmpe-660	163	1	cervical	cervical	ADJ
ajmpe-660	163	2	cancer	cancer	NOUN
ajmpe-660	163	3	and	and	CCONJ
ajmpe-660	163	4	human	human	ADJ
ajmpe-660	163	5	papillomavirus	papillomavirus	NOUN
ajmpe-660	163	6	(	(	PUNCT
ajmpe-660	163	7	hpv	hpv	NOUN
ajmpe-660	163	8	)	)	PUNCT
ajmpe-660	163	9	infection	infection	NOUN
ajmpe-660	163	10	have	have	VERB
ajmpe-660	163	11	a	a	DET
ajmpe-660	163	12	great	great	ADJ
ajmpe-660	163	13	correlation	correlation	NOUN
ajmpe-660	163	14	.	.	PUNCT
ajmpe-660	164	1	curcumin	curcumin	NOUN
ajmpe-660	164	2	can	can	AUX
ajmpe-660	164	3	significantly	significantly	ADV
ajmpe-660	164	4	down	down	ADV
ajmpe-660	164	5	-	-	PUNCT
ajmpe-660	164	6	regulate	regulate	VERB
ajmpe-660	164	7	the	the	DET
ajmpe-660	164	8	expression	expression	NOUN
ajmpe-660	164	9	of	of	ADP
ajmpe-660	164	10	hpv	hpv	PROPN
ajmpe-660	164	11	e6	e6	PROPN
ajmpe-660	164	12	mrna	mrna	PROPN
ajmpe-660	164	13	in	in	ADP
ajmpe-660	164	14	hela	hela	PROPN
ajmpe-660	164	15	cells	cell	NOUN
ajmpe-660	164	16	of	of	ADP
ajmpe-660	164	17	cervical	cervical	ADJ
ajmpe-660	164	18	cancer	cancer	NOUN
ajmpe-660	164	19	,	,	PUNCT
ajmpe-660	164	20	so	so	SCONJ
ajmpe-660	164	21	as	as	SCONJ
ajmpe-660	164	22	to	to	PART
ajmpe-660	164	23	play	play	VERB
ajmpe-660	164	24	an	an	DET
ajmpe-660	164	25	anti	anti	ADJ
ajmpe-660	164	26	-	-	ADJ
ajmpe-660	164	27	hpv	hpv	ADJ
ajmpe-660	164	28	effect	effect	NOUN
ajmpe-660	164	29	,	,	PUNCT
ajmpe-660	164	30	and	and	CCONJ
ajmpe-660	164	31	promote	promote	VERB
ajmpe-660	164	32	the	the	DET
ajmpe-660	164	33	generation	generation	NOUN
ajmpe-660	164	34	of	of	ADP
ajmpe-660	164	35	reactive	reactive	ADJ
ajmpe-660	164	36	oxygen	oxygen	NOUN
ajmpe-660	164	37	species	specie	NOUN
ajmpe-660	164	38	(	(	PUNCT
ajmpe-660	164	39	ros	ros	PROPN
ajmpe-660	164	40	)	)	PUNCT
ajmpe-660	164	41	and	and	CCONJ
ajmpe-660	164	42	damage	damage	NOUN
ajmpe-660	164	43	dna	dna	NOUN
ajmpe-660	165	1	[	[	X
ajmpe-660	165	2	41	41	NUM
ajmpe-660	165	3	]	]	PUNCT
ajmpe-660	165	4	.	.	PUNCT
ajmpe-660	166	1	by	by	ADP
ajmpe-660	166	2	inhibiting	inhibit	VERB
ajmpe-660	166	3	the	the	DET
ajmpe-660	166	4	activity	activity	NOUN
ajmpe-660	166	5	of	of	ADP
ajmpe-660	166	6	pi3k	pi3k	PROPN
ajmpe-660	166	7	/	/	SYM
ajmpe-660	166	8	akt	akt	PROPN
ajmpe-660	166	9	/	/	SYM
ajmpe-660	166	10	mtor	mtor	PROPN
ajmpe-660	166	11	,	,	PUNCT
ajmpe-660	166	12	curcumin	curcumin	PROPN
ajmpe-660	166	13	can	can	AUX
ajmpe-660	166	14	induce	induce	VERB
ajmpe-660	166	15	autophagy	autophagy	NOUN
ajmpe-660	166	16	and	and	CCONJ
ajmpe-660	166	17	inhibit	inhibit	VERB
ajmpe-660	166	18	the	the	DET
ajmpe-660	166	19	proliferation	proliferation	NOUN
ajmpe-660	166	20	of	of	ADP
ajmpe-660	166	21	cervical	cervical	ADJ
ajmpe-660	166	22	cancer	cancer	NOUN
ajmpe-660	166	23	siha	siha	NOUN
ajmpe-660	166	24	cells	cell	NOUN
ajmpe-660	166	25	,	,	PUNCT
ajmpe-660	166	26	up	up	ADV
ajmpe-660	166	27	-	-	PUNCT
ajmpe-660	166	28	regulate	regulate	VERB
ajmpe-660	166	29	the	the	DET
ajmpe-660	166	30	expression	expression	NOUN
ajmpe-660	166	31	of	of	ADP
ajmpe-660	166	32	tumor	tumor	NOUN
ajmpe-660	166	33	suppressor	suppressor	NOUN
ajmpe-660	166	34	genes	gene	NOUN
ajmpe-660	166	35	p53	p53	NOUN
ajmpe-660	166	36	,	,	PUNCT
ajmpe-660	166	37	p21	p21	NOUN
ajmpe-660	166	38	and	and	CCONJ
ajmpe-660	166	39	p27	p27	NOUN
ajmpe-660	166	40	,	,	PUNCT
ajmpe-660	166	41	and	and	CCONJ
ajmpe-660	166	42	secrete	secrete	VERB
ajmpe-660	166	43	ifn	ifn	NOUN
ajmpe-660	166	44	-	-	PUNCT
ajmpe-660	166	45	γ	γ	NOUN
ajmpe-660	166	46	[	[	X
ajmpe-660	166	47	42	42	NUM
ajmpe-660	166	48	]	]	PUNCT
ajmpe-660	166	49	.	.	PUNCT
ajmpe-660	167	1	7	7	X
ajmpe-660	167	2	.	.	X
ajmpe-660	167	3	curcumin	curcumin	NOUN
ajmpe-660	167	4	and	and	CCONJ
ajmpe-660	167	5	esophageal	esophageal	ADJ
ajmpe-660	167	6	cancer	cancer	NOUN
ajmpe-660	167	7	the	the	DET
ajmpe-660	167	8	incidence	incidence	NOUN
ajmpe-660	167	9	of	of	ADP
ajmpe-660	167	10	esophageal	esophageal	ADJ
ajmpe-660	167	11	cancer	cancer	NOUN
ajmpe-660	167	12	ranks	rank	VERB
ajmpe-660	167	13	the	the	DET
ajmpe-660	167	14	seventh	seventh	ADJ
ajmpe-660	167	15	in	in	ADP
ajmpe-660	167	16	the	the	DET
ajmpe-660	167	17	world	world	NOUN
ajmpe-660	167	18	,	,	PUNCT
ajmpe-660	167	19	and	and	CCONJ
ajmpe-660	167	20	the	the	DET
ajmpe-660	167	21	overall	overall	ADJ
ajmpe-660	167	22	mortality	mortality	NOUN
ajmpe-660	167	23	ranks	rank	VERB
ajmpe-660	167	24	the	the	DET
ajmpe-660	167	25	sixth	sixth	ADJ
ajmpe-660	167	26	[	[	X
ajmpe-660	167	27	10	10	NUM
ajmpe-660	167	28	]	]	PUNCT
ajmpe-660	167	29	.	.	PUNCT
ajmpe-660	168	1	china	china	PROPN
ajmpe-660	168	2	is	be	AUX
ajmpe-660	168	3	a	a	DET
ajmpe-660	168	4	high	high	ADJ
ajmpe-660	168	5	-	-	PUNCT
ajmpe-660	168	6	incidence	incidence	NOUN
ajmpe-660	168	7	area	area	NOUN
ajmpe-660	168	8	of	of	ADP
ajmpe-660	168	9	esophageal	esophageal	ADJ
ajmpe-660	168	10	cancer	cancer	NOUN
ajmpe-660	168	11	,	,	PUNCT
ajmpe-660	168	12	and	and	CCONJ
ajmpe-660	168	13	pickled	pickled	ADJ
ajmpe-660	168	14	vegetable	vegetable	NOUN
ajmpe-660	168	15	consumption	consumption	NOUN
ajmpe-660	168	16	,	,	PUNCT
ajmpe-660	168	17	smoking	smoking	NOUN
ajmpe-660	168	18	,	,	PUNCT
ajmpe-660	168	19	alcohol	alcohol	NOUN
ajmpe-660	168	20	consumption	consumption	NOUN
ajmpe-660	168	21	,	,	PUNCT
ajmpe-660	168	22	low	low	ADJ
ajmpe-660	168	23	intake	intake	NOUN
ajmpe-660	168	24	of	of	ADP
ajmpe-660	168	25	fruits	fruit	NOUN
ajmpe-660	168	26	and	and	CCONJ
ajmpe-660	168	27	vegetables	vegetable	NOUN
ajmpe-660	168	28	are	be	AUX
ajmpe-660	168	29	all	all	PRON
ajmpe-660	168	30	its	its	PRON
ajmpe-660	168	31	risk	risk	NOUN
ajmpe-660	168	32	factors	factor	NOUN
ajmpe-660	168	33	[	[	X
ajmpe-660	168	34	43	43	NUM
ajmpe-660	168	35	]	]	PUNCT
ajmpe-660	168	36	.	.	PUNCT
ajmpe-660	169	1	li	li	PROPN
ajmpe-660	169	2	et	et	PROPN
ajmpe-660	169	3	al	al	PROPN
ajmpe-660	170	1	[	[	X
ajmpe-660	170	2	44	44	NUM
ajmpe-660	170	3	]	]	PUNCT
ajmpe-660	170	4	.	.	PUNCT
ajmpe-660	171	1	found	find	VERB
ajmpe-660	171	2	that	that	SCONJ
ajmpe-660	171	3	curcumin	curcumin	NOUN
ajmpe-660	171	4	inhibited	inhibit	VERB
ajmpe-660	171	5	the	the	DET
ajmpe-660	171	6	proliferation	proliferation	NOUN
ajmpe-660	171	7	of	of	ADP
ajmpe-660	171	8	esophageal	esophageal	ADJ
ajmpe-660	171	9	cancer	cancer	NOUN
ajmpe-660	171	10	ec109	ec109	PROPN
ajmpe-660	171	11	cells	cell	NOUN
ajmpe-660	171	12	by	by	ADP
ajmpe-660	171	13	up	up	ADV
ajmpe-660	171	14	-	-	PUNCT
ajmpe-660	171	15	regulating	regulate	VERB
ajmpe-660	171	16	the	the	DET
ajmpe-660	171	17	expression	expression	NOUN
ajmpe-660	171	18	of	of	ADP
ajmpe-660	171	19	pten	pten	NOUN
ajmpe-660	171	20	,	,	PUNCT
ajmpe-660	171	21	gsk3β	gsk3β	PROPN
ajmpe-660	171	22	and	and	CCONJ
ajmpe-660	171	23	caspase	caspase	NOUN
ajmpe-660	171	24	3	3	NUM
ajmpe-660	171	25	and	and	CCONJ
ajmpe-660	171	26	inhibiting	inhibit	VERB
ajmpe-660	171	27	the	the	DET
ajmpe-660	171	28	pi3k	pi3k	PROPN
ajmpe-660	171	29	/	/	SYM
ajmpe-660	171	30	akt	akt	PROPN
ajmpe-660	171	31	signaling	signal	VERB
ajmpe-660	171	32	pathway	pathway	NOUN
ajmpe-660	171	33	.	.	PUNCT
ajmpe-660	172	1	lin	lin	PROPN
ajmpe-660	172	2	et	et	PROPN
ajmpe-660	172	3	al	al	PROPN
ajmpe-660	172	4	.	.	PUNCT
ajmpe-660	173	1	[	[	X
ajmpe-660	173	2	45	45	NUM
ajmpe-660	173	3	]	]	PUNCT
ajmpe-660	173	4	found	find	VERB
ajmpe-660	173	5	that	that	SCONJ
ajmpe-660	173	6	curcumin	curcumin	NOUN
ajmpe-660	173	7	inhibited	inhibit	VERB
ajmpe-660	173	8	the	the	DET
ajmpe-660	173	9	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-660	173	10	american	american	PROPN
ajmpe-660	173	11	journal	journal	PROPN
ajmpe-660	173	12	of	of	ADP
ajmpe-660	173	13	medical	medical	ADJ
ajmpe-660	173	14	and	and	CCONJ
ajmpe-660	173	15	physical	physical	ADJ
ajmpe-660	173	16	education	education	PROPN
ajmpe-660	173	17	vol.8	vol.8	PROPN
ajmpe-660	173	18	,	,	PUNCT
ajmpe-660	173	19	issue	issue	NOUN
ajmpe-660	173	20	5	5	NUM
ajmpe-660	173	21	;	;	PUNCT
ajmpe-660	173	22	september	september	PROPN
ajmpe-660	173	23	-	-	PUNCT
ajmpe-660	173	24	october	october	PROPN
ajmpe-660	173	25	2023	2023	NUM
ajmpe-660	173	26	;	;	PUNCT
ajmpe-660	173	27	issn	issn	PROPN
ajmpe-660	173	28	:	:	PUNCT
ajmpe-660	173	29	2994	2994	NUM
ajmpe-660	173	30	-	-	SYM
ajmpe-660	173	31	0524	0524	NUM
ajmpe-660	173	32	impact	impact	NOUN
ajmpe-660	173	33	factor	factor	NOUN
ajmpe-660	173	34	:	:	PUNCT
ajmpe-660	173	35	6.14	6.14	NUM
ajmpe-660	173	36	1252	1252	NUM
ajmpe-660	173	37	columbia	columbia	PROPN
ajmpe-660	173	38	rd	rd	PROPN
ajmpe-660	173	39	nw	nw	PROPN
ajmpe-660	173	40	,	,	PUNCT
ajmpe-660	173	41	washington	washington	PROPN
ajmpe-660	173	42	dc	dc	PROPN
ajmpe-660	173	43	,	,	PUNCT
ajmpe-660	173	44	united	united	PROPN
ajmpe-660	173	45	states	states	PROPN
ajmpe-660	173	46	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	173	47	;	;	PUNCT
ajmpe-660	173	48	mail	mail	NOUN
ajmpe-660	173	49	:	:	PUNCT
ajmpe-660	173	50	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	174	1	15	15	NUM
ajmpe-660	175	1	|	|	ADV
ajmpe-660	175	2	a	a	DET
ajmpe-660	175	3	m	m	NOUN
ajmpe-660	175	4	e	e	NOUN
ajmpe-660	175	5	r	r	NOUN
ajmpe-660	175	6	i	i	NOUN
ajmpe-660	175	7	c	c	VERB
ajmpe-660	175	8	a	a	DET
ajmpe-660	175	9	n	n	NOUN
ajmpe-660	176	1	j	j	NOUN
ajmpe-660	176	2	o	o	X
ajmpe-660	176	3	u	u	NOUN
ajmpe-660	176	4	r	r	NOUN
ajmpe-660	176	5	n	n	NOUN
ajmpe-660	176	6	a	a	DET
ajmpe-660	176	7	l	l	NOUN
ajmpe-660	176	8	o	o	X
ajmpe-660	177	1	f	f	X
ajmpe-660	177	2	m	m	NOUN
ajmpe-660	177	3	e	e	NOUN
ajmpe-660	178	1	d	d	NOUN
ajmpe-660	178	2	i	i	PRON
ajmpe-660	178	3	c	c	VERB
ajmpe-660	178	4	a	a	DET
ajmpe-660	178	5	l	l	NOUN
ajmpe-660	178	6	a	a	X
ajmpe-660	178	7	n	n	NOUN
ajmpe-660	179	1	d	d	NOUN
ajmpe-660	179	2	p	p	NOUN
ajmpe-660	179	3	h	h	NOUN
ajmpe-660	179	4	y	y	NOUN
ajmpe-660	179	5	s	s	VERB
ajmpe-660	180	1	i	i	INTJ
ajmpe-660	180	2	c	c	VERB
ajmpe-660	180	3	a	a	DET
ajmpe-660	180	4	l	l	NOUN
ajmpe-660	180	5	e	e	NOUN
ajmpe-660	180	6	d	d	X
ajmpe-660	180	7	u	u	X
ajmpe-660	180	8	c	c	PROPN
ajmpe-660	181	1	a	a	DET
ajmpe-660	181	2	t	t	NOUN
ajmpe-660	182	1	i	i	PRON
ajmpe-660	182	2	o	o	VERB
ajmpe-660	182	3	n	n	CCONJ
ajmpe-660	182	4	|	|	ADV
ajmpe-660	182	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	182	6	formation	formation	NOUN
ajmpe-660	182	7	of	of	ADP
ajmpe-660	182	8	rac1	rac1	NOUN
ajmpe-660	182	9	-	-	PUNCT
ajmpe-660	182	10	pi3k	pi3k	PROPN
ajmpe-660	182	11	-	-	PUNCT
ajmpe-660	182	12	akt	akt	NOUN
ajmpe-660	182	13	signaling	signal	VERB
ajmpe-660	182	14	complex	complex	NOUN
ajmpe-660	182	15	related	relate	VERB
ajmpe-660	182	16	to	to	ADP
ajmpe-660	182	17	lipid	lipid	ADJ
ajmpe-660	182	18	rafts	raft	NOUN
ajmpe-660	182	19	in	in	ADP
ajmpe-660	182	20	ec	ec	PROPN
ajmpe-660	182	21	cells	cell	NOUN
ajmpe-660	182	22	,	,	PUNCT
ajmpe-660	182	23	and	and	CCONJ
ajmpe-660	182	24	inhibited	inhibit	VERB
ajmpe-660	182	25	the	the	DET
ajmpe-660	182	26	invasion	invasion	NOUN
ajmpe-660	182	27	of	of	ADP
ajmpe-660	182	28	ec	ec	PROPN
ajmpe-660	182	29	cells	cell	NOUN
ajmpe-660	182	30	induced	induce	VERB
ajmpe-660	182	31	by	by	ADP
ajmpe-660	182	32	stromal	stromal	ADJ
ajmpe-660	182	33	cell	cell	NOUN
ajmpe-660	182	34	-	-	PUNCT
ajmpe-660	182	35	derived	derive	VERB
ajmpe-660	182	36	factor-1α	factor-1α	NOUN
ajmpe-660	182	37	(	(	PUNCT
ajmpe-660	182	38	sdf-1α	sdf-1α	NOUN
ajmpe-660	182	39	)	)	PUNCT
ajmpe-660	182	40	through	through	ADP
ajmpe-660	182	41	the	the	DET
ajmpe-660	182	42	localization	localization	NOUN
ajmpe-660	182	43	of	of	ADP
ajmpe-660	182	44	lipid	lipid	ADJ
ajmpe-660	182	45	rafts	raft	NOUN
ajmpe-660	182	46	on	on	ADP
ajmpe-660	182	47	the	the	DET
ajmpe-660	182	48	cell	cell	NOUN
ajmpe-660	182	49	surface	surface	NOUN
ajmpe-660	182	50	and	and	CCONJ
ajmpe-660	182	51	the	the	DET
ajmpe-660	182	52	enhancement	enhancement	NOUN
ajmpe-660	182	53	of	of	ADP
ajmpe-660	182	54	matrix	matrix	NOUN
ajmpe-660	182	55	metalloproteinase-2	metalloproteinase-2	NUM
ajmpe-660	182	56	(	(	PUNCT
ajmpe-660	182	57	mmp-2	mmp-2	NOUN
ajmpe-660	182	58	)	)	PUNCT
ajmpe-660	182	59	promoter	promoter	NOUN
ajmpe-660	182	60	activity	activity	NOUN
ajmpe-660	182	61	.	.	PUNCT
ajmpe-660	183	1	chen	chen	PROPN
ajmpe-660	183	2	et	et	PROPN
ajmpe-660	183	3	al	al	PROPN
ajmpe-660	183	4	.	.	PUNCT
ajmpe-660	184	1	[	[	X
ajmpe-660	184	2	46	46	NUM
ajmpe-660	184	3	]	]	PUNCT
ajmpe-660	184	4	confirmed	confirm	VERB
ajmpe-660	184	5	that	that	SCONJ
ajmpe-660	184	6	after	after	ADP
ajmpe-660	184	7	48	48	NUM
ajmpe-660	184	8	hours	hour	NOUN
ajmpe-660	184	9	of	of	ADP
ajmpe-660	184	10	intervention	intervention	NOUN
ajmpe-660	184	11	with	with	ADP
ajmpe-660	184	12	different	different	ADJ
ajmpe-660	184	13	concentrations	concentration	NOUN
ajmpe-660	184	14	of	of	ADP
ajmpe-660	184	15	curcumin	curcumin	NOUN
ajmpe-660	184	16	,	,	PUNCT
ajmpe-660	184	17	the	the	DET
ajmpe-660	184	18	cell	cell	NOUN
ajmpe-660	184	19	cycle	cycle	NOUN
ajmpe-660	184	20	of	of	ADP
ajmpe-660	184	21	esophageal	esophageal	ADJ
ajmpe-660	184	22	cancer	cancer	NOUN
ajmpe-660	184	23	eca109	eca109	PROPN
ajmpe-660	184	24	cells	cell	NOUN
ajmpe-660	184	25	changed	change	VERB
ajmpe-660	184	26	significantly	significantly	ADV
ajmpe-660	184	27	,	,	PUNCT
ajmpe-660	184	28	the	the	DET
ajmpe-660	184	29	proportion	proportion	NOUN
ajmpe-660	184	30	of	of	ADP
ajmpe-660	184	31	cells	cell	NOUN
ajmpe-660	184	32	in	in	ADP
ajmpe-660	184	33	g0	g0	PROPN
ajmpe-660	184	34	/	/	SYM
ajmpe-660	184	35	g1	g1	PROPN
ajmpe-660	184	36	phase	phase	NOUN
ajmpe-660	184	37	decreased	decrease	VERB
ajmpe-660	184	38	significantly	significantly	ADV
ajmpe-660	184	39	,	,	PUNCT
ajmpe-660	184	40	and	and	CCONJ
ajmpe-660	184	41	the	the	DET
ajmpe-660	184	42	proportion	proportion	NOUN
ajmpe-660	184	43	of	of	ADP
ajmpe-660	184	44	cells	cell	NOUN
ajmpe-660	184	45	in	in	ADP
ajmpe-660	184	46	g2	g2	PROPN
ajmpe-660	184	47	/	/	SYM
ajmpe-660	184	48	m	m	PROPN
ajmpe-660	184	49	phase	phase	NOUN
ajmpe-660	184	50	increased	increase	VERB
ajmpe-660	184	51	significantly	significantly	ADV
ajmpe-660	184	52	.	.	PUNCT
ajmpe-660	185	1	these	these	DET
ajmpe-660	185	2	results	result	NOUN
ajmpe-660	185	3	indicated	indicate	VERB
ajmpe-660	185	4	that	that	SCONJ
ajmpe-660	185	5	curcumin	curcumin	NOUN
ajmpe-660	185	6	could	could	AUX
ajmpe-660	185	7	induce	induce	VERB
ajmpe-660	185	8	g2	g2	PROPN
ajmpe-660	185	9	/	/	SYM
ajmpe-660	185	10	m	m	PROPN
ajmpe-660	185	11	phase	phase	NOUN
ajmpe-660	185	12	arrest	arrest	NOUN
ajmpe-660	185	13	,	,	PUNCT
ajmpe-660	185	14	inhibit	inhibit	VERB
ajmpe-660	185	15	the	the	DET
ajmpe-660	185	16	proliferation	proliferation	NOUN
ajmpe-660	185	17	and	and	CCONJ
ajmpe-660	185	18	induce	induce	VERB
ajmpe-660	185	19	apoptosis	apoptosis	NOUN
ajmpe-660	185	20	of	of	ADP
ajmpe-660	185	21	eca-109	eca-109	ADJ
ajmpe-660	185	22	cells	cell	NOUN
ajmpe-660	185	23	.	.	PUNCT
ajmpe-660	186	1	8	8	NUM
ajmpe-660	186	2	.	.	X
ajmpe-660	186	3	curcumin	curcumin	NOUN
ajmpe-660	186	4	and	and	CCONJ
ajmpe-660	186	5	other	other	ADJ
ajmpe-660	186	6	tumors	tumor	NOUN
ajmpe-660	186	7	zhao	zhao	PROPN
ajmpe-660	186	8	et	et	PROPN
ajmpe-660	186	9	al	al	PROPN
ajmpe-660	186	10	.	.	PUNCT
ajmpe-660	187	1	[	[	X
ajmpe-660	187	2	47	47	NUM
ajmpe-660	187	3	]	]	PUNCT
ajmpe-660	187	4	found	find	VERB
ajmpe-660	187	5	that	that	SCONJ
ajmpe-660	187	6	curcumin	curcumin	NOUN
ajmpe-660	187	7	inhibited	inhibit	VERB
ajmpe-660	187	8	the	the	DET
ajmpe-660	187	9	growth	growth	NOUN
ajmpe-660	187	10	of	of	ADP
ajmpe-660	187	11	mouse	mouse	NOUN
ajmpe-660	187	12	prostate	prostate	NOUN
ajmpe-660	187	13	cancer	cancer	NOUN
ajmpe-660	187	14	xenografts	xenograft	NOUN
ajmpe-660	187	15	in	in	ADP
ajmpe-660	187	16	vivo	vivo	NOUN
ajmpe-660	187	17	and	and	CCONJ
ajmpe-660	187	18	promoted	promote	VERB
ajmpe-660	187	19	the	the	DET
ajmpe-660	187	20	apoptosis	apoptosis	NOUN
ajmpe-660	187	21	of	of	ADP
ajmpe-660	187	22	prostate	prostate	NOUN
ajmpe-660	187	23	lncap	lncap	NOUN
ajmpe-660	187	24	cells	cell	NOUN
ajmpe-660	187	25	by	by	ADP
ajmpe-660	187	26	inhibiting	inhibit	VERB
ajmpe-660	187	27	jnk	jnk	PROPN
ajmpe-660	187	28	pathway	pathway	NOUN
ajmpe-660	187	29	in	in	ADP
ajmpe-660	187	30	vitro	vitro	X
ajmpe-660	187	31	.	.	PUNCT
ajmpe-660	188	1	liu	liu	PROPN
ajmpe-660	188	2	et	et	PROPN
ajmpe-660	188	3	al	al	PROPN
ajmpe-660	188	4	.	.	PUNCT
ajmpe-660	189	1	[	[	X
ajmpe-660	189	2	48	48	NUM
ajmpe-660	189	3	]	]	PUNCT
ajmpe-660	189	4	confirmed	confirm	VERB
ajmpe-660	189	5	that	that	SCONJ
ajmpe-660	189	6	curcumin	curcumin	NOUN
ajmpe-660	189	7	treatment	treatment	NOUN
ajmpe-660	189	8	of	of	ADP
ajmpe-660	189	9	prostate	prostate	NOUN
ajmpe-660	189	10	cancer	cancer	NOUN
ajmpe-660	189	11	cell	cell	NOUN
ajmpe-660	189	12	lines	line	NOUN
ajmpe-660	189	13	du44	du44	PROPN
ajmpe-660	189	14	and	and	CCONJ
ajmpe-660	189	15	133rv145	133rv145	NUM
ajmpe-660	189	16	inhibited	inhibit	VERB
ajmpe-660	189	17	the	the	DET
ajmpe-660	189	18	proliferation	proliferation	NOUN
ajmpe-660	189	19	and	and	CCONJ
ajmpe-660	189	20	invasion	invasion	NOUN
ajmpe-660	189	21	of	of	ADP
ajmpe-660	189	22	cancer	cancer	NOUN
ajmpe-660	189	23	cells	cell	NOUN
ajmpe-660	189	24	in	in	ADP
ajmpe-660	189	25	vitro	vitro	NOUN
ajmpe-660	189	26	,	,	PUNCT
ajmpe-660	189	27	as	as	ADV
ajmpe-660	189	28	well	well	ADV
ajmpe-660	189	29	as	as	ADP
ajmpe-660	189	30	cell	cell	NOUN
ajmpe-660	189	31	cycle	cycle	NOUN
ajmpe-660	189	32	arrest	arrest	NOUN
ajmpe-660	189	33	.	.	PUNCT
ajmpe-660	190	1	gong	gong	NOUN
ajmpe-660	190	2	et	et	PROPN
ajmpe-660	190	3	al	al	PROPN
ajmpe-660	190	4	.	.	PUNCT
ajmpe-660	191	1	[	[	X
ajmpe-660	191	2	49	49	NUM
ajmpe-660	191	3	]	]	PUNCT
ajmpe-660	191	4	found	find	VERB
ajmpe-660	191	5	that	that	SCONJ
ajmpe-660	191	6	the	the	DET
ajmpe-660	191	7	viability	viability	NOUN
ajmpe-660	191	8	of	of	ADP
ajmpe-660	191	9	human	human	ADJ
ajmpe-660	191	10	renal	renal	ADJ
ajmpe-660	191	11	cell	cell	NOUN
ajmpe-660	191	12	adenocarcinoma	adenocarcinoma	NOUN
ajmpe-660	191	13	achn	achn	VERB
ajmpe-660	191	14	cells	cell	NOUN
ajmpe-660	191	15	was	be	AUX
ajmpe-660	191	16	inhibited	inhibit	VERB
ajmpe-660	191	17	and	and	CCONJ
ajmpe-660	191	18	the	the	DET
ajmpe-660	191	19	number	number	NOUN
ajmpe-660	191	20	of	of	ADP
ajmpe-660	191	21	apoptosis	apoptosis	NOUN
ajmpe-660	191	22	increased	increase	VERB
ajmpe-660	191	23	after	after	ADP
ajmpe-660	191	24	curcumin	curcumin	NOUN
ajmpe-660	191	25	treatment	treatment	NOUN
ajmpe-660	191	26	.	.	PUNCT
ajmpe-660	192	1	the	the	DET
ajmpe-660	192	2	results	result	NOUN
ajmpe-660	192	3	in	in	ADP
ajmpe-660	192	4	c57bl	c57bl	ADP
ajmpe-660	192	5	/	/	SYM
ajmpe-660	192	6	6	6	NUM
ajmpe-660	192	7	nude	nude	ADJ
ajmpe-660	192	8	mice	mouse	NOUN
ajmpe-660	192	9	verified	verify	VERB
ajmpe-660	192	10	that	that	SCONJ
ajmpe-660	192	11	the	the	DET
ajmpe-660	192	12	tumor	tumor	NOUN
ajmpe-660	192	13	size	size	NOUN
ajmpe-660	192	14	,	,	PUNCT
ajmpe-660	192	15	weight	weight	NOUN
ajmpe-660	192	16	and	and	CCONJ
ajmpe-660	192	17	volume	volume	NOUN
ajmpe-660	192	18	were	be	AUX
ajmpe-660	192	19	also	also	ADV
ajmpe-660	192	20	significantly	significantly	ADV
ajmpe-660	192	21	inhibited	inhibit	VERB
ajmpe-660	192	22	after	after	ADP
ajmpe-660	192	23	curcumin	curcumin	NOUN
ajmpe-660	192	24	treatment	treatment	NOUN
ajmpe-660	192	25	,	,	PUNCT
ajmpe-660	192	26	and	and	CCONJ
ajmpe-660	192	27	confirmed	confirm	VERB
ajmpe-660	192	28	that	that	SCONJ
ajmpe-660	192	29	the	the	DET
ajmpe-660	192	30	expression	expression	NOUN
ajmpe-660	192	31	of	of	ADP
ajmpe-660	192	32	akt	akt	PROPN
ajmpe-660	192	33	/	/	SYM
ajmpe-660	192	34	mtor	mtor	PROPN
ajmpe-660	192	35	protein	protein	NOUN
ajmpe-660	192	36	in	in	ADP
ajmpe-660	192	37	the	the	DET
ajmpe-660	192	38	treatment	treatment	NOUN
ajmpe-660	192	39	group	group	NOUN
ajmpe-660	192	40	was	be	AUX
ajmpe-660	192	41	significantly	significantly	ADV
ajmpe-660	192	42	reduced	reduce	VERB
ajmpe-660	192	43	,	,	PUNCT
ajmpe-660	192	44	while	while	SCONJ
ajmpe-660	192	45	autophagyrelated	autophagyrelated	ADJ
ajmpe-660	192	46	proteins	protein	NOUN
ajmpe-660	192	47	were	be	AUX
ajmpe-660	192	48	significantly	significantly	ADV
ajmpe-660	192	49	increased	increase	VERB
ajmpe-660	192	50	.	.	PUNCT
ajmpe-660	193	1	these	these	DET
ajmpe-660	193	2	results	result	NOUN
ajmpe-660	193	3	indicate	indicate	VERB
ajmpe-660	193	4	that	that	SCONJ
ajmpe-660	193	5	curcumin	curcumin	NOUN
ajmpe-660	193	6	plays	play	VERB
ajmpe-660	193	7	a	a	DET
ajmpe-660	193	8	role	role	NOUN
ajmpe-660	193	9	in	in	ADP
ajmpe-660	193	10	antirenal	antirenal	ADJ
ajmpe-660	193	11	cell	cell	NOUN
ajmpe-660	193	12	carcinoma	carcinoma	NOUN
ajmpe-660	193	13	through	through	ADP
ajmpe-660	193	14	akt	akt	PROPN
ajmpe-660	193	15	/	/	SYM
ajmpe-660	193	16	mtor	mtor	PROPN
ajmpe-660	193	17	pathway	pathway	NOUN
ajmpe-660	193	18	.	.	PUNCT
ajmpe-660	194	1	zhou	zhou	PROPN
ajmpe-660	194	2	et	et	PROPN
ajmpe-660	194	3	al	al	PROPN
ajmpe-660	194	4	.	.	PUNCT
ajmpe-660	195	1	[	[	X
ajmpe-660	195	2	50	50	NUM
ajmpe-660	195	3	]	]	PUNCT
ajmpe-660	195	4	found	find	VERB
ajmpe-660	195	5	that	that	SCONJ
ajmpe-660	195	6	curcumin	curcumin	NOUN
ajmpe-660	195	7	had	have	VERB
ajmpe-660	195	8	stronger	strong	ADJ
ajmpe-660	195	9	cytotoxic	cytotoxic	ADJ
ajmpe-660	195	10	activity	activity	NOUN
ajmpe-660	195	11	on	on	ADP
ajmpe-660	195	12	acute	acute	ADJ
ajmpe-660	195	13	myeloid	myeloid	NOUN
ajmpe-660	195	14	leukemia	leukemia	NOUN
ajmpe-660	195	15	(	(	PUNCT
ajmpe-660	195	16	aml	aml	NOUN
ajmpe-660	195	17	)	)	PUNCT
ajmpe-660	195	18	cells	cell	NOUN
ajmpe-660	195	19	,	,	PUNCT
ajmpe-660	195	20	and	and	CCONJ
ajmpe-660	195	21	flavin	flavin	NOUN
ajmpe-660	195	22	inhibited	inhibit	VERB
ajmpe-660	195	23	the	the	DET
ajmpe-660	195	24	phosphorylation	phosphorylation	NOUN
ajmpe-660	195	25	of	of	ADP
ajmpe-660	195	26	akt	akt	PROPN
ajmpe-660	195	27	,	,	PUNCT
ajmpe-660	195	28	pras70	pras70	NOUN
ajmpe-660	195	29	,	,	PUNCT
ajmpe-660	195	30	6e	6e	NOUN
ajmpe-660	195	31	-	-	PUNCT
ajmpe-660	195	32	bp1	bp1	PROPN
ajmpe-660	195	33	,	,	PUNCT
ajmpe-660	195	34	p27s2k	p27s2k	PROPN
ajmpe-660	195	35	,	,	PUNCT
ajmpe-660	195	36	raf-5	raf-5	ADV
ajmpe-660	195	37	and	and	CCONJ
ajmpe-660	195	38	p1	p1	NOUN
ajmpe-660	195	39	in	in	ADP
ajmpe-660	195	40	aml	aml	PROPN
ajmpe-660	195	41	cell	cell	NOUN
ajmpe-660	195	42	lines	line	NOUN
ajmpe-660	195	43	(	(	PUNCT
ajmpe-660	195	44	ml-4	ml-4	NOUN
ajmpe-660	195	45	and	and	CCONJ
ajmpe-660	195	46	oci	oci	PROPN
ajmpe-660	195	47	-	-	PUNCT
ajmpe-660	195	48	aml1	aml1	NOUN
ajmpe-660	195	49	)	)	PUNCT
ajmpe-660	195	50	in	in	ADP
ajmpe-660	195	51	a	a	DET
ajmpe-660	195	52	dosedependent	dosedependent	NOUN
ajmpe-660	195	53	manner	manner	NOUN
ajmpe-660	195	54	.	.	PUNCT
ajmpe-660	196	1	regulation	regulation	NOUN
ajmpe-660	196	2	of	of	ADP
ajmpe-660	196	3	cell	cell	NOUN
ajmpe-660	196	4	cycle	cycle	NOUN
ajmpe-660	196	5	d21	d21	NOUN
ajmpe-660	196	6	leads	lead	VERB
ajmpe-660	196	7	to	to	ADP
ajmpe-660	196	8	cell	cell	NOUN
ajmpe-660	196	9	cycle	cycle	NOUN
ajmpe-660	196	10	arrest	arrest	NOUN
ajmpe-660	196	11	and	and	CCONJ
ajmpe-660	196	12	apoptosis	apoptosis	NOUN
ajmpe-660	196	13	in	in	ADP
ajmpe-660	196	14	ml-5	ml-5	PROPN
ajmpe-660	196	15	and	and	CCONJ
ajmpe-660	196	16	oci	oci	PROPN
ajmpe-660	196	17	-	-	PUNCT
ajmpe-660	196	18	aml79	aml79	ADJ
ajmpe-660	196	19	cells	cell	NOUN
ajmpe-660	196	20	.	.	PUNCT
ajmpe-660	197	1	hu	hu	PROPN
ajmpe-660	197	2	et	et	PROPN
ajmpe-660	197	3	al	al	PROPN
ajmpe-660	197	4	.	.	PUNCT
ajmpe-660	198	1	[	[	X
ajmpe-660	198	2	51	51	NUM
ajmpe-660	198	3	]	]	PUNCT
ajmpe-660	198	4	found	find	VERB
ajmpe-660	198	5	that	that	SCONJ
ajmpe-660	198	6	curcumin	curcumin	NOUN
ajmpe-660	198	7	showed	show	VERB
ajmpe-660	198	8	anti	anti	ADJ
ajmpe-660	198	9	-	-	ADJ
ajmpe-660	198	10	proliferation	proliferation	ADJ
ajmpe-660	198	11	and	and	CCONJ
ajmpe-660	198	12	colony	colony	NOUN
ajmpe-660	198	13	formation	formation	NOUN
ajmpe-660	198	14	inhibitory	inhibitory	ADJ
ajmpe-660	198	15	activities	activity	NOUN
ajmpe-660	198	16	in	in	ADP
ajmpe-660	198	17	the	the	DET
ajmpe-660	198	18	treatment	treatment	NOUN
ajmpe-660	198	19	of	of	ADP
ajmpe-660	198	20	human	human	ADJ
ajmpe-660	198	21	breast	breast	NOUN
ajmpe-660	198	22	cancer	cancer	NOUN
ajmpe-660	198	23	mcf-7	mcf-7	PUNCT
ajmpe-660	198	24	and	and	CCONJ
ajmpe-660	198	25	mda	mda	PROPN
ajmpe-660	198	26	-	-	PUNCT
ajmpe-660	198	27	mb-231	mb-231	PROPN
ajmpe-660	198	28	cell	cell	NOUN
ajmpe-660	198	29	lines	line	NOUN
ajmpe-660	198	30	,	,	PUNCT
ajmpe-660	198	31	and	and	CCONJ
ajmpe-660	198	32	it	it	PRON
ajmpe-660	198	33	also	also	ADV
ajmpe-660	198	34	inhibited	inhibit	VERB
ajmpe-660	198	35	the	the	DET
ajmpe-660	198	36	migration	migration	NOUN
ajmpe-660	198	37	of	of	ADP
ajmpe-660	198	38	mda	mda	PROPN
ajmpe-660	198	39	-	-	PUNCT
ajmpe-660	198	40	mb-231	mb-231	PROPN
ajmpe-660	198	41	cells	cell	NOUN
ajmpe-660	198	42	.	.	PUNCT
ajmpe-660	199	1	in	in	ADP
ajmpe-660	199	2	addition	addition	NOUN
ajmpe-660	199	3	,	,	PUNCT
ajmpe-660	199	4	curcumin	curcumin	NOUN
ajmpe-660	199	5	downregulated	downregulate	VERB
ajmpe-660	199	6	the	the	DET
ajmpe-660	199	7	mrna	mrna	PROPN
ajmpe-660	199	8	expression	expression	NOUN
ajmpe-660	199	9	of	of	ADP
ajmpe-660	199	10	vimentin	vimentin	NOUN
ajmpe-660	199	11	,	,	PUNCT
ajmpe-660	199	12	fibroniconin	fibroniconin	NOUN
ajmpe-660	199	13	and	and	CCONJ
ajmpe-660	199	14	β	β	NOUN
ajmpe-660	199	15	-	-	NOUN
ajmpe-660	199	16	catenin	catenin	NOUN
ajmpe-660	199	17	,	,	PUNCT
ajmpe-660	199	18	and	and	CCONJ
ajmpe-660	199	19	upregulated	upregulate	VERB
ajmpe-660	199	20	the	the	DET
ajmpe-660	199	21	mrna	mrna	PROPN
ajmpe-660	199	22	expression	expression	NOUN
ajmpe-660	199	23	level	level	NOUN
ajmpe-660	199	24	of	of	ADP
ajmpe-660	199	25	ecadherin	ecadherin	NOUN
ajmpe-660	199	26	,	,	PUNCT
ajmpe-660	199	27	indicating	indicate	VERB
ajmpe-660	199	28	that	that	SCONJ
ajmpe-660	199	29	the	the	DET
ajmpe-660	199	30	inhibitory	inhibitory	ADJ
ajmpe-660	199	31	effect	effect	NOUN
ajmpe-660	199	32	of	of	ADP
ajmpe-660	199	33	curcumin	curcumin	NOUN
ajmpe-660	199	34	on	on	ADP
ajmpe-660	199	35	breast	breast	NOUN
ajmpe-660	199	36	cancer	cancer	NOUN
ajmpe-660	199	37	cells	cell	NOUN
ajmpe-660	199	38	was	be	AUX
ajmpe-660	199	39	closely	closely	ADV
ajmpe-660	199	40	related	relate	VERB
ajmpe-660	199	41	to	to	ADP
ajmpe-660	199	42	epithelial	epithelial	ADJ
ajmpe-660	199	43	-	-	PUNCT
ajmpe-660	199	44	mesenchymal	mesenchymal	NOUN
ajmpe-660	199	45	transition	transition	NOUN
ajmpe-660	199	46	(	(	PUNCT
ajmpe-660	199	47	emt	emt	PROPN
ajmpe-660	199	48	)	)	PUNCT
ajmpe-660	199	49	.	.	PUNCT
ajmpe-660	200	1	shi	shi	PROPN
ajmpe-660	200	2	et	et	PROPN
ajmpe-660	200	3	al	al	PROPN
ajmpe-660	200	4	.	.	PUNCT
ajmpe-660	201	1	[	[	X
ajmpe-660	201	2	52	52	NUM
ajmpe-660	201	3	]	]	PUNCT
ajmpe-660	201	4	found	find	VERB
ajmpe-660	201	5	that	that	SCONJ
ajmpe-660	201	6	curcumin	curcumin	NOUN
ajmpe-660	201	7	can	can	AUX
ajmpe-660	201	8	inhibit	inhibit	VERB
ajmpe-660	201	9	the	the	DET
ajmpe-660	201	10	cell	cell	NOUN
ajmpe-660	201	11	proliferation	proliferation	NOUN
ajmpe-660	201	12	of	of	ADP
ajmpe-660	201	13	bladder	bladder	NOUN
ajmpe-660	201	14	cancer	cancer	NOUN
ajmpe-660	201	15	cells	cell	NOUN
ajmpe-660	201	16	t24	t24	NOUN
ajmpe-660	201	17	and	and	CCONJ
ajmpe-660	201	18	5637	5637	NUM
ajmpe-660	201	19	,	,	PUNCT
ajmpe-660	201	20	and	and	CCONJ
ajmpe-660	201	21	reduce	reduce	VERB
ajmpe-660	201	22	the	the	DET
ajmpe-660	201	23	migration	migration	NOUN
ajmpe-660	201	24	and	and	CCONJ
ajmpe-660	201	25	invasion	invasion	NOUN
ajmpe-660	201	26	ability	ability	NOUN
ajmpe-660	201	27	of	of	ADP
ajmpe-660	201	28	t24	t24	NOUN
ajmpe-660	201	29	and	and	CCONJ
ajmpe-660	201	30	5637	5637	NUM
ajmpe-660	201	31	cells	cell	NOUN
ajmpe-660	201	32	by	by	ADP
ajmpe-660	201	33	regulating	regulate	VERB
ajmpe-660	201	34	the	the	DET
ajmpe-660	201	35	expression	expression	NOUN
ajmpe-660	201	36	of	of	ADP
ajmpe-660	201	37	β	β	NOUN
ajmpe-660	201	38	-	-	ADJ
ajmpe-660	201	39	catenin	catenin	ADJ
ajmpe-660	201	40	and	and	CCONJ
ajmpe-660	201	41	reversing	reverse	VERB
ajmpe-660	201	42	emt	emt	PROPN
ajmpe-660	201	43	.	.	PUNCT
ajmpe-660	202	1	bharti	bharti	PROPN
ajmpe-660	202	2	et	et	PROPN
ajmpe-660	202	3	al	al	PROPN
ajmpe-660	202	4	.	.	PUNCT
ajmpe-660	203	1	[	[	X
ajmpe-660	203	2	53	53	NUM
ajmpe-660	203	3	]	]	PUNCT
ajmpe-660	203	4	found	find	VERB
ajmpe-660	203	5	that	that	SCONJ
ajmpe-660	203	6	the	the	DET
ajmpe-660	203	7	transcription	transcription	NOUN
ajmpe-660	203	8	factor	factor	NOUN
ajmpe-660	203	9	nuclear	nuclear	ADJ
ajmpe-660	203	10	factor	factor	NOUN
ajmpe-660	203	11	-	-	PUNCT
ajmpe-660	203	12	kappab	kappab	NOUN
ajmpe-660	203	13	(	(	PUNCT
ajmpe-660	203	14	nf	nf	NOUN
ajmpe-660	203	15	-	-	PUNCT
ajmpe-660	203	16	kappab	kappab	NOUN
ajmpe-660	203	17	)	)	PUNCT
ajmpe-660	203	18	plays	play	VERB
ajmpe-660	203	19	a	a	DET
ajmpe-660	203	20	central	central	ADJ
ajmpe-660	203	21	role	role	NOUN
ajmpe-660	203	22	in	in	ADP
ajmpe-660	203	23	cell	cell	NOUN
ajmpe-660	203	24	survival	survival	NOUN
ajmpe-660	203	25	and	and	CCONJ
ajmpe-660	203	26	proliferation	proliferation	NOUN
ajmpe-660	203	27	of	of	ADP
ajmpe-660	203	28	human	human	ADJ
ajmpe-660	203	29	multiple	multiple	ADJ
ajmpe-660	203	30	myeloma	myeloma	NOUN
ajmpe-660	203	31	(	(	PUNCT
ajmpe-660	203	32	mm	mm	NOUN
ajmpe-660	203	33	)	)	PUNCT
ajmpe-660	203	34	,	,	PUNCT
ajmpe-660	203	35	and	and	CCONJ
ajmpe-660	203	36	that	that	SCONJ
ajmpe-660	203	37	curcumin	curcumin	NOUN
ajmpe-660	203	38	could	could	AUX
ajmpe-660	203	39	down	down	ADV
ajmpe-660	203	40	-	-	PUNCT
ajmpe-660	203	41	regulate	regulate	VERB
ajmpe-660	203	42	the	the	DET
ajmpe-660	203	43	expression	expression	NOUN
ajmpe-660	203	44	of	of	ADP
ajmpe-660	203	45	nfkappab	nfkappab	NOUN
ajmpe-660	203	46	-	-	PUNCT
ajmpe-660	203	47	regulated	regulate	VERB
ajmpe-660	203	48	gene	gene	NOUN
ajmpe-660	203	49	products	product	NOUN
ajmpe-660	203	50	,	,	PUNCT
ajmpe-660	203	51	including	include	VERB
ajmpe-660	203	52	ikappabalpha	ikappabalpha	PROPN
ajmpe-660	203	53	,	,	PUNCT
ajmpe-660	203	54	bcl-2	bcl-2	NOUN
ajmpe-660	203	55	,	,	PUNCT
ajmpe-660	203	56	and	and	CCONJ
ajmpe-660	203	57	bcl-2	bcl-2	NOUN
ajmpe-660	203	58	.	.	PUNCT
ajmpe-660	204	1	bcl	bcl	NOUN
ajmpe-660	204	2	-	-	PUNCT
ajmpe-660	204	3	x	x	INTJ
ajmpe-660	204	4	(	(	PUNCT
ajmpe-660	204	5	l	l	NOUN
ajmpe-660	204	6	)	)	PUNCT
ajmpe-660	204	7	and	and	CCONJ
ajmpe-660	204	8	cyclin	cyclin	NOUN
ajmpe-660	204	9	d1	d1	PROPN
ajmpe-660	204	10	.	.	PUNCT
ajmpe-660	205	1	this	this	PRON
ajmpe-660	205	2	resulted	result	VERB
ajmpe-660	205	3	in	in	ADP
ajmpe-660	205	4	the	the	DET
ajmpe-660	205	5	arrest	arrest	NOUN
ajmpe-660	205	6	of	of	ADP
ajmpe-660	205	7	the	the	DET
ajmpe-660	205	8	g	g	NOUN
ajmpe-660	205	9	(	(	PUNCT
ajmpe-660	205	10	1	1	NUM
ajmpe-660	205	11	)	)	PUNCT
ajmpe-660	205	12	/s	/	NOUN
ajmpe-660	205	13	phase	phase	NOUN
ajmpe-660	205	14	of	of	ADP
ajmpe-660	205	15	the	the	DET
ajmpe-660	205	16	mm	mm	PROPN
ajmpe-660	205	17	cell	cell	NOUN
ajmpe-660	205	18	cycle	cycle	NOUN
ajmpe-660	205	19	and	and	CCONJ
ajmpe-660	205	20	effectively	effectively	ADV
ajmpe-660	205	21	inhibited	inhibit	VERB
ajmpe-660	205	22	the	the	DET
ajmpe-660	205	23	proliferation	proliferation	NOUN
ajmpe-660	205	24	of	of	ADP
ajmpe-660	205	25	mm	mm	PROPN
ajmpe-660	205	26	cells	cell	NOUN
ajmpe-660	205	27	.	.	PUNCT
ajmpe-660	206	1	thus	thus	ADV
ajmpe-660	206	2	,	,	PUNCT
ajmpe-660	206	3	it	it	PRON
ajmpe-660	206	4	provides	provide	VERB
ajmpe-660	206	5	a	a	DET
ajmpe-660	206	6	molecular	molecular	ADJ
ajmpe-660	206	7	basis	basis	NOUN
ajmpe-660	206	8	for	for	ADP
ajmpe-660	206	9	the	the	DET
ajmpe-660	206	10	use	use	NOUN
ajmpe-660	206	11	of	of	ADP
ajmpe-660	206	12	curcumin	curcumin	NOUN
ajmpe-660	206	13	in	in	ADP
ajmpe-660	206	14	the	the	DET
ajmpe-660	206	15	treatment	treatment	NOUN
ajmpe-660	206	16	of	of	ADP
ajmpe-660	206	17	mm	mm	PROPN
ajmpe-660	206	18	patients	patient	NOUN
ajmpe-660	206	19	.	.	PUNCT
ajmpe-660	207	1	9	9	X
ajmpe-660	207	2	.	.	X
ajmpe-660	207	3	conclusion	conclusion	NOUN
ajmpe-660	207	4	and	and	CCONJ
ajmpe-660	207	5	outlook	outlook	NOUN
ajmpe-660	207	6	in	in	ADP
ajmpe-660	207	7	summary	summary	NOUN
ajmpe-660	207	8	,	,	PUNCT
ajmpe-660	207	9	more	more	ADJ
ajmpe-660	207	10	and	and	CCONJ
ajmpe-660	207	11	more	more	ADJ
ajmpe-660	207	12	studies	study	NOUN
ajmpe-660	207	13	have	have	AUX
ajmpe-660	207	14	shown	show	VERB
ajmpe-660	207	15	that	that	SCONJ
ajmpe-660	207	16	the	the	DET
ajmpe-660	207	17	anti	anti	ADJ
ajmpe-660	207	18	-	-	ADJ
ajmpe-660	207	19	tumor	tumor	ADJ
ajmpe-660	207	20	activity	activity	NOUN
ajmpe-660	207	21	of	of	ADP
ajmpe-660	207	22	curcumin	curcumin	NOUN
ajmpe-660	207	23	involves	involve	VERB
ajmpe-660	207	24	the	the	DET
ajmpe-660	207	25	regulation	regulation	NOUN
ajmpe-660	207	26	of	of	ADP
ajmpe-660	207	27	a	a	DET
ajmpe-660	207	28	variety	variety	NOUN
ajmpe-660	207	29	of	of	ADP
ajmpe-660	207	30	cell	cell	NOUN
ajmpe-660	207	31	signaling	signal	VERB
ajmpe-660	207	32	pathways	pathway	NOUN
ajmpe-660	207	33	,	,	PUNCT
ajmpe-660	207	34	and	and	CCONJ
ajmpe-660	207	35	acts	act	VERB
ajmpe-660	207	36	on	on	ADP
ajmpe-660	207	37	a	a	DET
ajmpe-660	207	38	variety	variety	NOUN
ajmpe-660	207	39	of	of	ADP
ajmpe-660	207	40	molecular	molecular	ADJ
ajmpe-660	207	41	targets	target	NOUN
ajmpe-660	207	42	,	,	PUNCT
ajmpe-660	207	43	including	include	VERB
ajmpe-660	207	44	transcription	transcription	NOUN
ajmpe-660	207	45	factors	factor	NOUN
ajmpe-660	207	46	,	,	PUNCT
ajmpe-660	207	47	cytokines	cytokine	NOUN
ajmpe-660	207	48	,	,	PUNCT
ajmpe-660	207	49	growth	growth	NOUN
ajmpe-660	207	50	factors	factor	NOUN
ajmpe-660	207	51	and	and	CCONJ
ajmpe-660	207	52	their	their	PRON
ajmpe-660	207	53	receptors	receptor	NOUN
ajmpe-660	207	54	,	,	PUNCT
ajmpe-660	207	55	enzymes	enzyme	NOUN
ajmpe-660	207	56	,	,	PUNCT
ajmpe-660	207	57	inflammatory	inflammatory	ADJ
ajmpe-660	207	58	factors	factor	NOUN
ajmpe-660	207	59	,	,	PUNCT
ajmpe-660	207	60	and	and	CCONJ
ajmpe-660	207	61	genes	gene	NOUN
ajmpe-660	207	62	regulating	regulate	VERB
ajmpe-660	207	63	cell	cell	NOUN
ajmpe-660	207	64	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-660	207	65	american	american	PROPN
ajmpe-660	207	66	journal	journal	PROPN
ajmpe-660	207	67	of	of	ADP
ajmpe-660	207	68	medical	medical	ADJ
ajmpe-660	207	69	and	and	CCONJ
ajmpe-660	207	70	physical	physical	ADJ
ajmpe-660	207	71	education	education	PROPN
ajmpe-660	207	72	vol.8	vol.8	PROPN
ajmpe-660	207	73	,	,	PUNCT
ajmpe-660	207	74	issue	issue	NOUN
ajmpe-660	207	75	5	5	NUM
ajmpe-660	207	76	;	;	PUNCT
ajmpe-660	207	77	september	september	PROPN
ajmpe-660	207	78	-	-	PUNCT
ajmpe-660	207	79	october	october	PROPN
ajmpe-660	207	80	2023	2023	NUM
ajmpe-660	207	81	;	;	PUNCT
ajmpe-660	207	82	issn	issn	PROPN
ajmpe-660	207	83	:	:	PUNCT
ajmpe-660	207	84	2994	2994	NUM
ajmpe-660	207	85	-	-	SYM
ajmpe-660	207	86	0524	0524	NUM
ajmpe-660	207	87	impact	impact	NOUN
ajmpe-660	207	88	factor	factor	NOUN
ajmpe-660	207	89	:	:	PUNCT
ajmpe-660	207	90	6.14	6.14	NUM
ajmpe-660	207	91	1252	1252	NUM
ajmpe-660	207	92	columbia	columbia	PROPN
ajmpe-660	207	93	rd	rd	PROPN
ajmpe-660	207	94	nw	nw	PROPN
ajmpe-660	207	95	,	,	PUNCT
ajmpe-660	207	96	washington	washington	PROPN
ajmpe-660	207	97	dc	dc	PROPN
ajmpe-660	207	98	,	,	PUNCT
ajmpe-660	207	99	united	united	PROPN
ajmpe-660	207	100	states	states	PROPN
ajmpe-660	207	101	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	207	102	;	;	PUNCT
ajmpe-660	207	103	mail	mail	NOUN
ajmpe-660	207	104	:	:	PUNCT
ajmpe-660	207	105	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	208	1	16	16	NUM
ajmpe-660	209	1	|	|	ADV
ajmpe-660	209	2	a	a	DET
ajmpe-660	209	3	m	m	NOUN
ajmpe-660	209	4	e	e	NOUN
ajmpe-660	209	5	r	r	NOUN
ajmpe-660	210	1	i	i	NOUN
ajmpe-660	210	2	c	c	VERB
ajmpe-660	210	3	a	a	DET
ajmpe-660	210	4	n	n	NOUN
ajmpe-660	211	1	j	j	NOUN
ajmpe-660	211	2	o	o	X
ajmpe-660	211	3	u	u	NOUN
ajmpe-660	211	4	r	r	NOUN
ajmpe-660	211	5	n	n	NOUN
ajmpe-660	211	6	a	a	DET
ajmpe-660	211	7	l	l	NOUN
ajmpe-660	211	8	o	o	X
ajmpe-660	212	1	f	f	X
ajmpe-660	212	2	m	m	NOUN
ajmpe-660	212	3	e	e	NOUN
ajmpe-660	213	1	d	d	NOUN
ajmpe-660	213	2	i	i	PRON
ajmpe-660	213	3	c	c	VERB
ajmpe-660	213	4	a	a	DET
ajmpe-660	213	5	l	l	NOUN
ajmpe-660	213	6	a	a	X
ajmpe-660	213	7	n	n	NOUN
ajmpe-660	214	1	d	d	NOUN
ajmpe-660	214	2	p	p	NOUN
ajmpe-660	214	3	h	h	NOUN
ajmpe-660	214	4	y	y	NOUN
ajmpe-660	214	5	s	s	VERB
ajmpe-660	215	1	i	i	INTJ
ajmpe-660	215	2	c	c	VERB
ajmpe-660	215	3	a	a	DET
ajmpe-660	215	4	l	l	NOUN
ajmpe-660	215	5	e	e	NOUN
ajmpe-660	215	6	d	d	X
ajmpe-660	215	7	u	u	X
ajmpe-660	215	8	c	c	PROPN
ajmpe-660	216	1	a	a	DET
ajmpe-660	216	2	t	t	NOUN
ajmpe-660	217	1	i	i	PRON
ajmpe-660	217	2	o	o	VERB
ajmpe-660	217	3	n	n	CCONJ
ajmpe-660	217	4	|	|	ADV
ajmpe-660	217	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	217	6	proliferation	proliferation	NOUN
ajmpe-660	217	7	and	and	CCONJ
ajmpe-660	217	8	apoptosis	apoptosis	NOUN
ajmpe-660	217	9	.	.	PUNCT
ajmpe-660	218	1	the	the	DET
ajmpe-660	218	2	above	above	ADJ
ajmpe-660	218	3	research	research	NOUN
ajmpe-660	218	4	results	result	NOUN
ajmpe-660	218	5	let	let	VERB
ajmpe-660	218	6	us	we	PRON
ajmpe-660	218	7	see	see	VERB
ajmpe-660	218	8	the	the	DET
ajmpe-660	218	9	benefits	benefit	NOUN
ajmpe-660	218	10	of	of	ADP
ajmpe-660	218	11	curcumin	curcumin	NOUN
ajmpe-660	218	12	in	in	ADP
ajmpe-660	218	13	the	the	DET
ajmpe-660	218	14	treatment	treatment	NOUN
ajmpe-660	218	15	of	of	ADP
ajmpe-660	218	16	animal	animal	NOUN
ajmpe-660	218	17	and	and	CCONJ
ajmpe-660	218	18	human	human	ADJ
ajmpe-660	218	19	tumors	tumor	NOUN
ajmpe-660	218	20	,	,	PUNCT
ajmpe-660	218	21	but	but	CCONJ
ajmpe-660	218	22	it	it	PRON
ajmpe-660	218	23	has	have	AUX
ajmpe-660	218	24	not	not	PART
ajmpe-660	218	25	yet	yet	ADV
ajmpe-660	218	26	entered	enter	VERB
ajmpe-660	218	27	the	the	DET
ajmpe-660	218	28	clinical	clinical	ADJ
ajmpe-660	218	29	antiexperiment	antiexperiment	NOUN
ajmpe-660	218	30	.	.	PUNCT
ajmpe-660	219	1	it	it	PRON
ajmpe-660	219	2	is	be	AUX
ajmpe-660	219	3	still	still	ADV
ajmpe-660	219	4	necessary	necessary	ADJ
ajmpe-660	219	5	to	to	PART
ajmpe-660	219	6	develop	develop	VERB
ajmpe-660	219	7	curcumin	curcumin	NOUN
ajmpe-660	219	8	and	and	CCONJ
ajmpe-660	219	9	its	its	PRON
ajmpe-660	219	10	derivatives	derivative	NOUN
ajmpe-660	219	11	and	and	CCONJ
ajmpe-660	219	12	new	new	ADJ
ajmpe-660	219	13	dosage	dosage	NOUN
ajmpe-660	219	14	forms	form	NOUN
ajmpe-660	219	15	to	to	PART
ajmpe-660	219	16	improve	improve	VERB
ajmpe-660	219	17	its	its	PRON
ajmpe-660	219	18	absorption	absorption	NOUN
ajmpe-660	219	19	and	and	CCONJ
ajmpe-660	219	20	metabolic	metabolic	NOUN
ajmpe-660	219	21	characteristics	characteristic	NOUN
ajmpe-660	219	22	,	,	PUNCT
ajmpe-660	219	23	in	in	ADP
ajmpe-660	219	24	order	order	NOUN
ajmpe-660	219	25	to	to	PART
ajmpe-660	219	26	find	find	VERB
ajmpe-660	219	27	a	a	DET
ajmpe-660	219	28	more	more	ADV
ajmpe-660	219	29	appropriate	appropriate	ADJ
ajmpe-660	219	30	dose	dose	NOUN
ajmpe-660	219	31	or	or	CCONJ
ajmpe-660	219	32	dosage	dosage	NOUN
ajmpe-660	219	33	form	form	NOUN
ajmpe-660	219	34	,	,	PUNCT
ajmpe-660	219	35	give	give	VERB
ajmpe-660	219	36	precise	precise	ADJ
ajmpe-660	219	37	anti	anti	ADJ
ajmpe-660	219	38	-	-	ADJ
ajmpe-660	219	39	tumor	tumor	ADJ
ajmpe-660	219	40	treatment	treatment	NOUN
ajmpe-660	219	41	for	for	ADP
ajmpe-660	219	42	specific	specific	ADJ
ajmpe-660	219	43	tumors	tumor	NOUN
ajmpe-660	219	44	,	,	PUNCT
ajmpe-660	219	45	and	and	CCONJ
ajmpe-660	219	46	improve	improve	VERB
ajmpe-660	219	47	the	the	DET
ajmpe-660	219	48	efficacy	efficacy	NOUN
ajmpe-660	219	49	.	.	PUNCT
ajmpe-660	220	1	it	it	PRON
ajmpe-660	220	2	has	have	AUX
ajmpe-660	220	3	become	become	VERB
ajmpe-660	220	4	a	a	DET
ajmpe-660	220	5	clinically	clinically	ADV
ajmpe-660	220	6	effective	effective	ADJ
ajmpe-660	220	7	tumor	tumor	NOUN
ajmpe-660	220	8	treatment	treatment	NOUN
ajmpe-660	220	9	drug	drug	NOUN
ajmpe-660	220	10	.	.	PUNCT
ajmpe-660	221	1	references	reference	NOUN
ajmpe-660	221	2	kocaadam	kocaadam	PROPN
ajmpe-660	221	3	b	b	PROPN
ajmpe-660	221	4	,	,	PUNCT
ajmpe-660	221	5	şanlier	şanlier	PROPN
ajmpe-660	221	6	n.	n.	PROPN
ajmpe-660	221	7	curcumin	curcumin	PROPN
ajmpe-660	221	8	,	,	PUNCT
ajmpe-660	221	9	an	an	DET
ajmpe-660	221	10	active	active	ADJ
ajmpe-660	221	11	component	component	NOUN
ajmpe-660	221	12	of	of	ADP
ajmpe-660	221	13	turmeric	turmeric	NOUN
ajmpe-660	221	14	(	(	PUNCT
ajmpe-660	221	15	curcuma	curcuma	PROPN
ajmpe-660	221	16	longa	longa	NOUN
ajmpe-660	221	17	)	)	PUNCT
ajmpe-660	221	18	,	,	PUNCT
ajmpe-660	221	19	and	and	CCONJ
ajmpe-660	221	20	its	its	PRON
ajmpe-660	221	21	effects	effect	NOUN
ajmpe-660	221	22	on	on	ADP
ajmpe-660	221	23	health	health	NOUN
ajmpe-660	222	1	[	[	X
ajmpe-660	222	2	j	j	X
ajmpe-660	222	3	]	]	X
ajmpe-660	222	4	.	.	PUNCT
ajmpe-660	223	1	crit	crit	PROPN
ajmpe-660	223	2	rev	rev	PROPN
ajmpe-660	223	3	food	food	PROPN
ajmpe-660	223	4	sci	sci	PROPN
ajmpe-660	223	5	nutr	nutr	PROPN
ajmpe-660	223	6	,	,	PUNCT
ajmpe-660	223	7	2017	2017	NUM
ajmpe-660	223	8	,	,	PUNCT
ajmpe-660	223	9	57(13	57(13	NUM
ajmpe-660	223	10	):	):	PUNCT
ajmpe-660	223	11	2889	2889	NUM
ajmpe-660	223	12	-	-	SYM
ajmpe-660	223	13	95	95	NUM
ajmpe-660	223	14	.	.	PUNCT
ajmpe-660	224	1	cui	cui	PROPN
ajmpe-660	224	2	yuhan	yuhan	PROPN
ajmpe-660	224	3	,	,	PUNCT
ajmpe-660	224	4	an	an	DET
ajmpe-660	224	5	xiao	xiao	PROPN
ajmpe-660	224	6	,	,	PUNCT
ajmpe-660	224	7	wang	wang	PROPN
ajmpe-660	224	8	haifeng	haifeng	PROPN
ajmpe-660	224	9	,	,	PUNCT
ajmpe-660	224	10	et	et	PROPN
ajmpe-660	224	11	al	al	PROPN
ajmpe-660	224	12	.	.	PROPN
ajmpe-660	224	13	study	study	PROPN
ajmpe-660	224	14	on	on	ADP
ajmpe-660	224	15	chemical	chemical	ADJ
ajmpe-660	224	16	components	component	NOUN
ajmpe-660	224	17	of	of	ADP
ajmpe-660	224	18	curcumincuma	curcumincuma	PROPN
ajmpe-660	224	19	longa	longa	PROPN
ajmpe-660	225	1	[	[	X
ajmpe-660	225	2	j	j	X
ajmpe-660	225	3	]	]	X
ajmpe-660	225	4	.	.	PUNCT
ajmpe-660	226	1	chinese	chinese	ADJ
ajmpe-660	226	2	herbal	herbal	ADJ
ajmpe-660	226	3	medicine	medicine	NOUN
ajmpe-660	226	4	,	,	PUNCT
ajmpe-660	226	5	2016	2016	NUM
ajmpe-660	226	6	,	,	PUNCT
ajmpe-660	226	7	47(7	47(7	NUM
ajmpe-660	226	8	):	):	PUNCT
ajmpe-660	226	9	1074	1074	NUM
ajmpe-660	226	10	-	-	SYM
ajmpe-660	226	11	1078	1078	NUM
ajmpe-660	226	12	.	.	PUNCT
ajmpe-660	227	1	kunnumakkara	kunnumakkara	PROPN
ajmpe-660	227	2	ab	ab	PROPN
ajmpe-660	227	3	,	,	PUNCT
ajmpe-660	227	4	bordoloi	bordoloi	PROPN
ajmpe-660	227	5	d	d	PROPN
ajmpe-660	227	6	,	,	PUNCT
ajmpe-660	227	7	padmavathi	padmavathi	PROPN
ajmpe-660	227	8	g	g	PROPN
ajmpe-660	227	9	,	,	PUNCT
ajmpe-660	227	10	et	et	PROPN
ajmpe-660	227	11	al	al	PROPN
ajmpe-660	227	12	.	.	PROPN
ajmpe-660	227	13	curcumin	curcumin	PROPN
ajmpe-660	227	14	,	,	PUNCT
ajmpe-660	227	15	the	the	DET
ajmpe-660	227	16	golden	golden	ADJ
ajmpe-660	227	17	nutraceutical	nutraceutical	NOUN
ajmpe-660	227	18	:	:	PUNCT
ajmpe-660	227	19	multitargeting	multitargeting	NOUN
ajmpe-660	227	20	for	for	ADP
ajmpe-660	227	21	multiple	multiple	ADJ
ajmpe-660	227	22	chronic	chronic	ADJ
ajmpe-660	227	23	diseases[j	diseases[j	NOUN
ajmpe-660	227	24	]	]	PUNCT
ajmpe-660	227	25	.	.	PUNCT
ajmpe-660	228	1	br	br	PROPN
ajmpe-660	228	2	j	j	PROPN
ajmpe-660	228	3	pharmacol	pharmacol	PROPN
ajmpe-660	228	4	,	,	PUNCT
ajmpe-660	228	5	2017	2017	NUM
ajmpe-660	228	6	,	,	PUNCT
ajmpe-660	228	7	174	174	NUM
ajmpe-660	228	8	(	(	PUNCT
ajmpe-660	228	9	11	11	NUM
ajmpe-660	228	10	)	)	PUNCT
ajmpe-660	228	11	:	:	PUNCT
ajmpe-660	228	12	1325	1325	NUM
ajmpe-660	228	13	-	-	SYM
ajmpe-660	228	14	1348	1348	NUM
ajmpe-660	228	15	.	.	PUNCT
ajmpe-660	229	1	kuttan	kuttan	PROPN
ajmpe-660	229	2	r	r	PROPN
ajmpe-660	229	3	,	,	PUNCT
ajmpe-660	229	4	kuttan	kuttan	PROPN
ajmpe-660	229	5	g.	g.	PROPN
ajmpe-660	229	6	inhibituon	inhibituon	NOUN
ajmpe-660	229	7	of	of	ADP
ajmpe-660	229	8	lung	lung	NOUN
ajmpe-660	229	9	metasis	metasis	NOUN
ajmpe-660	229	10	in	in	ADP
ajmpe-660	229	11	mice	mouse	NOUN
ajmpe-660	229	12	induced	induce	VERB
ajmpe-660	229	13	by	by	ADP
ajmpe-660	229	14	bi6f10	bi6f10	NOUN
ajmpe-660	229	15	melanoma	melanoma	NOUN
ajmpe-660	229	16	calls	call	NOUN
ajmpe-660	229	17	polyphenolic	polyphenolic	ADJ
ajmpe-660	229	18	compounds	compound	NOUN
ajmpe-660	229	19	[	[	X
ajmpe-660	229	20	j	j	X
ajmpe-660	229	21	]	]	X
ajmpe-660	229	22	.	.	PUNCT
ajmpe-660	230	1	cancer	cancer	PROPN
ajmpe-660	230	2	lett	lett	PROPN
ajmpe-660	230	3	,	,	PUNCT
ajmpe-660	230	4	1985	1985	NUM
ajmpe-660	230	5	,	,	PUNCT
ajmpe-660	230	6	29:197	29:197	NUM
ajmpe-660	230	7	.	.	PUNCT
ajmpe-660	231	1	xiao	xiao	PROPN
ajmpe-660	231	2	xuyang	xuyang	PROPN
ajmpe-660	231	3	,	,	PUNCT
ajmpe-660	231	4	wang	wang	PROPN
ajmpe-660	231	5	xiaodong	xiaodong	PROPN
ajmpe-660	231	6	.	.	PUNCT
ajmpe-660	232	1	research	research	NOUN
ajmpe-660	232	2	progress	progress	NOUN
ajmpe-660	232	3	on	on	ADP
ajmpe-660	232	4	the	the	DET
ajmpe-660	232	5	anti	anti	ADJ
ajmpe-660	232	6	-	-	ADJ
ajmpe-660	232	7	tumor	tumor	ADJ
ajmpe-660	232	8	mechanism	mechanism	NOUN
ajmpe-660	232	9	of	of	ADP
ajmpe-660	232	10	curcumin	curcumin	NOUN
ajmpe-660	233	1	[	[	X
ajmpe-660	233	2	j	j	X
ajmpe-660	233	3	]	]	X
ajmpe-660	233	4	.	.	PUNCT
ajmpe-660	234	1	journal	journal	PROPN
ajmpe-660	234	2	of	of	ADP
ajmpe-660	234	3	jinzhou	jinzhou	PROPN
ajmpe-660	234	4	medical	medical	PROPN
ajmpe-660	234	5	college	college	PROPN
ajmpe-660	234	6	,	,	PUNCT
ajmpe-660	234	7	2006	2006	NUM
ajmpe-660	234	8	,	,	PUNCT
ajmpe-660	234	9	27	27	NUM
ajmpe-660	234	10	(	(	PUNCT
ajmpe-660	234	11	1	1	NUM
ajmpe-660	234	12	):	):	PUNCT
ajmpe-660	234	13	56	56	NUM
ajmpe-660	234	14	-	-	SYM
ajmpe-660	234	15	58	58	NUM
ajmpe-660	234	16	.	.	PUNCT
ajmpe-660	235	1	duan	duan	PROPN
ajmpe-660	235	2	jinqi	jinqi	PROPN
ajmpe-660	235	3	,	,	PUNCT
ajmpe-660	235	4	zhang	zhang	PROPN
ajmpe-660	235	5	linxi	linxi	PROPN
ajmpe-660	235	6	.	.	PUNCT
ajmpe-660	236	1	research	research	NOUN
ajmpe-660	236	2	progress	progress	NOUN
ajmpe-660	236	3	of	of	ADP
ajmpe-660	236	4	anti	anti	ADJ
ajmpe-660	236	5	-	-	ADJ
ajmpe-660	236	6	tumor	tumor	ADJ
ajmpe-660	236	7	mechanism	mechanism	NOUN
ajmpe-660	236	8	of	of	ADP
ajmpe-660	236	9	curcumin	curcumin	NOUN
ajmpe-660	237	1	[	[	X
ajmpe-660	237	2	j	j	X
ajmpe-660	237	3	]	]	X
ajmpe-660	237	4	.	.	PUNCT
ajmpe-660	238	1	jiangsu	jiangsu	PROPN
ajmpe-660	238	2	medicine	medicine	PROPN
ajmpe-660	238	3	,	,	PUNCT
ajmpe-660	238	4	2011	2011	NUM
ajmpe-660	238	5	,	,	PUNCT
ajmpe-660	238	6	27	27	NUM
ajmpe-660	238	7	(	(	PUNCT
ajmpe-660	238	8	15	15	NUM
ajmpe-660	238	9	):	):	PUNCT
ajmpe-660	238	10	1824	1824	NUM
ajmpe-660	238	11	-	-	SYM
ajmpe-660	238	12	1826	1826	NUM
ajmpe-660	238	13	.	.	PUNCT
ajmpe-660	239	1	aggarwal	aggarwal	NOUN
ajmpe-660	239	2	b	b	PROPN
ajmpe-660	239	3	b	b	PROPN
ajmpe-660	239	4	,	,	PUNCT
ajmpe-660	239	5	sung	sung	PROPN
ajmpe-660	239	6	b.	b.	PROPN
ajmpe-660	239	7	pharmacological	pharmacological	ADJ
ajmpe-660	239	8	basis	basis	NOUN
ajmpe-660	239	9	for	for	ADP
ajmpe-660	239	10	the	the	DET
ajmpe-660	239	11	role	role	NOUN
ajmpe-660	239	12	of	of	ADP
ajmpe-660	239	13	curcumin	curcumin	NOUN
ajmpe-660	239	14	in	in	ADP
ajmpe-660	239	15	chronic	chronic	ADJ
ajmpe-660	239	16	diseases	disease	NOUN
ajmpe-660	239	17	:	:	PUNCT
ajmpe-660	239	18	an	an	DET
ajmpe-660	239	19	age	age	NOUN
ajmpe-660	239	20	old	old	ADJ
ajmpe-660	239	21	spice	spice	NOUN
ajmpe-660	239	22	with	with	ADP
ajmpe-660	239	23	moderntargets	moderntarget	NOUN
ajmpe-660	240	1	[	[	X
ajmpe-660	240	2	j	j	X
ajmpe-660	240	3	]	]	X
ajmpe-660	240	4	.	.	PUNCT
ajmpe-660	241	1	trends	trend	NOUN
ajmpe-660	241	2	pharmacol	pharmacol	PROPN
ajmpe-660	241	3	sci	sci	PROPN
ajmpe-660	241	4	,	,	PUNCT
ajmpe-660	241	5	2009	2009	NUM
ajmpe-660	241	6	,	,	PUNCT
ajmpe-660	241	7	30(2	30(2	NUM
ajmpe-660	241	8	):	):	PUNCT
ajmpe-660	241	9	85	85	NUM
ajmpe-660	241	10	-94	-94	NUM
ajmpe-660	241	11	.	.	PUNCT
ajmpe-660	242	1	osorio	osorio	NOUN
ajmpe-660	242	2	-	-	PUNCT
ajmpe-660	242	3	tobón	tobón	NOUN
ajmpe-660	242	4	j	j	PROPN
ajmpe-660	242	5	f	f	X
ajmpe-660	242	6	,	,	PUNCT
ajmpe-660	242	7	carvalho	carvalho	PROPN
ajmpe-660	242	8	p	p	PROPN
ajmpe-660	242	9	i	i	PROPN
ajmpe-660	242	10	,	,	PUNCT
ajmpe-660	242	11	barbero	barbero	PROPN
ajmpe-660	242	12	g	g	PROPN
ajmpe-660	242	13	f	f	PROPN
ajmpe-660	242	14	,	,	PUNCT
ajmpe-660	242	15	et	et	PROPN
ajmpe-660	242	16	al	al	PROPN
ajmpe-660	242	17	.	.	PROPN
ajmpe-660	243	1	fast	fast	ADJ
ajmpe-660	243	2	analysis	analysis	NOUN
ajmpe-660	243	3	of	of	ADP
ajmpe-660	243	4	curcuminoids	curcuminoid	NOUN
ajmpe-660	243	5	from	from	ADP
ajmpe-660	243	6	turmeric	turmeric	ADJ
ajmpe-660	243	7	(	(	PUNCT
ajmpe-660	243	8	curcumincuma	curcumincuma	PROPN
ajmpe-660	243	9	longa	longa	PROPN
ajmpe-660	243	10	l.	l.	PROPN
ajmpe-660	243	11	)	)	PUNCT
ajmpe-660	243	12	by	by	ADP
ajmpe-660	243	13	high	high	ADJ
ajmpe-660	243	14	-	-	PUNCT
ajmpe-660	243	15	performance	performance	NOUN
ajmpe-660	243	16	liquid	liquid	ADJ
ajmpe-660	243	17	chromatography	chromatography	NOUN
ajmpe-660	243	18	using	use	VERB
ajmpe-660	243	19	a	a	DET
ajmpe-660	243	20	fused	fuse	VERB
ajmpe-660	243	21	-	-	PUNCT
ajmpe-660	243	22	core	core	NOUN
ajmpe-660	243	23	column	column	NOUN
ajmpe-660	244	1	[	[	X
ajmpe-660	244	2	j	j	X
ajmpe-660	244	3	]	]	X
ajmpe-660	244	4	.	.	PUNCT
ajmpe-660	245	1	food	food	NOUN
ajmpe-660	245	2	chem	chem	NOUN
ajmpe-660	245	3	,	,	PUNCT
ajmpe-660	245	4	2016	2016	NUM
ajmpe-660	245	5	,	,	PUNCT
ajmpe-660	245	6	200	200	NUM
ajmpe-660	245	7	:	:	SYM
ajmpe-660	245	8	167	167	NUM
ajmpe-660	245	9	-	-	SYM
ajmpe-660	245	10	74	74	NUM
ajmpe-660	245	11	.	.	PUNCT
ajmpe-660	246	1	cui	cui	PROPN
ajmpe-660	246	2	minghua	minghua	PROPN
ajmpe-660	246	3	,	,	PUNCT
ajmpe-660	246	4	fu	fu	PROPN
ajmpe-660	246	5	erhua	erhua	PROPN
ajmpe-660	246	6	,	,	PUNCT
ajmpe-660	246	7	lin	lin	PROPN
ajmpe-660	246	8	zhenhua	zhenhua	PROPN
ajmpe-660	246	9	,	,	PUNCT
ajmpe-660	246	10	park	park	PROPN
ajmpe-660	246	11	yong	yong	PROPN
ajmpe-660	246	12	-	-	PUNCT
ajmpe-660	246	13	shi	shi	PROPN
ajmpe-660	246	14	.	.	PUNCT
ajmpe-660	247	1	research	research	NOUN
ajmpe-660	247	2	progress	progress	NOUN
ajmpe-660	247	3	of	of	ADP
ajmpe-660	247	4	anti	anti	ADJ
ajmpe-660	247	5	-	-	ADJ
ajmpe-660	247	6	tumor	tumor	ADJ
ajmpe-660	247	7	pharmacological	pharmacological	ADJ
ajmpe-660	247	8	effects	effect	NOUN
ajmpe-660	247	9	of	of	ADP
ajmpe-660	247	10	curcumin	curcumin	NOUN
ajmpe-660	248	1	[	[	X
ajmpe-660	248	2	j	j	X
ajmpe-660	248	3	]	]	X
ajmpe-660	248	4	.	.	PUNCT
ajmpe-660	249	1	chinese	chinese	ADJ
ajmpe-660	249	2	journal	journal	PROPN
ajmpe-660	249	3	of	of	ADP
ajmpe-660	249	4	clinical	clinical	ADJ
ajmpe-660	249	5	pharmacology	pharmacology	NOUN
ajmpe-660	249	6	,	,	PUNCT
ajmpe-660	249	7	2021	2021	NUM
ajmpe-660	249	8	,	,	PUNCT
ajmpe-660	249	9	37(02):186188	37(02):186188	NUM
ajmpe-660	249	10	+	+	NUM
ajmpe-660	249	11	196	196	NUM
ajmpe-660	249	12	.	.	PUNCT
ajmpe-660	250	1	sung	sung	PROPN
ajmpe-660	250	2	h	h	PROPN
ajmpe-660	250	3	,	,	PUNCT
ajmpe-660	250	4	ferlay	ferlay	PROPN
ajmpe-660	250	5	j	j	PROPN
ajmpe-660	250	6	,	,	PUNCT
ajmpe-660	250	7	siegel	siegel	PROPN
ajmpe-660	250	8	r	r	PROPN
ajmpe-660	250	9	l	l	PROPN
ajmpe-660	250	10	,	,	PUNCT
ajmpe-660	250	11	et	et	PROPN
ajmpe-660	250	12	al	al	PROPN
ajmpe-660	250	13	.	.	PUNCT
ajmpe-660	251	1	global	global	ADJ
ajmpe-660	251	2	cancer	cancer	NOUN
ajmpe-660	251	3	statistics2020	statistics2020	PROPN
ajmpe-660	251	4	:	:	PUNCT
ajmpe-660	251	5	globocan	globocan	PROPN
ajmpe-660	251	6	estimates	estimate	NOUN
ajmpe-660	251	7	of	of	ADP
ajmpe-660	251	8	incidence	incidence	NOUN
ajmpe-660	251	9	and	and	CCONJ
ajmpe-660	251	10	mortalityworldwide	mortalityworldwide	NOUN
ajmpe-660	251	11	for	for	ADP
ajmpe-660	251	12	36	36	NUM
ajmpe-660	251	13	cancers	cancer	NOUN
ajmpe-660	251	14	in	in	ADP
ajmpe-660	251	15	185	185	NUM
ajmpe-660	251	16	countries	country	NOUN
ajmpe-660	252	1	[	[	X
ajmpe-660	252	2	j	j	X
ajmpe-660	252	3	]	]	X
ajmpe-660	252	4	.	.	PUNCT
ajmpe-660	253	1	ca	can	AUX
ajmpe-660	253	2	cancerj	cancerj	VERB
ajmpe-660	253	3	clin	clin	PROPN
ajmpe-660	253	4	,	,	PUNCT
ajmpe-660	253	5	2021	2021	NUM
ajmpe-660	253	6	,	,	PUNCT
ajmpe-660	253	7	71(3	71(3	NUM
ajmpe-660	253	8	):	):	PUNCT
ajmpe-660	253	9	209	209	NUM
ajmpe-660	253	10	-	-	SYM
ajmpe-660	253	11	249	249	NUM
ajmpe-660	253	12	.	.	PUNCT
ajmpe-660	254	1	[	[	X
ajmpe-660	254	2	11	11	NUM
ajmpe-660	254	3	]	]	X
ajmpe-660	254	4	tian	tian	ADJ
ajmpe-660	254	5	tongde	tongde	NOUN
ajmpe-660	254	6	,	,	PUNCT
ajmpe-660	254	7	yue	yue	PROPN
ajmpe-660	254	8	liyun	liyun	PROPN
ajmpe-660	254	9	,	,	PUNCT
ajmpe-660	254	10	tian	tian	PROPN
ajmpe-660	254	11	tongliang	tongliang	PROPN
ajmpe-660	254	12	,	,	PUNCT
ajmpe-660	254	13	et	et	PROPN
ajmpe-660	254	14	al	al	PROPN
ajmpe-660	254	15	.	.	PROPN
ajmpe-660	254	16	relationship	relationship	NOUN
ajmpe-660	254	17	between	between	ADP
ajmpe-660	254	18	tumor	tumor	NOUN
ajmpe-660	254	19	inflammatory	inflammatory	ADJ
ajmpe-660	254	20	microenvironment	microenvironment	NOUN
ajmpe-660	254	21	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-660	254	22	american	american	PROPN
ajmpe-660	254	23	journal	journal	PROPN
ajmpe-660	254	24	of	of	ADP
ajmpe-660	254	25	medical	medical	ADJ
ajmpe-660	254	26	and	and	CCONJ
ajmpe-660	254	27	physical	physical	ADJ
ajmpe-660	254	28	education	education	PROPN
ajmpe-660	254	29	vol.8	vol.8	PROPN
ajmpe-660	254	30	,	,	PUNCT
ajmpe-660	254	31	issue	issue	NOUN
ajmpe-660	254	32	5	5	NUM
ajmpe-660	254	33	;	;	PUNCT
ajmpe-660	254	34	september	september	PROPN
ajmpe-660	254	35	-	-	PUNCT
ajmpe-660	254	36	october	october	PROPN
ajmpe-660	254	37	2023	2023	NUM
ajmpe-660	254	38	;	;	PUNCT
ajmpe-660	254	39	issn	issn	PROPN
ajmpe-660	254	40	:	:	PUNCT
ajmpe-660	254	41	2994	2994	NUM
ajmpe-660	254	42	-	-	SYM
ajmpe-660	254	43	0524	0524	NUM
ajmpe-660	254	44	impact	impact	NOUN
ajmpe-660	254	45	factor	factor	NOUN
ajmpe-660	254	46	:	:	PUNCT
ajmpe-660	254	47	6.14	6.14	NUM
ajmpe-660	254	48	1252	1252	NUM
ajmpe-660	254	49	columbia	columbia	PROPN
ajmpe-660	254	50	rd	rd	PROPN
ajmpe-660	254	51	nw	nw	PROPN
ajmpe-660	254	52	,	,	PUNCT
ajmpe-660	254	53	washington	washington	PROPN
ajmpe-660	254	54	dc	dc	PROPN
ajmpe-660	254	55	,	,	PUNCT
ajmpe-660	254	56	united	united	PROPN
ajmpe-660	254	57	states	states	PROPN
ajmpe-660	254	58	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	254	59	;	;	PUNCT
ajmpe-660	254	60	mail	mail	NOUN
ajmpe-660	254	61	:	:	PUNCT
ajmpe-660	254	62	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	254	63	17	17	NUM
ajmpe-660	255	1	|	|	ADV
ajmpe-660	255	2	a	a	DET
ajmpe-660	255	3	m	m	NOUN
ajmpe-660	255	4	e	e	NOUN
ajmpe-660	255	5	r	r	NOUN
ajmpe-660	256	1	i	i	NOUN
ajmpe-660	256	2	c	c	VERB
ajmpe-660	256	3	a	a	DET
ajmpe-660	256	4	n	n	NOUN
ajmpe-660	257	1	j	j	NOUN
ajmpe-660	257	2	o	o	X
ajmpe-660	257	3	u	u	NOUN
ajmpe-660	257	4	r	r	NOUN
ajmpe-660	257	5	n	n	NOUN
ajmpe-660	257	6	a	a	DET
ajmpe-660	257	7	l	l	NOUN
ajmpe-660	257	8	o	o	X
ajmpe-660	258	1	f	f	X
ajmpe-660	258	2	m	m	NOUN
ajmpe-660	258	3	e	e	NOUN
ajmpe-660	259	1	d	d	NOUN
ajmpe-660	259	2	i	i	PRON
ajmpe-660	259	3	c	c	VERB
ajmpe-660	259	4	a	a	DET
ajmpe-660	259	5	l	l	NOUN
ajmpe-660	259	6	a	a	X
ajmpe-660	259	7	n	n	NOUN
ajmpe-660	260	1	d	d	NOUN
ajmpe-660	260	2	p	p	NOUN
ajmpe-660	260	3	h	h	NOUN
ajmpe-660	260	4	y	y	NOUN
ajmpe-660	260	5	s	s	VERB
ajmpe-660	261	1	i	i	INTJ
ajmpe-660	261	2	c	c	VERB
ajmpe-660	261	3	a	a	DET
ajmpe-660	261	4	l	l	NOUN
ajmpe-660	261	5	e	e	NOUN
ajmpe-660	261	6	d	d	X
ajmpe-660	261	7	u	u	X
ajmpe-660	261	8	c	c	PROPN
ajmpe-660	262	1	a	a	DET
ajmpe-660	262	2	t	t	NOUN
ajmpe-660	263	1	i	i	PRON
ajmpe-660	263	2	o	o	VERB
ajmpe-660	263	3	n	n	CCONJ
ajmpe-660	263	4	|	|	ADV
ajmpe-660	263	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NOUN
ajmpe-660	263	6	and	and	CCONJ
ajmpe-660	263	7	immunity	immunity	NOUN
ajmpe-660	263	8	and	and	CCONJ
ajmpe-660	263	9	intervention	intervention	NOUN
ajmpe-660	263	10	strategy	strategy	NOUN
ajmpe-660	263	11	of	of	ADP
ajmpe-660	263	12	traditional	traditional	ADJ
ajmpe-660	263	13	chinese	chinese	ADJ
ajmpe-660	263	14	medicine	medicine	NOUN
ajmpe-660	264	1	[	[	X
ajmpe-660	264	2	j	j	X
ajmpe-660	264	3	]	]	X
ajmpe-660	264	4	.	.	PUNCT
ajmpe-660	265	1	chinese	chinese	ADJ
ajmpe-660	265	2	journal	journal	PROPN
ajmpe-660	265	3	of	of	ADP
ajmpe-660	265	4	traditional	traditional	ADJ
ajmpe-660	265	5	chinese	chinese	ADJ
ajmpe-660	265	6	medicine	medicine	NOUN
ajmpe-660	265	7	,	,	PUNCT
ajmpe-660	265	8	2017	2017	NUM
ajmpe-660	265	9	,	,	PUNCT
ajmpe-660	265	10	58(3):209	58(3):209	NOUN
ajmpe-660	265	11	-	-	PUNCT
ajmpe-660	265	12	213	213	NUM
ajmpe-660	265	13	.	.	PUNCT
ajmpe-660	266	1	xu	xu	PROPN
ajmpe-660	266	2	ming	ming	PROPN
ajmpe-660	266	3	,	,	PUNCT
ajmpe-660	266	4	lu	lu	PROPN
ajmpe-660	266	5	jiahui	jiahui	PROPN
ajmpe-660	266	6	.	.	PUNCT
ajmpe-660	267	1	pathogenesis	pathogenesis	NOUN
ajmpe-660	267	2	and	and	CCONJ
ajmpe-660	267	3	treatment	treatment	NOUN
ajmpe-660	267	4	of	of	ADP
ajmpe-660	267	5	malignant	malignant	ADJ
ajmpe-660	267	6	tumor	tumor	NOUN
ajmpe-660	267	7	from	from	ADP
ajmpe-660	267	8	phlegm	phlegm	NOUN
ajmpe-660	267	9	,	,	PUNCT
ajmpe-660	267	10	blood	blood	NOUN
ajmpe-660	267	11	stasis	stasis	NOUN
ajmpe-660	267	12	and	and	CCONJ
ajmpe-660	267	13	poison	poison	NOUN
ajmpe-660	267	14	[	[	X
ajmpe-660	267	15	j	j	X
ajmpe-660	267	16	]	]	X
ajmpe-660	267	17	.	.	PUNCT
ajmpe-660	268	1	international	international	ADJ
ajmpe-660	268	2	journal	journal	PROPN
ajmpe-660	268	3	of	of	ADP
ajmpe-660	268	4	traditional	traditional	ADJ
ajmpe-660	268	5	chinese	chinese	ADJ
ajmpe-660	268	6	medicine	medicine	NOUN
ajmpe-660	268	7	and	and	CCONJ
ajmpe-660	268	8	chinese	chinese	PROPN
ajmpe-660	268	9	materia	materia	PROPN
ajmpe-660	268	10	medica	medica	PROPN
ajmpe-660	268	11	,	,	PUNCT
ajmpe-660	268	12	2016	2016	NUM
ajmpe-660	268	13	,	,	PUNCT
ajmpe-660	268	14	38(11	38(11	NUM
ajmpe-660	268	15	):	):	PUNCT
ajmpe-660	268	16	10281029	10281029	NUM
ajmpe-660	268	17	.	.	PUNCT
ajmpe-660	269	1	ling	ling	PROPN
ajmpe-660	269	2	changquan	changquan	PROPN
ajmpe-660	269	3	,	,	PUNCT
ajmpe-660	269	4	yue	yue	PROPN
ajmpe-660	269	5	xiaoqiang	xiaoqiang	PROPN
ajmpe-660	269	6	,	,	PUNCT
ajmpe-660	269	7	ling	ling	PROPN
ajmpe-660	269	8	chen	chen	PROPN
ajmpe-660	269	9	.	.	PUNCT
ajmpe-660	270	1	threeadvantages	threeadvantage	NOUN
ajmpe-660	270	2	of	of	ADP
ajmpe-660	270	3	using	use	VERB
ajmpe-660	270	4	traditional	traditional	ADJ
ajmpe-660	270	5	chinese	chinese	ADJ
ajmpe-660	270	6	medicine	medicine	NOUN
ajmpe-660	270	7	to	to	ADP
ajmpe-660	270	8	preventand	preventand	NOUN
ajmpe-660	270	9	treat	treat	VERB
ajmpe-660	270	10	tumor	tumor	NOUN
ajmpe-660	271	1	[	[	X
ajmpe-660	271	2	j	j	X
ajmpe-660	271	3	]	]	X
ajmpe-660	271	4	.	.	PUNCT
ajmpe-660	272	1	journal	journal	PROPN
ajmpe-660	272	2	of	of	ADP
ajmpe-660	272	3	integrative	integrative	ADJ
ajmpe-660	272	4	medicine	medicine	NOUN
ajmpe-660	272	5	,	,	PUNCT
ajmpe-660	272	6	2014	2014	NUM
ajmpe-660	272	7	,	,	PUNCT
ajmpe-660	272	8	12(4):331	12(4):331	PROPN
ajmpe-660	272	9	-	-	PUNCT
ajmpe-660	272	10	335	335	NUM
ajmpe-660	272	11	.	.	PUNCT
ajmpe-660	273	1	lin	lin	PROPN
ajmpe-660	273	2	yuanxiong	yuanxiong	PROPN
ajmpe-660	273	3	.	.	PUNCT
ajmpe-660	274	1	effect	effect	NOUN
ajmpe-660	274	2	of	of	ADP
ajmpe-660	274	3	curcumin	curcumin	NOUN
ajmpe-660	274	4	on	on	ADP
ajmpe-660	274	5	the	the	DET
ajmpe-660	274	6	proliferation	proliferation	NOUN
ajmpe-660	274	7	and	and	CCONJ
ajmpe-660	274	8	cell	cell	NOUN
ajmpe-660	274	9	cycle	cycle	NOUN
ajmpe-660	274	10	of	of	ADP
ajmpe-660	274	11	nasopharyngeal	nasopharyngeal	ADJ
ajmpe-660	274	12	carcinoma	carcinoma	NOUN
ajmpe-660	274	13	cne-1	cne-1	PUNCT
ajmpe-660	274	14	cells	cell	NOUN
ajmpe-660	274	15	[	[	X
ajmpe-660	274	16	j	j	X
ajmpe-660	274	17	]	]	X
ajmpe-660	274	18	.	.	PUNCT
ajmpe-660	275	1	journal	journal	PROPN
ajmpe-660	275	2	of	of	ADP
ajmpe-660	275	3	qiqihar	qiqihar	PROPN
ajmpe-660	275	4	medical	medical	PROPN
ajmpe-660	275	5	college	college	PROPN
ajmpe-660	275	6	,	,	PUNCT
ajmpe-660	275	7	2010	2010	NUM
ajmpe-660	275	8	,	,	PUNCT
ajmpe-660	275	9	31(12):1855	31(12):1855	NUM
ajmpe-660	275	10	-	-	SYM
ajmpe-660	275	11	1856	1856	NUM
ajmpe-660	275	12	.	.	PUNCT
ajmpe-660	276	1	wang	wang	PROPN
ajmpe-660	276	2	guiqiu	guiqiu	PROPN
ajmpe-660	276	3	.	.	PUNCT
ajmpe-660	277	1	the	the	DET
ajmpe-660	277	2	effect	effect	NOUN
ajmpe-660	277	3	of	of	ADP
ajmpe-660	277	4	curcumin	curcumin	NOUN
ajmpe-660	277	5	on	on	ADP
ajmpe-660	277	6	the	the	DET
ajmpe-660	277	7	apoptosis	apoptosis	NOUN
ajmpe-660	277	8	of	of	ADP
ajmpe-660	277	9	human	human	ADJ
ajmpe-660	277	10	nasopharyngeal	nasopharyngeal	ADJ
ajmpe-660	277	11	carcinoma	carcinoma	NOUN
ajmpe-660	277	12	cell	cell	NOUN
ajmpe-660	277	13	line	line	NOUN
ajmpe-660	277	14	cne-2z	cne-2z	ADJ
ajmpe-660	277	15	and	and	CCONJ
ajmpe-660	277	16	its	its	PRON
ajmpe-660	277	17	mechanism	mechanism	NOUN
ajmpe-660	278	1	[	[	X
ajmpe-660	278	2	j	j	X
ajmpe-660	278	3	]	]	X
ajmpe-660	278	4	.	.	PUNCT
ajmpe-660	279	1	journal	journal	PROPN
ajmpe-660	279	2	of	of	ADP
ajmpe-660	279	3	practical	practical	ADJ
ajmpe-660	279	4	medicine	medicine	NOUN
ajmpe-660	279	5	&	&	CCONJ
ajmpe-660	279	6	clinic	clinic	PROPN
ajmpe-660	279	7	,	,	PUNCT
ajmpe-660	279	8	2013	2013	NUM
ajmpe-660	279	9	,	,	PUNCT
ajmpe-660	279	10	16(12):1126	16(12):1126	NUM
ajmpe-660	279	11	-	-	SYM
ajmpe-660	279	12	1129	1129	NUM
ajmpe-660	279	13	.	.	PUNCT
ajmpe-660	280	1	[	[	X
ajmpe-660	280	2	16	16	NUM
ajmpe-660	280	3	]	]	X
ajmpe-660	280	4	chen	chen	PROPN
ajmpe-660	280	5	j.	j.	PROPN
ajmpe-660	280	6	effects	effect	NOUN
ajmpe-660	280	7	of	of	ADP
ajmpe-660	280	8	curcumin	curcumin	NOUN
ajmpe-660	280	9	on	on	ADP
ajmpe-660	280	10	proliferation	proliferation	NOUN
ajmpe-660	280	11	and	and	CCONJ
ajmpe-660	280	12	invasion	invasion	NOUN
ajmpe-660	280	13	of	of	ADP
ajmpe-660	280	14	nasopharyngeal	nasopharyngeal	ADJ
ajmpe-660	280	15	carcinoma	carcinoma	NOUN
ajmpe-660	280	16	by	by	ADP
ajmpe-660	280	17	regulating	regulate	VERB
ajmpe-660	280	18	tiam1	tiam1	NOUN
ajmpe-660	280	19	protein	protein	NOUN
ajmpe-660	280	20	expression	expression	NOUN
ajmpe-660	280	21	[	[	X
ajmpe-660	280	22	j	j	X
ajmpe-660	280	23	]	]	X
ajmpe-660	280	24	.	.	PUNCT
ajmpe-660	281	1	journal	journal	PROPN
ajmpe-660	281	2	of	of	ADP
ajmpe-660	281	3	central	central	PROPN
ajmpe-660	281	4	south	south	PROPN
ajmpe-660	281	5	medical	medical	ADJ
ajmpe-660	281	6	science	science	NOUN
ajmpe-660	281	7	,	,	PUNCT
ajmpe-660	281	8	2019	2019	NUM
ajmpe-660	281	9	,	,	PUNCT
ajmpe-660	281	10	47(5):483507	47(5):483507	NUM
ajmpe-660	281	11	.	.	PUNCT
ajmpe-660	282	1	jin	jin	PROPN
ajmpe-660	282	2	h	h	PROPN
ajmpe-660	282	3	,	,	PUNCT
ajmpe-660	282	4	qiao	qiao	PROPN
ajmpe-660	282	5	f	f	PROPN
ajmpe-660	282	6	,	,	PUNCT
ajmpe-660	282	7	wang	wang	PROPN
ajmpe-660	282	8	y	y	PROPN
ajmpe-660	282	9	,	,	PUNCT
ajmpe-660	283	1	et	et	PROPN
ajmpe-660	283	2	al	al	PROPN
ajmpe-660	283	3	.	.	PUNCT
ajmpe-660	283	4	curcumin	curcumin	PROPN
ajmpe-660	283	5	inhibits	inhibit	VERB
ajmpe-660	283	6	cell	cell	NOUN
ajmpe-660	283	7	proliferation	proliferation	NOUN
ajmpe-660	283	8	andinduces	andinduce	NOUN
ajmpe-660	283	9	apoptosis	apoptosis	NOUN
ajmpe-660	283	10	of	of	ADP
ajmpe-660	283	11	human	human	ADJ
ajmpe-660	283	12	non	non	ADJ
ajmpe-660	283	13	small	small	ADJ
ajmpe-660	283	14	cell	cell	NOUN
ajmpe-660	283	15	lung	lung	NOUN
ajmpe-660	283	16	cancer	cancer	NOUN
ajmpe-660	283	17	cells	cell	NOUN
ajmpe-660	283	18	throughthe	throughthe	DET
ajmpe-660	283	19	upregulation	upregulation	NOUN
ajmpe-660	283	20	of	of	ADP
ajmpe-660	283	21	mir	mir	PROPN
ajmpe-660	283	22	192	192	NUM
ajmpe-660	283	23	5p	5p	NOUN
ajmpe-660	283	24	and	and	CCONJ
ajmpe-660	283	25	suppression	suppression	NOUN
ajmpe-660	283	26	of	of	ADP
ajmpe-660	283	27	pi3k	pi3k	PROPN
ajmpe-660	283	28	/	/	SYM
ajmpe-660	283	29	akt	akt	PROPN
ajmpe-660	283	30	sig	sig	NOUN
ajmpe-660	283	31	-	-	PUNCT
ajmpe-660	283	32	naling	nale	VERB
ajmpe-660	283	33	pathway[j	pathway[j	NOUN
ajmpe-660	283	34	]	]	PUNCT
ajmpe-660	283	35	.	.	PUNCT
ajmpe-660	284	1	oncology	oncology	NOUN
ajmpe-660	284	2	reports	report	NOUN
ajmpe-660	284	3	,	,	PUNCT
ajmpe-660	284	4	2015	2015	NUM
ajmpe-660	284	5	,	,	PUNCT
ajmpe-660	284	6	34(5	34(5	NUM
ajmpe-660	284	7	):	):	PUNCT
ajmpe-660	284	8	2782	2782	NUM
ajmpe-660	284	9	2789	2789	NUM
ajmpe-660	284	10	.	.	PUNCT
ajmpe-660	285	1	chen	chen	PROPN
ajmpe-660	285	2	shi	shi	PROPN
ajmpe-660	285	3	,	,	PUNCT
ajmpe-660	285	4	li	li	PROPN
ajmpe-660	285	5	dechuan	dechuan	PROPN
ajmpe-660	285	6	,	,	PUNCT
ajmpe-660	285	7	liu	liu	PROPN
ajmpe-660	285	8	hua	hua	PROPN
ajmpe-660	285	9	.	.	PUNCT
ajmpe-660	286	1	apoptosis	apoptosis	NOUN
ajmpe-660	286	2	of	of	ADP
ajmpe-660	286	3	human	human	ADJ
ajmpe-660	286	4	lung	lung	NOUN
ajmpe-660	286	5	cancer	cancer	NOUN
ajmpe-660	286	6	cells	cell	NOUN
ajmpe-660	286	7	induced	induce	VERB
ajmpe-660	286	8	by	by	ADP
ajmpe-660	286	9	curcumin	curcumin	NOUN
ajmpe-660	286	10	and	and	CCONJ
ajmpe-660	286	11	its	its	PRON
ajmpe-660	286	12	mechanism	mechanism	NOUN
ajmpe-660	287	1	[	[	X
ajmpe-660	287	2	j	j	X
ajmpe-660	287	3	]	]	X
ajmpe-660	287	4	.	.	PUNCT
ajmpe-660	288	1	journal	journal	PROPN
ajmpe-660	288	2	of	of	ADP
ajmpe-660	288	3	wuhan	wuhan	PROPN
ajmpe-660	288	4	university	university	PROPN
ajmpe-660	288	5	:	:	PUNCT
ajmpe-660	288	6	medical	medical	PROPN
ajmpe-660	288	7	edition	edition	NOUN
ajmpe-660	288	8	,	,	PUNCT
ajmpe-660	288	9	2012	2012	NUM
ajmpe-660	288	10	,	,	PUNCT
ajmpe-660	288	11	33	33	NUM
ajmpe-660	288	12	(	(	PUNCT
ajmpe-660	288	13	4	4	NUM
ajmpe-660	288	14	)	)	PUNCT
ajmpe-660	288	15	:	:	PUNCT
ajmpe-660	288	16	507	507	NUM
ajmpe-660	288	17	-	-	SYM
ajmpe-660	288	18	510	510	NUM
ajmpe-660	288	19	.	.	PUNCT
ajmpe-660	289	1	xu	xu	PROPN
ajmpe-660	289	2	y	y	PROPN
ajmpe-660	289	3	,	,	PUNCT
ajmpe-660	289	4	zhang	zhang	PROPN
ajmpe-660	289	5	j	j	PROPN
ajmpe-660	289	6	,	,	PUNCT
ajmpe-660	289	7	han	han	PROPN
ajmpe-660	289	8	j	j	PROPN
ajmpe-660	289	9	,	,	PUNCT
ajmpe-660	289	10	et	et	PROPN
ajmpe-660	289	11	al	al	PROPN
ajmpe-660	289	12	.	.	PUNCT
ajmpe-660	289	13	curcumin	curcumin	PROPN
ajmpe-660	289	14	inhibits	inhibit	VERB
ajmpe-660	289	15	tumor	tumor	NOUN
ajmpe-660	289	16	proliferation	proliferation	NOUN
ajmpe-660	289	17	in	in	ADP
ajmpe-660	289	18	-	-	PUNCT
ajmpe-660	289	19	duced	duce	VERB
ajmpe-660	289	20	by	by	ADP
ajmpe-660	289	21	neutrophil	neutrophil	ADJ
ajmpe-660	289	22	elastase	elastase	NOUN
ajmpe-660	289	23	through	through	ADP
ajmpe-660	289	24	the	the	DET
ajmpe-660	289	25	upregulation	upregulation	NOUN
ajmpe-660	289	26	of	of	ADP
ajmpe-660	289	27	α1	α1	PROPN
ajmpe-660	289	28	antitryp	antitryp	NOUN
ajmpe-660	289	29	-	-	PUNCT
ajmpe-660	289	30	sin	sin	NOUN
ajmpe-660	289	31	in	in	ADP
ajmpe-660	289	32	lung	lung	NOUN
ajmpe-660	289	33	cancer[j	cancer[j	NOUN
ajmpe-660	289	34	]	]	PUNCT
ajmpe-660	289	35	.	.	PUNCT
ajmpe-660	290	1	molecular	molecular	ADJ
ajmpe-660	290	2	oncology	oncology	NOUN
ajmpe-660	290	3	,	,	PUNCT
ajmpe-660	290	4	2012	2012	NUM
ajmpe-660	290	5	,	,	PUNCT
ajmpe-660	290	6	6	6	NUM
ajmpe-660	290	7	(	(	PUNCT
ajmpe-660	290	8	4	4	NUM
ajmpe-660	290	9	)	)	PUNCT
ajmpe-660	290	10	:	:	PUNCT
ajmpe-660	291	1	405	405	NUM
ajmpe-660	291	2	417	417	NUM
ajmpe-660	291	3	.	.	PUNCT
ajmpe-660	292	1	jiang	jiang	PROPN
ajmpe-660	292	2	j	j	PROPN
ajmpe-660	292	3	,	,	PUNCT
ajmpe-660	292	4	cao	cao	PROPN
ajmpe-660	292	5	y	y	PROPN
ajmpe-660	292	6	d	d	PROPN
ajmpe-660	292	7	,	,	PUNCT
ajmpe-660	292	8	mo	mo	PROPN
ajmpe-660	292	9	na	na	PROPN
ajmpe-660	292	10	,	,	PUNCT
ajmpe-660	292	11	et	et	PROPN
ajmpe-660	292	12	al	al	PROPN
ajmpe-660	292	13	.	.	PUNCT
ajmpe-660	292	14	curcumin	curcumin	PROPN
ajmpe-660	292	15	inhibits	inhibit	VERB
ajmpe-660	292	16	a549	a549	PROPN
ajmpe-660	292	17	cell	cell	NOUN
ajmpe-660	292	18	proliferation	proliferation	NOUN
ajmpe-660	292	19	through	through	ADP
ajmpe-660	292	20	p53	p53	NOUN
ajmpe-660	292	21	/p21	/p21	PUNCT
ajmpe-660	292	22	/pcna	/pcna	PROPN
ajmpe-660	292	23	/	/	SYM
ajmpe-660	292	24	ei	ei	NOUN
ajmpe-660	292	25	f4e	f4e	NOUN
ajmpe-660	292	26	signaling	signal	VERB
ajmpe-660	292	27	pathway	pathway	NOUN
ajmpe-660	293	1	[	[	X
ajmpe-660	293	2	j	j	X
ajmpe-660	293	3	]	]	X
ajmpe-660	293	4	.	.	PUNCT
ajmpe-660	294	1	journal	journal	PROPN
ajmpe-660	294	2	of	of	ADP
ajmpe-660	294	3	the	the	DET
ajmpe-660	294	4	third	third	ADJ
ajmpe-660	294	5	military	military	PROPN
ajmpe-660	294	6	medical	medical	ADJ
ajmpe-660	294	7	university	university	NOUN
ajmpe-660	294	8	,	,	PUNCT
ajmpe-660	294	9	2012	2012	NUM
ajmpe-660	294	10	,	,	PUNCT
ajmpe-660	294	11	34	34	NUM
ajmpe-660	294	12	(	(	PUNCT
ajmpe-660	294	13	1	1	NUM
ajmpe-660	294	14	)	)	PUNCT
ajmpe-660	294	15	:	:	PUNCT
ajmpe-660	294	16	49	49	NUM
ajmpe-660	294	17	-	-	SYM
ajmpe-660	294	18	53	53	NUM
ajmpe-660	294	19	.	.	PUNCT
ajmpe-660	295	1	he	he	PRON
ajmpe-660	295	2	qiuxia	qiuxia	PROPN
ajmpe-660	295	3	,	,	PUNCT
ajmpe-660	295	4	hou	hou	PROPN
ajmpe-660	295	5	hailong	hailong	PROPN
ajmpe-660	295	6	,	,	PUNCT
ajmpe-660	295	7	yuan	yuan	PROPN
ajmpe-660	295	8	yanqiang	yanqiang	PROPN
ajmpe-660	295	9	,	,	PUNCT
ajmpe-660	295	10	et	et	PROPN
ajmpe-660	295	11	al	al	PROPN
ajmpe-660	295	12	.	.	PUNCT
ajmpe-660	296	1	effects	effect	NOUN
ajmpe-660	296	2	of	of	ADP
ajmpe-660	296	3	curcumin	curcumin	NOUN
ajmpe-660	296	4	on	on	ADP
ajmpe-660	296	5	proliferation	proliferation	NOUN
ajmpe-660	296	6	and	and	CCONJ
ajmpe-660	296	7	apoptosis	apoptosis	NOUN
ajmpe-660	296	8	of	of	ADP
ajmpe-660	296	9	lung	lung	NOUN
ajmpe-660	296	10	adenocarcinoma	adenocarcinoma	PROPN
ajmpe-660	296	11	a549	a549	PROPN
ajmpe-660	296	12	cells	cell	NOUN
ajmpe-660	296	13	[	[	X
ajmpe-660	296	14	j	j	X
ajmpe-660	296	15	]	]	X
ajmpe-660	296	16	.	.	PUNCT
ajmpe-660	297	1	chin	chin	PROPN
ajmpe-660	297	2	j	j	PROPN
ajmpe-660	297	3	traditional	traditional	ADJ
ajmpe-660	297	4	chinese	chinese	ADJ
ajmpe-660	297	5	medicine	medicine	NOUN
ajmpe-660	297	6	,	,	PUNCT
ajmpe-660	297	7	2010	2010	NUM
ajmpe-660	297	8	,	,	PUNCT
ajmpe-660	297	9	28	28	NUM
ajmpe-660	297	10	(	(	PUNCT
ajmpe-660	297	11	10	10	NUM
ajmpe-660	297	12	)	)	PUNCT
ajmpe-660	297	13	:	:	PUNCT
ajmpe-660	297	14	2130	2130	NUM
ajmpe-660	297	15	-	-	SYM
ajmpe-660	297	16	2132	2132	NUM
ajmpe-660	297	17	.	.	PUNCT
ajmpe-660	298	1	[	[	X
ajmpe-660	298	2	22	22	NUM
ajmpe-660	298	3	]	]	X
ajmpe-660	298	4	li	li	PROPN
ajmpe-660	298	5	ziguang	ziguang	PROPN
ajmpe-660	298	6	,	,	PUNCT
ajmpe-660	298	7	wang	wang	PROPN
ajmpe-660	298	8	enju	enju	PROPN
ajmpe-660	298	9	,	,	PUNCT
ajmpe-660	298	10	liu	liu	PROPN
ajmpe-660	298	11	zhaoyang	zhaoyang	PROPN
ajmpe-660	298	12	,	,	PUNCT
ajmpe-660	298	13	et	et	PROPN
ajmpe-660	298	14	al	al	PROPN
ajmpe-660	298	15	.	.	PUNCT
ajmpe-660	299	1	the	the	DET
ajmpe-660	299	2	role	role	NOUN
ajmpe-660	299	3	of	of	ADP
ajmpe-660	299	4	erk1/2	erk1/2	PROPN
ajmpe-660	299	5	in	in	ADP
ajmpe-660	299	6	the	the	DET
ajmpe-660	299	7	inhibitory	inhibitory	ADJ
ajmpe-660	299	8	effect	effect	NOUN
ajmpe-660	299	9	of	of	ADP
ajmpe-660	299	10	curcumin	curcumin	NOUN
ajmpe-660	299	11	on	on	ADP
ajmpe-660	299	12	the	the	DET
ajmpe-660	299	13	proliferation	proliferation	NOUN
ajmpe-660	299	14	of	of	ADP
ajmpe-660	299	15	lung	lung	NOUN
ajmpe-660	299	16	cancer	cancer	NOUN
ajmpe-660	299	17	a549	a549	PROPN
ajmpe-660	299	18	cells	cell	NOUN
ajmpe-660	300	1	[	[	X
ajmpe-660	300	2	j	j	X
ajmpe-660	300	3	]	]	X
ajmpe-660	300	4	.	.	PUNCT
ajmpe-660	301	1	journal	journal	PROPN
ajmpe-660	301	2	of	of	ADP
ajmpe-660	301	3	bengbu	bengbu	PROPN
ajmpe-660	301	4	medical	medical	PROPN
ajmpe-660	301	5	college	college	NOUN
ajmpe-660	301	6	,	,	PUNCT
ajmpe-660	301	7	2011	2011	NUM
ajmpe-660	301	8	,	,	PUNCT
ajmpe-660	301	9	36	36	NUM
ajmpe-660	301	10	(	(	PUNCT
ajmpe-660	301	11	3	3	NUM
ajmpe-660	301	12	)	)	PUNCT
ajmpe-660	301	13	:	:	PUNCT
ajmpe-660	301	14	231	231	NUM
ajmpe-660	301	15	-	-	SYM
ajmpe-660	301	16	234	234	NUM
ajmpe-660	301	17	.	.	PUNCT
ajmpe-660	302	1	liu	liu	PROPN
ajmpe-660	302	2	x	x	PROPN
ajmpe-660	302	3	,	,	PUNCT
ajmpe-660	302	4	sun	sun	PROPN
ajmpe-660	302	5	k	k	PROPN
ajmpe-660	302	6	,	,	PUNCT
ajmpe-660	302	7	song	song	NOUN
ajmpe-660	302	8	a	a	PROPN
ajmpe-660	302	9	,	,	PUNCT
ajmpe-660	302	10	et	et	PROPN
ajmpe-660	302	11	al	al	PROPN
ajmpe-660	302	12	.	.	PUNCT
ajmpe-660	302	13	curcumin	curcumin	PROPN
ajmpe-660	302	14	inhibits	inhibit	VERB
ajmpe-660	302	15	prolif	prolif	NOUN
ajmpe-660	302	16	-	-	PUNCT
ajmpe-660	302	17	eration	eration	NOUN
ajmpe-660	302	18	of	of	ADP
ajmpe-660	302	19	gastric	gastric	ADJ
ajmpe-660	302	20	cancer	cancer	NOUN
ajmpe-660	302	21	cells	cell	NOUN
ajmpe-660	302	22	by	by	ADP
ajmpe-660	302	23	impairing	impair	VERB
ajmpe-660	302	24	atpsensitivepotassium	atpsensitivepotassium	NOUN
ajmpe-660	302	25	channel	channel	NOUN
ajmpe-660	302	26	opening	opening	NOUN
ajmpe-660	302	27	[	[	X
ajmpe-660	302	28	j	j	X
ajmpe-660	302	29	]	]	X
ajmpe-660	302	30	.	.	PUNCT
ajmpe-660	303	1	world	world	PROPN
ajmpe-660	303	2	j	j	PROPN
ajmpe-660	303	3	surg	surg	PROPN
ajmpe-660	303	4	oncol	oncol	PROPN
ajmpe-660	303	5	,	,	PUNCT
ajmpe-660	303	6	2014	2014	NUM
ajmpe-660	303	7	,	,	PUNCT
ajmpe-660	303	8	12	12	NUM
ajmpe-660	303	9	:	:	SYM
ajmpe-660	303	10	389	389	NUM
ajmpe-660	303	11	.	.	PUNCT
ajmpe-660	304	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-660	304	2	american	american	PROPN
ajmpe-660	304	3	journal	journal	PROPN
ajmpe-660	304	4	of	of	ADP
ajmpe-660	304	5	medical	medical	ADJ
ajmpe-660	304	6	and	and	CCONJ
ajmpe-660	304	7	physical	physical	ADJ
ajmpe-660	304	8	education	education	PROPN
ajmpe-660	304	9	vol.8	vol.8	PROPN
ajmpe-660	304	10	,	,	PUNCT
ajmpe-660	304	11	issue	issue	NOUN
ajmpe-660	304	12	5	5	NUM
ajmpe-660	304	13	;	;	PUNCT
ajmpe-660	304	14	september	september	PROPN
ajmpe-660	304	15	-	-	PUNCT
ajmpe-660	304	16	october	october	PROPN
ajmpe-660	304	17	2023	2023	NUM
ajmpe-660	304	18	;	;	PUNCT
ajmpe-660	304	19	issn	issn	PROPN
ajmpe-660	304	20	:	:	PUNCT
ajmpe-660	304	21	2994	2994	NUM
ajmpe-660	304	22	-	-	SYM
ajmpe-660	304	23	0524	0524	NUM
ajmpe-660	304	24	impact	impact	NOUN
ajmpe-660	304	25	factor	factor	NOUN
ajmpe-660	304	26	:	:	PUNCT
ajmpe-660	304	27	6.14	6.14	NUM
ajmpe-660	304	28	1252	1252	NUM
ajmpe-660	304	29	columbia	columbia	PROPN
ajmpe-660	304	30	rd	rd	PROPN
ajmpe-660	304	31	nw	nw	PROPN
ajmpe-660	304	32	,	,	PUNCT
ajmpe-660	304	33	washington	washington	PROPN
ajmpe-660	304	34	dc	dc	PROPN
ajmpe-660	304	35	,	,	PUNCT
ajmpe-660	304	36	united	united	PROPN
ajmpe-660	304	37	states	states	PROPN
ajmpe-660	304	38	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	304	39	;	;	PUNCT
ajmpe-660	304	40	mail	mail	NOUN
ajmpe-660	304	41	:	:	PUNCT
ajmpe-660	304	42	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	304	43	18	18	NUM
ajmpe-660	305	1	|	|	ADV
ajmpe-660	305	2	a	a	DET
ajmpe-660	305	3	m	m	NOUN
ajmpe-660	305	4	e	e	NOUN
ajmpe-660	305	5	r	r	NOUN
ajmpe-660	305	6	i	i	NOUN
ajmpe-660	305	7	c	c	VERB
ajmpe-660	305	8	a	a	DET
ajmpe-660	305	9	n	n	NOUN
ajmpe-660	306	1	j	j	NOUN
ajmpe-660	306	2	o	o	X
ajmpe-660	306	3	u	u	NOUN
ajmpe-660	306	4	r	r	NOUN
ajmpe-660	306	5	n	n	NOUN
ajmpe-660	306	6	a	a	DET
ajmpe-660	306	7	l	l	NOUN
ajmpe-660	306	8	o	o	X
ajmpe-660	307	1	f	f	X
ajmpe-660	307	2	m	m	NOUN
ajmpe-660	307	3	e	e	NOUN
ajmpe-660	308	1	d	d	NOUN
ajmpe-660	308	2	i	i	PRON
ajmpe-660	308	3	c	c	VERB
ajmpe-660	308	4	a	a	DET
ajmpe-660	308	5	l	l	NOUN
ajmpe-660	308	6	a	a	X
ajmpe-660	308	7	n	n	NOUN
ajmpe-660	309	1	d	d	NOUN
ajmpe-660	309	2	p	p	NOUN
ajmpe-660	309	3	h	h	NOUN
ajmpe-660	309	4	y	y	NOUN
ajmpe-660	309	5	s	s	VERB
ajmpe-660	310	1	i	i	INTJ
ajmpe-660	310	2	c	c	VERB
ajmpe-660	310	3	a	a	DET
ajmpe-660	310	4	l	l	NOUN
ajmpe-660	310	5	e	e	NOUN
ajmpe-660	310	6	d	d	X
ajmpe-660	310	7	u	u	X
ajmpe-660	310	8	c	c	PROPN
ajmpe-660	311	1	a	a	DET
ajmpe-660	311	2	t	t	NOUN
ajmpe-660	312	1	i	i	PRON
ajmpe-660	312	2	o	o	VERB
ajmpe-660	313	1	n	n	CCONJ
ajmpe-660	313	2	|	|	ADV
ajmpe-660	313	3	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	313	4	ji	ji	PROPN
ajmpe-660	313	5	j	j	PROPN
ajmpe-660	313	6	,	,	PUNCT
ajmpe-660	313	7	wang	wang	PROPN
ajmpe-660	313	8	h	h	PROPN
ajmpe-660	313	9	s	s	PROPN
ajmpe-660	313	10	,	,	PUNCT
ajmpe-660	313	11	gao	gao	PROPN
ajmpe-660	313	12	y	y	PROPN
ajmpe-660	313	13	y	y	PROPN
ajmpe-660	313	14	,	,	PUNCT
ajmpe-660	313	15	et	et	PROPN
ajmpe-660	313	16	al	al	PROPN
ajmpe-660	313	17	.	.	PUNCT
ajmpe-660	314	1	synergistic	synergistic	ADJ
ajmpe-660	314	2	anti	anti	ADJ
ajmpe-660	314	3	-	-	ADJ
ajmpe-660	314	4	tumoreffect	tumoreffect	NOUN
ajmpe-660	314	5	of	of	ADP
ajmpe-660	314	6	klf4	klf4	NOUN
ajmpe-660	314	7	and	and	CCONJ
ajmpe-660	314	8	curcumin	curcumin	NOUN
ajmpe-660	314	9	in	in	ADP
ajmpe-660	314	10	human	human	ADJ
ajmpe-660	314	11	gastric	gastric	ADJ
ajmpe-660	314	12	carcinomacell	carcinomacell	PROPN
ajmpe-660	314	13	line[j	line[j	PROPN
ajmpe-660	314	14	]	]	PUNCT
ajmpe-660	314	15	.	.	PUNCT
ajmpe-660	315	1	asian	asian	PROPN
ajmpe-660	315	2	pac	pac	PROPN
ajmpe-660	315	3	j	j	PROPN
ajmpe-660	315	4	cancer	cancer	NOUN
ajmpe-660	315	5	prev	prev	NOUN
ajmpe-660	315	6	,	,	PUNCT
ajmpe-660	315	7	2014	2014	NUM
ajmpe-660	315	8	,	,	PUNCT
ajmpe-660	315	9	15	15	NUM
ajmpe-660	315	10	(	(	PUNCT
ajmpe-660	315	11	18	18	NUM
ajmpe-660	315	12	)	)	PUNCT
ajmpe-660	315	13	:	:	PUNCT
ajmpe-660	315	14	7747	7747	NUM
ajmpe-660	315	15	-	-	SYM
ajmpe-660	315	16	7752	7752	NUM
ajmpe-660	315	17	.	.	PUNCT
ajmpe-660	316	1	chen	chen	PROPN
ajmpe-660	316	2	x	x	PROPN
ajmpe-660	316	3	,	,	PUNCT
ajmpe-660	316	4	chen	chen	PROPN
ajmpe-660	316	5	x	x	PROPN
ajmpe-660	316	6	,	,	PUNCT
ajmpe-660	316	7	zhang	zhang	PROPN
ajmpe-660	316	8	x	x	PROPN
ajmpe-660	316	9	,	,	PUNCT
ajmpe-660	316	10	et	et	PROPN
ajmpe-660	316	11	al	al	PROPN
ajmpe-660	316	12	.	.	PROPN
ajmpe-660	316	13	curcuminoid	curcuminoid	PROPN
ajmpe-660	316	14	b63	b63	ADJ
ajmpe-660	316	15	in	in	ADP
ajmpe-660	316	16	-	-	PUNCT
ajmpe-660	316	17	duces	duce	NOUN
ajmpe-660	316	18	ros	ros	PROPN
ajmpe-660	316	19	-	-	PUNCT
ajmpe-660	316	20	mediated	mediate	VERB
ajmpe-660	316	21	paraptosis	paraptosis	NOUN
ajmpe-660	316	22	-	-	PUNCT
ajmpe-660	316	23	like	like	ADJ
ajmpe-660	316	24	cell	cell	NOUN
ajmpe-660	316	25	death	death	NOUN
ajmpe-660	316	26	by	by	ADP
ajmpe-660	316	27	targeting	target	VERB
ajmpe-660	316	28	trxr1	trxr1	NOUN
ajmpe-660	316	29	in	in	ADP
ajmpe-660	316	30	gastric	gastric	ADJ
ajmpe-660	316	31	cells[j	cells[j	PROPN
ajmpe-660	316	32	]	]	PUNCT
ajmpe-660	316	33	.	.	PUNCT
ajmpe-660	317	1	redox	redox	PROPN
ajmpe-660	317	2	biol	biol	PROPN
ajmpe-660	317	3	,	,	PUNCT
ajmpe-660	317	4	2019	2019	NUM
ajmpe-660	317	5	,	,	PUNCT
ajmpe-660	317	6	21	21	NUM
ajmpe-660	317	7	:	:	SYM
ajmpe-660	317	8	101061	101061	NUM
ajmpe-660	317	9	.	.	PUNCT
ajmpe-660	318	1	zhou	zhou	PROPN
ajmpe-660	318	2	x	x	PROPN
ajmpe-660	318	3	,	,	PUNCT
ajmpe-660	318	4	wang	wang	PROPN
ajmpe-660	318	5	w	w	PROPN
ajmpe-660	318	6	,	,	PUNCT
ajmpe-660	318	7	li	li	PROPN
ajmpe-660	318	8	p	p	PROPN
ajmpe-660	318	9	,	,	PUNCT
ajmpe-660	318	10	et	et	PROPN
ajmpe-660	318	11	al	al	PROPN
ajmpe-660	318	12	.	.	PUNCT
ajmpe-660	319	1	curcumin	curcumin	NOUN
ajmpe-660	319	2	enhances	enhance	VERB
ajmpe-660	319	3	theeffects	theeffect	NOUN
ajmpe-660	319	4	of	of	ADP
ajmpe-660	319	5	5	5	NUM
ajmpe-660	319	6	-	-	PUNCT
ajmpe-660	319	7	fluorouracil	fluorouracil	NOUN
ajmpe-660	319	8	and	and	CCONJ
ajmpe-660	319	9	oxaliplatin	oxaliplatin	NOUN
ajmpe-660	319	10	in	in	ADP
ajmpe-660	319	11	inducing	induce	VERB
ajmpe-660	319	12	gastric	gastric	ADJ
ajmpe-660	319	13	cancer	cancer	NOUN
ajmpe-660	319	14	cell	cell	NOUN
ajmpe-660	319	15	apoptosis	apoptosis	NOUN
ajmpe-660	319	16	both	both	CCONJ
ajmpe-660	319	17	in	in	ADP
ajmpe-660	319	18	vitro	vitro	X
ajmpe-660	319	19	and	and	CCONJ
ajmpe-660	319	20	in	in	ADP
ajmpe-660	319	21	vivo[j	vivo[j	NOUN
ajmpe-660	319	22	]	]	PUNCT
ajmpe-660	319	23	.	.	PUNCT
ajmpe-660	320	1	oncol	oncol	ADJ
ajmpe-660	320	2	res	re	NOUN
ajmpe-660	320	3	,	,	PUNCT
ajmpe-660	320	4	2016	2016	NUM
ajmpe-660	320	5	,	,	PUNCT
ajmpe-660	320	6	23	23	NUM
ajmpe-660	320	7	(	(	PUNCT
ajmpe-660	320	8	1	1	NUM
ajmpe-660	320	9	-	-	SYM
ajmpe-660	320	10	2	2	NUM
ajmpe-660	320	11	)	)	PUNCT
ajmpe-660	320	12	:	:	PUNCT
ajmpe-660	320	13	29	29	NUM
ajmpe-660	320	14	-	-	SYM
ajmpe-660	320	15	34	34	NUM
ajmpe-660	320	16	.	.	PUNCT
ajmpe-660	321	1	[	[	X
ajmpe-660	321	2	27	27	NUM
ajmpe-660	321	3	]	]	X
ajmpe-660	321	4	yang	yang	PROPN
ajmpe-660	321	5	weili	weili	PROPN
ajmpe-660	321	6	,	,	PUNCT
ajmpe-660	321	7	yang	yang	PROPN
ajmpe-660	321	8	rongping	rongping	PROPN
ajmpe-660	321	9	,	,	PUNCT
ajmpe-660	321	10	luo	luo	PROPN
ajmpe-660	321	11	yongsheng	yongsheng	PROPN
ajmpe-660	321	12	,	,	PUNCT
ajmpe-660	321	13	et	et	PROPN
ajmpe-660	321	14	al	al	PROPN
ajmpe-660	321	15	.	.	PROPN
ajmpe-660	322	1	clinical	clinical	ADJ
ajmpe-660	322	2	analysis	analysis	NOUN
ajmpe-660	322	3	of	of	ADP
ajmpe-660	322	4	curcumin	curcumin	NOUN
ajmpe-660	322	5	combined	combine	VERB
ajmpe-660	322	6	with	with	ADP
ajmpe-660	322	7	folfox	folfox	ADJ
ajmpe-660	322	8	regimen	regiman	NOUN
ajmpe-660	322	9	in	in	ADP
ajmpe-660	322	10	the	the	DET
ajmpe-660	322	11	treatment	treatment	NOUN
ajmpe-660	322	12	of	of	ADP
ajmpe-660	322	13	advanced	advanced	ADJ
ajmpe-660	322	14	gastric	gastric	ADJ
ajmpe-660	322	15	cancer	cancer	NOUN
ajmpe-660	323	1	[	[	X
ajmpe-660	323	2	j	j	X
ajmpe-660	323	3	]	]	X
ajmpe-660	323	4	.	.	PUNCT
ajmpe-660	324	1	journal	journal	PROPN
ajmpe-660	324	2	of	of	ADP
ajmpe-660	324	3	inner	inner	PROPN
ajmpe-660	324	4	mongolia	mongolia	PROPN
ajmpe-660	324	5	medical	medical	PROPN
ajmpe-660	324	6	university	university	PROPN
ajmpe-660	324	7	,	,	PUNCT
ajmpe-660	324	8	2019	2019	NUM
ajmpe-660	324	9	,	,	PUNCT
ajmpe-660	324	10	12	12	NUM
ajmpe-660	324	11	(	(	PUNCT
ajmpe-660	324	12	1	1	NUM
ajmpe-660	324	13	):	):	PUNCT
ajmpe-660	324	14	96	96	NUM
ajmpe-660	324	15	-	-	SYM
ajmpe-660	324	16	99	99	NUM
ajmpe-660	324	17	.	.	PUNCT
ajmpe-660	325	1	shastri	shastri	PROPN
ajmpe-660	325	2	a	a	DET
ajmpe-660	325	3	a	a	PROPN
ajmpe-660	325	4	,	,	PUNCT
ajmpe-660	325	5	saleh	saleh	NOUN
ajmpe-660	325	6	a	a	PRON
ajmpe-660	325	7	,	,	PUNCT
ajmpe-660	325	8	savage	savage	NOUN
ajmpe-660	325	9	j	j	PROPN
ajmpe-660	325	10	e	e	PROPN
ajmpe-660	325	11	,	,	PUNCT
ajmpe-660	325	12	et	et	PROPN
ajmpe-660	325	13	al	al	PROPN
ajmpe-660	325	14	.	.	PUNCT
ajmpe-660	326	1	dietary	dietary	ADJ
ajmpe-660	326	2	alterations	alteration	NOUN
ajmpe-660	326	3	modulate	modulate	VERB
ajmpe-660	326	4	the	the	DET
ajmpe-660	326	5	microrna	microrna	PROPN
ajmpe-660	326	6	29/30	29/30	NUM
ajmpe-660	326	7	andigf1	andigf1	PROPN
ajmpe-660	326	8	/	/	SYM
ajmpe-660	326	9	akt	akt	PROPN
ajmpe-660	326	10	signaling	signal	VERB
ajmpe-660	326	11	axis	axis	NOUN
ajmpe-660	326	12	in	in	ADP
ajmpe-660	326	13	breast	breast	NOUN
ajmpe-660	326	14	cancer	cancer	NOUN
ajmpe-660	326	15	livermetastasis[j	livermetastasis[j	PROPN
ajmpe-660	326	16	]	]	PUNCT
ajmpe-660	326	17	.	.	PUNCT
ajmpe-660	327	1	nutr	nutr	PROPN
ajmpe-660	327	2	metab(lond	metab(lond	PROPN
ajmpe-660	327	3	)	)	PUNCT
ajmpe-660	327	4	,	,	PUNCT
ajmpe-660	327	5	2020	2020	NUM
ajmpe-660	327	6	,	,	PUNCT
ajmpe-660	327	7	3(17):23	3(17):23	NOUN
ajmpe-660	327	8	-	-	SYM
ajmpe-660	327	9	043	043	NUM
ajmpe-660	327	10	.	.	PUNCT
ajmpe-660	328	1	chen	chen	PROPN
ajmpe-660	328	2	c	c	PROPN
ajmpe-660	328	3	p	p	PROPN
ajmpe-660	328	4	,	,	PUNCT
ajmpe-660	328	5	xu	xu	PROPN
ajmpe-660	329	1	q	q	X
ajmpe-660	329	2	,	,	PUNCT
ajmpe-660	329	3	zhao	zhao	PROPN
ajmpe-660	329	4	h	h	PROPN
ajmpe-660	329	5	f.	f.	PROPN
ajmpe-660	329	6	intervention	intervention	PROPN
ajmpe-660	329	7	effect	effect	NOUN
ajmpe-660	329	8	of	of	ADP
ajmpe-660	329	9	curcumin	curcumin	NOUN
ajmpe-660	329	10	on	on	ADP
ajmpe-660	329	11	the	the	DET
ajmpe-660	329	12	expression	expression	NOUN
ajmpe-660	329	13	of	of	ADP
ajmpe-660	329	14	mir-29	mir-29	PROPN
ajmpe-660	329	15	and	and	CCONJ
ajmpe-660	329	16	vegf	vegf	PROPN
ajmpe-660	329	17	in	in	ADP
ajmpe-660	329	18	hepatocellular	hepatocellular	ADJ
ajmpe-660	329	19	carcinoma	carcinoma	NOUN
ajmpe-660	329	20	cells	cell	NOUN
ajmpe-660	330	1	[	[	X
ajmpe-660	330	2	j	j	X
ajmpe-660	330	3	]	]	X
ajmpe-660	330	4	.	.	PUNCT
ajmpe-660	331	1	zhejiang	zhejiang	PROPN
ajmpe-660	331	2	journal	journal	PROPN
ajmpe-660	331	3	of	of	ADP
ajmpe-660	331	4	integrated	integrate	VERB
ajmpe-660	331	5	traditional	traditional	ADJ
ajmpe-660	331	6	chinese	chinese	ADJ
ajmpe-660	331	7	and	and	CCONJ
ajmpe-660	331	8	western	western	ADJ
ajmpe-660	331	9	medicine	medicine	NOUN
ajmpe-660	331	10	,	,	PUNCT
ajmpe-660	331	11	2020	2020	NUM
ajmpe-660	331	12	,	,	PUNCT
ajmpe-660	331	13	30	30	NUM
ajmpe-660	331	14	(	(	PUNCT
ajmpe-660	331	15	10	10	NUM
ajmpe-660	331	16	)	)	PUNCT
ajmpe-660	331	17	:	:	PUNCT
ajmpe-660	331	18	785	785	NUM
ajmpe-660	331	19	-	-	SYM
ajmpe-660	331	20	790	790	NUM
ajmpe-660	331	21	,	,	PUNCT
ajmpe-660	331	22	869	869	NUM
ajmpe-660	331	23	.	.	PUNCT
ajmpe-660	332	1	chen	chen	PROPN
ajmpe-660	332	2	s	s	PROPN
ajmpe-660	332	3	,	,	PUNCT
ajmpe-660	332	4	yang	yang	PROPN
ajmpe-660	332	5	c	c	PROPN
ajmpe-660	332	6	,	,	PUNCT
ajmpe-660	332	7	sun	sun	PROPN
ajmpe-660	332	8	c	c	AUX
ajmpe-660	332	9	,	,	PUNCT
ajmpe-660	332	10	et	et	PROPN
ajmpe-660	332	11	al	al	PROPN
ajmpe-660	332	12	.	.	PROPN
ajmpe-660	332	13	mir-21	mir-21	PROPN
ajmpe-660	332	14	-	-	PUNCT
ajmpe-660	332	15	5psuppressed	5psuppressed	NUM
ajmpe-660	332	16	the	the	DET
ajmpe-660	332	17	sensitivity	sensitivity	NOUN
ajmpe-660	332	18	of	of	ADP
ajmpe-660	332	19	hepatocellular	hepatocellular	ADJ
ajmpe-660	332	20	carcinomacells	carcinomacell	NOUN
ajmpe-660	332	21	to	to	ADP
ajmpe-660	332	22	cisplatin	cisplatin	NOUN
ajmpe-660	332	23	by	by	ADP
ajmpe-660	332	24	targeting	target	VERB
ajmpe-660	332	25	faslg[j	faslg[j	NOUN
ajmpe-660	332	26	]	]	PUNCT
ajmpe-660	332	27	.	.	PUNCT
ajmpe-660	333	1	dna	dna	PROPN
ajmpe-660	333	2	cellbiol	cellbiol	PROPN
ajmpe-660	333	3	,	,	PUNCT
ajmpe-660	333	4	2019	2019	NUM
ajmpe-660	333	5	,	,	PUNCT
ajmpe-660	333	6	38(8):865	38(8):865	NUM
ajmpe-660	333	7	-	-	SYM
ajmpe-660	333	8	873	873	NUM
ajmpe-660	333	9	.	.	PUNCT
ajmpe-660	334	1	li	li	PROPN
ajmpe-660	334	2	j	j	PROPN
ajmpe-660	334	3	,	,	PUNCT
ajmpe-660	334	4	wei	wei	PROPN
ajmpe-660	334	5	h	h	PROPN
ajmpe-660	334	6	,	,	PUNCT
ajmpe-660	334	7	liu	liu	PROPN
ajmpe-660	334	8	y	y	PROPN
ajmpe-660	334	9	,	,	PUNCT
ajmpe-660	334	10	et	et	PROPN
ajmpe-660	334	11	al	al	PROPN
ajmpe-660	334	12	.	.	PROPN
ajmpe-660	334	13	curcumin	curcumin	VERB
ajmpe-660	334	14	inhibitshepatocellular	inhibitshepatocellular	ADJ
ajmpe-660	334	15	carcinoma	carcinoma	NOUN
ajmpe-660	334	16	via	via	ADP
ajmpe-660	334	17	regulating	regulate	VERB
ajmpe-660	334	18	mir-21	mir-21	PROPN
ajmpe-660	334	19	/	/	SYM
ajmpe-660	334	20	timp3	timp3	NOUN
ajmpe-660	334	21	axis[j	axis[j	PROPN
ajmpe-660	334	22	]	]	PUNCT
ajmpe-660	334	23	.	.	PUNCT
ajmpe-660	335	1	evid	evid	PROPN
ajmpe-660	335	2	based	base	VERB
ajmpe-660	335	3	complement	complement	PROPN
ajmpe-660	335	4	alternatmed	alternatme	VERB
ajmpe-660	335	5	,	,	PUNCT
ajmpe-660	335	6	2020	2020	NUM
ajmpe-660	335	7	,	,	PUNCT
ajmpe-660	335	8	7(17):2892	7(17):2892	NOUN
ajmpe-660	335	9	-	-	SYM
ajmpe-660	335	10	917	917	NUM
ajmpe-660	335	11	.	.	PUNCT
ajmpe-660	336	1	zhou	zhou	PROPN
ajmpe-660	336	2	c	c	PROPN
ajmpe-660	336	3	,	,	PUNCT
ajmpe-660	336	4	hu	hu	PROPN
ajmpe-660	337	1	c	c	PROPN
ajmpe-660	337	2	,	,	PUNCT
ajmpe-660	337	3	wang	wang	PROPN
ajmpe-660	337	4	b	b	PROPN
ajmpe-660	337	5	,	,	PUNCT
ajmpe-660	337	6	et	et	PROPN
ajmpe-660	337	7	al	al	PROPN
ajmpe-660	337	8	.	.	PROPN
ajmpe-660	337	9	curcuminsuppresses	curcuminsuppresse	VERB
ajmpe-660	337	10	cell	cell	NOUN
ajmpe-660	337	11	proliferation	proliferation	NOUN
ajmpe-660	337	12	,	,	PUNCT
ajmpe-660	337	13	migration	migration	NOUN
ajmpe-660	337	14	,	,	PUNCT
ajmpe-660	337	15	and	and	CCONJ
ajmpe-660	337	16	invasionthrough	invasionthrough	NUM
ajmpe-660	337	17	modulating	modulate	VERB
ajmpe-660	337	18	mir-21	mir-21	NOUN
ajmpe-660	337	19	-	-	PUNCT
ajmpe-660	337	20	5p	5p	NUM
ajmpe-660	337	21	/	/	SYM
ajmpe-660	337	22	sox6	sox6	NOUN
ajmpe-660	337	23	axis	axis	ADJ
ajmpe-660	337	24	inhepatocellular	inhepatocellular	ADJ
ajmpe-660	337	25	carcinoma	carcinoma	NOUN
ajmpe-660	338	1	[	[	X
ajmpe-660	338	2	j	j	X
ajmpe-660	338	3	]	]	X
ajmpe-660	338	4	.	.	PUNCT
ajmpe-660	339	1	cancer	cancer	NOUN
ajmpe-660	339	2	biother	biother	PROPN
ajmpe-660	339	3	radiopharm	radiopharm	NOUN
ajmpe-660	339	4	,	,	PUNCT
ajmpe-660	339	5	2020	2020	NUM
ajmpe-660	339	6	,	,	PUNCT
ajmpe-660	339	7	8(4):37	8(4):37	NUM
ajmpe-660	339	8	-	-	SYM
ajmpe-660	339	9	34	34	NUM
ajmpe-660	339	10	.	.	PUNCT
ajmpe-660	339	11	.	.	PUNCT
ajmpe-660	340	1	fang	fang	PROPN
ajmpe-660	340	2	l	l	PROPN
ajmpe-660	340	3	,	,	PUNCT
ajmpe-660	340	4	zhou	zhou	PROPN
ajmpe-660	340	5	j	j	PROPN
ajmpe-660	340	6	,	,	PUNCT
ajmpe-660	340	7	xie	xie	PROPN
ajmpe-660	340	8	h	h	PROPN
ajmpe-660	340	9	,	,	PUNCT
ajmpe-660	340	10	et	et	PROPN
ajmpe-660	340	11	al	al	PROPN
ajmpe-660	340	12	.	.	PUNCT
ajmpe-660	340	13	effects	effect	NOUN
ajmpe-660	340	14	of	of	ADP
ajmpe-660	340	15	curcumin	curcumin	NOUN
ajmpe-660	340	16	on	on	ADP
ajmpe-660	340	17	cell	cell	NOUN
ajmpe-660	340	18	proliferation	proliferation	NOUN
ajmpe-660	340	19	,	,	PUNCT
ajmpe-660	340	20	cell	cell	NOUN
ajmpe-660	340	21	cycle	cycle	NOUN
ajmpe-660	340	22	distribution	distribution	NOUN
ajmpe-660	340	23	and	and	CCONJ
ajmpe-660	340	24	cyclind1	cyclind1	NOUN
ajmpe-660	340	25	gene	gene	NOUN
ajmpe-660	340	26	expression	expression	NOUN
ajmpe-660	340	27	in	in	ADP
ajmpe-660	340	28	human	human	ADJ
ajmpe-660	340	29	colon	colon	NOUN
ajmpe-660	340	30	cancer	cancer	NOUN
ajmpe-660	340	31	ht-29	ht-29	PUNCT
ajmpe-660	340	32	cells	cell	NOUN
ajmpe-660	341	1	[	[	X
ajmpe-660	341	2	j	j	X
ajmpe-660	341	3	]	]	X
ajmpe-660	341	4	.	.	PUNCT
ajmpe-660	342	1	chongqing	chongqing	PROPN
ajmpe-660	342	2	med	med	PROPN
ajmpe-660	342	3	,	,	PUNCT
ajmpe-660	342	4	2016	2016	NUM
ajmpe-660	342	5	,	,	PUNCT
ajmpe-660	342	6	45(32	45(32	NUM
ajmpe-660	342	7	):	):	PUNCT
ajmpe-660	342	8	44794481	44794481	NUM
ajmpe-660	342	9	.	.	PUNCT
ajmpe-660	343	1	mudduluru	mudduluru	PROPN
ajmpe-660	343	2	g	g	PROPN
ajmpe-660	343	3	,	,	PUNCT
ajmpe-660	343	4	george	george	PROPN
ajmpe-660	343	5	-	-	PUNCT
ajmpe-660	343	6	william	william	PROPN
ajmpe-660	343	7	jn	jn	PROPN
ajmpe-660	343	8	,	,	PUNCT
ajmpe-660	343	9	muppala	muppala	PROPN
ajmpe-660	343	10	s	s	PROPN
ajmpe-660	343	11	,	,	PUNCT
ajmpe-660	343	12	et	et	PROPN
ajmpe-660	343	13	al	al	PROPN
ajmpe-660	343	14	.	.	PUNCT
ajmpe-660	343	15	curcumin	curcumin	PROPN
ajmpe-660	343	16	regulates	regulate	VERB
ajmpe-660	343	17	mir-21expression	mir-21expression	NOUN
ajmpe-660	343	18	and	and	CCONJ
ajmpe-660	343	19	inhibits	inhibit	VERB
ajmpe-660	343	20	invasion	invasion	NOUN
ajmpe-660	343	21	and	and	CCONJ
ajmpe-660	343	22	metastasis	metastasis	NOUN
ajmpe-660	343	23	in	in	ADP
ajmpe-660	343	24	colorectal	colorectal	ADJ
ajmpe-660	343	25	cancer[j	cancer[j	NOUN
ajmpe-660	343	26	]	]	PUNCT
ajmpe-660	343	27	.	.	PUNCT
ajmpe-660	344	1	bioscience	bioscience	NOUN
ajmpe-660	344	2	reports	report	NOUN
ajmpe-660	344	3	,	,	PUNCT
ajmpe-660	344	4	2011	2011	NUM
ajmpe-660	344	5	,	,	PUNCT
ajmpe-660	344	6	31(3	31(3	NUM
ajmpe-660	344	7	):	):	PUNCT
ajmpe-660	344	8	185	185	NUM
ajmpe-660	344	9	-	-	SYM
ajmpe-660	344	10	197	197	NUM
ajmpe-660	345	1	[	[	SYM
ajmpe-660	345	2	35	35	NUM
ajmpe-660	345	3	]	]	SYM
ajmpe-660	345	4	tuorkey	tuorkey	ADJ
ajmpe-660	345	5	m.	m.	NOUN
ajmpe-660	345	6	curcumin	curcumin	NOUN
ajmpe-660	345	7	a	a	DET
ajmpe-660	345	8	potent	potent	ADJ
ajmpe-660	345	9	cancer	cancer	NOUN
ajmpe-660	345	10	preventive	preventive	ADJ
ajmpe-660	345	11	agent	agent	NOUN
ajmpe-660	345	12	:	:	PUNCT
ajmpe-660	345	13	mechanisms	mechanism	NOUN
ajmpe-660	345	14	of	of	ADP
ajmpe-660	345	15	cancer	cancer	NOUN
ajmpe-660	345	16	cellkilling[j	cellkilling[j	NOUN
ajmpe-660	345	17	]	]	PUNCT
ajmpe-660	345	18	.	.	PUNCT
ajmpe-660	346	1	interventional	interventional	ADJ
ajmpe-660	346	2	medicine	medicine	NOUN
ajmpe-660	346	3	and	and	CCONJ
ajmpe-660	346	4	applied	apply	VERB
ajmpe-660	346	5	science	science	NOUN
ajmpe-660	346	6	,	,	PUNCT
ajmpe-660	346	7	2014	2014	NUM
ajmpe-660	346	8	,	,	PUNCT
ajmpe-660	346	9	6(4	6(4	NUM
ajmpe-660	346	10	):	):	PUNCT
ajmpe-660	346	11	139	139	NUM
ajmpe-660	346	12	-	-	SYM
ajmpe-660	346	13	146	146	NUM
ajmpe-660	346	14	.	.	PUNCT
ajmpe-660	346	15	luo	luo	PROPN
ajmpe-660	346	16	qiang	qiang	PROPN
ajmpe-660	346	17	,	,	PUNCT
ajmpe-660	346	18	sun	sun	PROPN
ajmpe-660	346	19	li	li	PROPN
ajmpe-660	346	20	,	,	PUNCT
ajmpe-660	346	21	zhang	zhang	PROPN
ajmpe-660	346	22	zhang	zhang	PROPN
ajmpe-660	346	23	,	,	PUNCT
ajmpe-660	346	24	et	et	PROPN
ajmpe-660	346	25	al	al	PROPN
ajmpe-660	346	26	.	.	PROPN
ajmpe-660	346	27	effect	effect	NOUN
ajmpe-660	346	28	of	of	ADP
ajmpe-660	346	29	curcumin	curcumin	NOUN
ajmpe-660	346	30	on	on	ADP
ajmpe-660	346	31	apoptosis	apoptosis	NOUN
ajmpe-660	346	32	of	of	ADP
ajmpe-660	346	33	human	human	ADJ
ajmpe-660	346	34	colon	colon	NOUN
ajmpe-660	346	35	cancer	cancer	NOUN
ajmpe-660	346	36	sw620	sw620	PROPN
ajmpe-660	346	37	cells	cell	NOUN
ajmpe-660	347	1	[	[	X
ajmpe-660	347	2	j	j	X
ajmpe-660	347	3	]	]	X
ajmpe-660	347	4	.	.	PUNCT
ajmpe-660	348	1	chinese	chinese	ADJ
ajmpe-660	348	2	journal	journal	PROPN
ajmpe-660	348	3	of	of	ADP
ajmpe-660	348	4	gerology	gerology	NOUN
ajmpe-660	348	5	,	,	PUNCT
ajmpe-660	348	6	2011	2011	NUM
ajmpe-660	348	7	,	,	PUNCT
ajmpe-660	348	8	31(16	31(16	NUM
ajmpe-660	348	9	):	):	PUNCT
ajmpe-660	348	10	3108	3108	NUM
ajmpe-660	348	11	-	-	SYM
ajmpe-660	348	12	3109	3109	NUM
ajmpe-660	348	13	.	.	PUNCT
ajmpe-660	349	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-660	349	2	american	american	PROPN
ajmpe-660	349	3	journal	journal	PROPN
ajmpe-660	349	4	of	of	ADP
ajmpe-660	349	5	medical	medical	ADJ
ajmpe-660	349	6	and	and	CCONJ
ajmpe-660	349	7	physical	physical	ADJ
ajmpe-660	349	8	education	education	PROPN
ajmpe-660	349	9	vol.8	vol.8	PROPN
ajmpe-660	349	10	,	,	PUNCT
ajmpe-660	349	11	issue	issue	NOUN
ajmpe-660	349	12	5	5	NUM
ajmpe-660	349	13	;	;	PUNCT
ajmpe-660	349	14	september	september	PROPN
ajmpe-660	349	15	-	-	PUNCT
ajmpe-660	349	16	october	october	PROPN
ajmpe-660	349	17	2023	2023	NUM
ajmpe-660	349	18	;	;	PUNCT
ajmpe-660	349	19	issn	issn	PROPN
ajmpe-660	349	20	:	:	PUNCT
ajmpe-660	349	21	2994	2994	NUM
ajmpe-660	349	22	-	-	SYM
ajmpe-660	349	23	0524	0524	NUM
ajmpe-660	349	24	impact	impact	NOUN
ajmpe-660	349	25	factor	factor	NOUN
ajmpe-660	349	26	:	:	PUNCT
ajmpe-660	349	27	6.14	6.14	NUM
ajmpe-660	349	28	1252	1252	NUM
ajmpe-660	349	29	columbia	columbia	PROPN
ajmpe-660	349	30	rd	rd	PROPN
ajmpe-660	349	31	nw	nw	PROPN
ajmpe-660	349	32	,	,	PUNCT
ajmpe-660	349	33	washington	washington	PROPN
ajmpe-660	349	34	dc	dc	PROPN
ajmpe-660	349	35	,	,	PUNCT
ajmpe-660	349	36	united	united	PROPN
ajmpe-660	349	37	states	states	PROPN
ajmpe-660	349	38	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	349	39	;	;	PUNCT
ajmpe-660	349	40	mail	mail	NOUN
ajmpe-660	349	41	:	:	PUNCT
ajmpe-660	349	42	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	349	43	19	19	NUM
ajmpe-660	350	1	|	|	ADV
ajmpe-660	350	2	a	a	DET
ajmpe-660	350	3	m	m	NOUN
ajmpe-660	350	4	e	e	NOUN
ajmpe-660	350	5	r	r	NOUN
ajmpe-660	351	1	i	i	NOUN
ajmpe-660	351	2	c	c	VERB
ajmpe-660	351	3	a	a	DET
ajmpe-660	351	4	n	n	NOUN
ajmpe-660	352	1	j	j	NOUN
ajmpe-660	352	2	o	o	X
ajmpe-660	352	3	u	u	NOUN
ajmpe-660	352	4	r	r	NOUN
ajmpe-660	352	5	n	n	NOUN
ajmpe-660	352	6	a	a	DET
ajmpe-660	352	7	l	l	NOUN
ajmpe-660	352	8	o	o	X
ajmpe-660	353	1	f	f	X
ajmpe-660	353	2	m	m	NOUN
ajmpe-660	353	3	e	e	NOUN
ajmpe-660	354	1	d	d	NOUN
ajmpe-660	354	2	i	i	PRON
ajmpe-660	354	3	c	c	VERB
ajmpe-660	354	4	a	a	DET
ajmpe-660	354	5	l	l	NOUN
ajmpe-660	354	6	a	a	X
ajmpe-660	354	7	n	n	NOUN
ajmpe-660	355	1	d	d	NOUN
ajmpe-660	355	2	p	p	NOUN
ajmpe-660	355	3	h	h	NOUN
ajmpe-660	355	4	y	y	NOUN
ajmpe-660	355	5	s	s	VERB
ajmpe-660	356	1	i	i	INTJ
ajmpe-660	356	2	c	c	VERB
ajmpe-660	356	3	a	a	DET
ajmpe-660	356	4	l	l	NOUN
ajmpe-660	356	5	e	e	NOUN
ajmpe-660	356	6	d	d	X
ajmpe-660	356	7	u	u	X
ajmpe-660	356	8	c	c	PROPN
ajmpe-660	357	1	a	a	DET
ajmpe-660	357	2	t	t	NOUN
ajmpe-660	358	1	i	i	PRON
ajmpe-660	358	2	o	o	VERB
ajmpe-660	359	1	n	n	CCONJ
ajmpe-660	359	2	|	|	ADV
ajmpe-660	359	3	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	360	1	zhang	zhang	PROPN
ajmpe-660	360	2	z	z	PROPN
ajmpe-660	360	3	,	,	PUNCT
ajmpe-660	360	4	chen	chen	PROPN
ajmpe-660	360	5	h	h	PROPN
ajmpe-660	360	6	,	,	PUNCT
ajmpe-660	360	7	xu	xu	PROPN
ajmpe-660	361	1	c	c	X
ajmpe-660	361	2	,	,	PUNCT
ajmpe-660	361	3	et	et	PROPN
ajmpe-660	361	4	al	al	PROPN
ajmpe-660	361	5	.	.	PUNCT
ajmpe-660	361	6	curcumin	curcumin	PROPN
ajmpe-660	361	7	inhibits	inhibit	VERB
ajmpe-660	361	8	tumor	tumor	NOUN
ajmpe-660	361	9	epithelial‑mesenchymal	epithelial‑mesenchymal	ADJ
ajmpe-660	361	10	transition	transition	NOUN
ajmpe-660	361	11	by	by	ADP
ajmpe-660	361	12	downregulating	downregulate	VERB
ajmpe-660	361	13	the	the	DET
ajmpe-660	361	14	wnt	wnt	NOUN
ajmpe-660	361	15	signaling	signal	VERB
ajmpe-660	361	16	pathway	pathway	NOUN
ajmpe-660	361	17	and	and	CCONJ
ajmpe-660	361	18	upregulating	upregulating	ADJ
ajmpe-660	361	19	nkd2	nkd2	PROPN
ajmpe-660	361	20	expression	expression	NOUN
ajmpe-660	361	21	in	in	ADP
ajmpe-660	361	22	colon	colon	NOUN
ajmpe-660	361	23	cancer	cancer	NOUN
ajmpe-660	361	24	cells	cell	NOUN
ajmpe-660	361	25	[	[	X
ajmpe-660	361	26	j	j	X
ajmpe-660	361	27	]	]	X
ajmpe-660	361	28	.	.	PUNCT
ajmpe-660	362	1	oncol	oncol	PROPN
ajmpe-660	362	2	rep	rep	PROPN
ajmpe-660	362	3	,	,	PUNCT
ajmpe-660	362	4	2016	2016	NUM
ajmpe-660	362	5	,	,	PUNCT
ajmpe-660	362	6	35(5	35(5	NUM
ajmpe-660	362	7	):	):	PUNCT
ajmpe-660	362	8	2615	2615	NUM
ajmpe-660	362	9	-	-	SYM
ajmpe-660	362	10	23	23	NUM
ajmpe-660	362	11	.	.	PUNCT
ajmpe-660	363	1	seo	seo	NOUN
ajmpe-660	363	2	j	j	PROPN
ajmpe-660	363	3	a	a	PROPN
ajmpe-660	363	4	,	,	PUNCT
ajmpe-660	363	5	kim	kim	PROPN
ajmpe-660	363	6	b	b	PROPN
ajmpe-660	363	7	,	,	PUNCT
ajmpe-660	363	8	dhanasekaran	dhanasekaran	PROPN
ajmpe-660	363	9	d	d	PROPN
ajmpe-660	363	10	n	n	CCONJ
ajmpe-660	363	11	,	,	PUNCT
ajmpe-660	363	12	et	et	PROPN
ajmpe-660	363	13	al	al	PROPN
ajmpe-660	363	14	.	.	PUNCT
ajmpe-660	363	15	curcumin	curcumin	NOUN
ajmpe-660	363	16	induces	induce	VERB
ajmpe-660	363	17	apoptosis	apoptosis	NOUN
ajmpe-660	363	18	by	by	ADP
ajmpe-660	363	19	inhibiting	inhibit	VERB
ajmpe-660	363	20	sarco	sarco	PROPN
ajmpe-660	363	21	/	/	SYM
ajmpe-660	363	22	endoplasmic	endoplasmic	ADJ
ajmpe-660	363	23	reticulum	reticulum	NOUN
ajmpe-660	363	24	ca2	ca2	PROPN
ajmpe-660	363	25	+	+	CCONJ
ajmpe-660	363	26	atpase	atpase	NOUN
ajmpe-660	363	27	activity	activity	NOUN
ajmpe-660	363	28	in	in	ADP
ajmpe-660	363	29	ovarian	ovarian	ADJ
ajmpe-660	363	30	cancer	cancer	NOUN
ajmpe-660	363	31	cells	cell	NOUN
ajmpe-660	363	32	[	[	X
ajmpe-660	363	33	j	j	X
ajmpe-660	363	34	]	]	X
ajmpe-660	363	35	.	.	PUNCT
ajmpe-660	364	1	cancer	cancer	PROPN
ajmpe-660	364	2	lett	lett	PROPN
ajmpe-660	364	3	,	,	PUNCT
ajmpe-660	364	4	2016	2016	NUM
ajmpe-660	364	5	,	,	PUNCT
ajmpe-660	364	6	371	371	NUM
ajmpe-660	364	7	(	(	PUNCT
ajmpe-660	364	8	1	1	NUM
ajmpe-660	364	9	):	):	PUNCT
ajmpe-660	364	10	30	30	NUM
ajmpe-660	364	11	-	-	SYM
ajmpe-660	364	12	7	7	NUM
ajmpe-660	364	13	.	.	PUNCT
ajmpe-660	365	1	liu	liu	PROPN
ajmpe-660	365	2	l	l	PROPN
ajmpe-660	365	3	d	d	PROPN
ajmpe-660	365	4	,	,	PUNCT
ajmpe-660	365	5	pang	pang	NOUN
ajmpe-660	365	6	y	y	PROPN
ajmpe-660	365	7	x	x	PROPN
ajmpe-660	365	8	,	,	PUNCT
ajmpe-660	365	9	zhao	zhao	NOUN
ajmpe-660	365	10	x	x	SYM
ajmpe-660	365	11	r	r	NOUN
ajmpe-660	365	12	,	,	PUNCT
ajmpe-660	365	13	et	et	PROPN
ajmpe-660	365	14	al	al	PROPN
ajmpe-660	365	15	.	.	PUNCT
ajmpe-660	366	1	curcumin	curcumin	PROPN
ajmpe-660	366	2	induces	induce	VERB
ajmpe-660	366	3	apoptotic	apoptotic	ADJ
ajmpe-660	366	4	cell	cell	NOUN
ajmpe-660	366	5	death	death	NOUN
ajmpe-660	366	6	and	and	CCONJ
ajmpe-660	366	7	protective	protective	ADJ
ajmpe-660	366	8	autophagy	autophagy	NOUN
ajmpe-660	366	9	by	by	ADP
ajmpe-660	366	10	inhibiting	inhibit	VERB
ajmpe-660	366	11	akt	akt	PROPN
ajmpe-660	366	12	/	/	SYM
ajmpe-660	366	13	mtor	mtor	PROPN
ajmpe-660	366	14	/	/	SYM
ajmpe-660	366	15	p70s6k	p70s6k	PROPN
ajmpe-660	366	16	pathway	pathway	NOUN
ajmpe-660	366	17	in	in	ADP
ajmpe-660	366	18	human	human	ADJ
ajmpe-660	366	19	ovarian	ovarian	ADJ
ajmpe-660	366	20	cancer	cancer	NOUN
ajmpe-660	366	21	cells	cell	NOUN
ajmpe-660	366	22	[	[	X
ajmpe-660	366	23	j	j	X
ajmpe-660	366	24	]	]	X
ajmpe-660	366	25	.	.	PUNCT
ajmpe-660	367	1	arch	arch	PROPN
ajmpe-660	367	2	gynecol	gynecol	PROPN
ajmpe-660	367	3	obstet	obstet	NOUN
ajmpe-660	367	4	,	,	PUNCT
ajmpe-660	367	5	2019	2019	NUM
ajmpe-660	367	6	,	,	PUNCT
ajmpe-660	367	7	299(6	299(6	NUM
ajmpe-660	367	8	):	):	PUNCT
ajmpe-660	367	9	1627	1627	NUM
ajmpe-660	367	10	-	-	SYM
ajmpe-660	367	11	39	39	NUM
ajmpe-660	367	12	.	.	PUNCT
ajmpe-660	368	1	weir	weir	PROPN
ajmpe-660	368	2	n	n	PROPN
ajmpe-660	368	3	m	m	PROPN
ajmpe-660	368	4	,	,	PUNCT
ajmpe-660	368	5	selvendiran	selvendiran	ADJ
ajmpe-660	368	6	k	k	NOUN
ajmpe-660	368	7	,	,	PUNCT
ajmpe-660	368	8	kutala	kutala	PROPN
ajmpe-660	368	9	v	v	NUM
ajmpe-660	368	10	k	k	PROPN
ajmpe-660	368	11	,	,	PUNCT
ajmpe-660	368	12	et	et	PROPN
ajmpe-660	368	13	al	al	PROPN
ajmpe-660	368	14	.	.	PUNCT
ajmpe-660	369	1	curcumin	curcumin	PROPN
ajmpe-660	369	2	induces	induce	VERB
ajmpe-660	369	3	g2	g2	PROPN
ajmpe-660	369	4	/	/	SYM
ajmpe-660	369	5	m	m	NOUN
ajmpe-660	369	6	arrest	arrest	NOUN
ajmpe-660	369	7	and	and	CCONJ
ajmpe-660	369	8	apoptosis	apoptosis	NOUN
ajmpe-660	369	9	in	in	ADP
ajmpe-660	369	10	cisplatin	cisplatin	NOUN
ajmpe-660	369	11	-	-	PUNCT
ajmpe-660	369	12	resistant	resistant	ADJ
ajmpe-660	369	13	human	human	ADJ
ajmpe-660	369	14	ovarian	ovarian	ADJ
ajmpe-660	369	15	cancer	cancer	NOUN
ajmpe-660	369	16	cells	cell	NOUN
ajmpe-660	369	17	by	by	ADP
ajmpe-660	369	18	modulating	modulate	VERB
ajmpe-660	369	19	akt	akt	NOUN
ajmpe-660	369	20	and	and	CCONJ
ajmpe-660	369	21	p38	p38	VERB
ajmpe-660	369	22	mapk	mapk	NOUN
ajmpe-660	370	1	[	[	X
ajmpe-660	370	2	j	j	X
ajmpe-660	370	3	]	]	X
ajmpe-660	370	4	.	.	PUNCT
ajmpe-660	371	1	cancer	cancer	NOUN
ajmpe-660	371	2	biol	biol	PROPN
ajmpe-660	371	3	ther	ther	ADV
ajmpe-660	371	4	,	,	PUNCT
ajmpe-660	371	5	2007	2007	NUM
ajmpe-660	371	6	,	,	PUNCT
ajmpe-660	371	7	6(2	6(2	NUM
ajmpe-660	371	8	):	):	PUNCT
ajmpe-660	371	9	178	178	NUM
ajmpe-660	371	10	-	-	SYM
ajmpe-660	371	11	84	84	NUM
ajmpe-660	371	12	.	.	PUNCT
ajmpe-660	372	1	kumar	kumar	PROPN
ajmpe-660	372	2	d	d	PROPN
ajmpe-660	372	3	,	,	PUNCT
ajmpe-660	372	4	basu	basu	PROPN
ajmpe-660	372	5	s	s	PROPN
ajmpe-660	372	6	,	,	PUNCT
ajmpe-660	372	7	parija	parija	NOUN
ajmpe-660	372	8	l	l	NOUN
ajmpe-660	372	9	,	,	PUNCT
ajmpe-660	372	10	et	et	PROPN
ajmpe-660	372	11	al	al	PROPN
ajmpe-660	372	12	.	.	PROPN
ajmpe-660	372	13	curcumin	curcumin	PROPN
ajmpe-660	372	14	and	and	CCONJ
ajmpe-660	372	15	ellagic	ellagic	PROPN
ajmpe-660	372	16	acid	acid	NOUN
ajmpe-660	372	17	synergistically	synergistically	ADV
ajmpe-660	372	18	induce	induce	VERB
ajmpe-660	372	19	ros	ros	PROPN
ajmpe-660	372	20	generation	generation	NOUN
ajmpe-660	372	21	,	,	PUNCT
ajmpe-660	372	22	dna	dna	NOUN
ajmpe-660	372	23	damage	damage	NOUN
ajmpe-660	372	24	,	,	PUNCT
ajmpe-660	372	25	p53	p53	NOUN
ajmpe-660	372	26	accumulation	accumulation	NOUN
ajmpe-660	372	27	and	and	CCONJ
ajmpe-660	372	28	apoptosis	apoptosis	NOUN
ajmpe-660	372	29	in	in	ADP
ajmpe-660	372	30	hela	hela	ADJ
ajmpe-660	372	31	cervical	cervical	ADJ
ajmpe-660	372	32	carcinoma	carcinoma	NOUN
ajmpe-660	372	33	cells	cell	NOUN
ajmpe-660	372	34	.	.	PUNCT
ajmpe-660	373	1	biomed	biome	VERB
ajmpe-660	373	2	pharmacother	pharmacother	ADJ
ajmpe-660	373	3	,	,	PUNCT
ajmpe-660	373	4	2016	2016	NUM
ajmpe-660	373	5	,	,	PUNCT
ajmpe-660	373	6	8(1):31	8(1):31	NUM
ajmpe-660	373	7	-	-	SYM
ajmpe-660	373	8	37	37	NUM
ajmpe-660	373	9	.	.	PUNCT
ajmpe-660	374	1	fan	fan	PROPN
ajmpe-660	374	2	shizhen	shizhen	ADV
ajmpe-660	374	3	,	,	PUNCT
ajmpe-660	374	4	chen	chen	PROPN
ajmpe-660	374	5	xuna	xuna	PROPN
ajmpe-660	374	6	,	,	PUNCT
ajmpe-660	374	7	yu	yu	PROPN
ajmpe-660	374	8	bohai	bohai	PROPN
ajmpe-660	374	9	,	,	PUNCT
ajmpe-660	374	10	et	et	PROPN
ajmpe-660	374	11	al	al	PROPN
ajmpe-660	374	12	.	.	PUNCT
ajmpe-660	374	13	curcumin	curcumin	PROPN
ajmpe-660	374	14	promotes	promote	VERB
ajmpe-660	374	15	autophagy	autophagy	ADV
ajmpe-660	374	16	in	in	ADP
ajmpe-660	374	17	siha	siha	NOUN
ajmpe-660	374	18	cells	cell	NOUN
ajmpe-660	374	19	by	by	ADP
ajmpe-660	374	20	inhibiting	inhibit	VERB
ajmpe-660	374	21	pi3k	pi3k	PROPN
ajmpe-660	374	22	/	/	SYM
ajmpe-660	374	23	akt	akt	PROPN
ajmpe-660	374	24	/	/	SYM
ajmpe-660	374	25	mtor	mtor	PROPN
ajmpe-660	374	26	.	.	PUNCT
ajmpe-660	375	1	chin	chin	PROPN
ajmpe-660	375	2	j	j	PROPN
ajmpe-660	375	3	lab	lab	NOUN
ajmpe-660	375	4	diagnostics	diagnostic	NOUN
ajmpe-660	375	5	,	,	PUNCT
ajmpe-660	375	6	2017	2017	NUM
ajmpe-660	375	7	,	,	PUNCT
ajmpe-660	375	8	5	5	NUM
ajmpe-660	375	9	(	(	PUNCT
ajmpe-660	375	10	21	21	NUM
ajmpe-660	375	11	):	):	PUNCT
ajmpe-660	375	12	897	897	NUM
ajmpe-660	375	13	-	-	SYM
ajmpe-660	375	14	900	900	NUM
ajmpe-660	375	15	.	.	PUNCT
ajmpe-660	376	1	yang	yang	PROPN
ajmpe-660	376	2	s	s	PROPN
ajmpe-660	376	3	,	,	PUNCT
ajmpe-660	376	4	lin	lin	PROPN
ajmpe-660	376	5	s	s	PROPN
ajmpe-660	376	6	,	,	PUNCT
ajmpe-660	376	7	li	li	PROPN
ajmpe-660	376	8	n	n	PROPN
ajmpe-660	376	9	,	,	PUNCT
ajmpe-660	376	10	et	et	PROPN
ajmpe-660	376	11	al	al	PROPN
ajmpe-660	376	12	.	.	PROPN
ajmpe-660	376	13	burden	burden	PROPN
ajmpe-660	376	14	,	,	PUNCT
ajmpe-660	376	15	trends	trend	NOUN
ajmpe-660	376	16	,	,	PUNCT
ajmpe-660	376	17	and	and	CCONJ
ajmpe-660	376	18	risk	risk	NOUN
ajmpe-660	376	19	factors	factor	NOUN
ajmpe-660	376	20	of	of	ADP
ajmpe-660	376	21	esophageal	esophageal	ADJ
ajmpe-660	376	22	cancer	cancer	NOUN
ajmpe-660	376	23	in	in	ADP
ajmpe-660	376	24	china	china	PROPN
ajmpe-660	376	25	from	from	ADP
ajmpe-660	376	26	1990	1990	NUM
ajmpe-660	376	27	to	to	ADP
ajmpe-660	376	28	2017	2017	NUM
ajmpe-660	376	29	:	:	PUNCT
ajmpe-660	376	30	an	an	DET
ajmpe-660	376	31	up	up	ADP
ajmpe-660	376	32	-	-	PUNCT
ajmpe-660	376	33	to	to	ADP
ajmpe-660	376	34	-	-	PUNCT
ajmpe-660	376	35	date	date	NOUN
ajmpe-660	376	36	overview	overview	NOUN
ajmpe-660	376	37	and	and	CCONJ
ajmpe-660	376	38	comparison	comparison	NOUN
ajmpe-660	376	39	with	with	ADP
ajmpe-660	376	40	those	those	PRON
ajmpe-660	376	41	in	in	ADP
ajmpe-660	376	42	japan	japan	PROPN
ajmpe-660	376	43	and	and	CCONJ
ajmpe-660	376	44	south	south	PROPN
ajmpe-660	376	45	korea	korea	PROPN
ajmpe-660	377	1	[	[	X
ajmpe-660	377	2	j	j	X
ajmpe-660	377	3	]	]	X
ajmpe-660	377	4	.	.	PUNCT
ajmpe-660	378	1	j	j	PROPN
ajmpe-660	378	2	hematol	hematol	PROPN
ajmpe-660	378	3	oncol	oncol	PROPN
ajmpe-660	378	4	,	,	PUNCT
ajmpe-660	378	5	2020	2020	NUM
ajmpe-660	378	6	,	,	PUNCT
ajmpe-660	378	7	13(1	13(1	NUM
ajmpe-660	378	8	):	):	PUNCT
ajmpe-660	378	9	14	14	NUM
ajmpe-660	378	10	-	-	SYM
ajmpe-660	378	11	6	6	NUM
ajmpe-660	378	12	.	.	PUNCT
ajmpe-660	379	1	li	li	PROPN
ajmpe-660	379	2	x	x	PROPN
ajmpe-660	379	3	j	j	PROPN
ajmpe-660	379	4	,	,	PUNCT
ajmpe-660	379	5	luo	luo	PROPN
ajmpe-660	379	6	q	q	PROPN
ajmpe-660	379	7	,	,	PUNCT
ajmpe-660	379	8	sun	sun	PROPN
ajmpe-660	379	9	l	l	PROPN
ajmpe-660	379	10	,	,	PUNCT
ajmpe-660	379	11	et	et	PROPN
ajmpe-660	379	12	al	al	PROPN
ajmpe-660	379	13	.	.	PUNCT
ajmpe-660	379	14	effects	effect	NOUN
ajmpe-660	379	15	of	of	ADP
ajmpe-660	379	16	curcumin	curcumin	NOUN
ajmpe-660	379	17	on	on	ADP
ajmpe-660	379	18	proliferation	proliferation	NOUN
ajmpe-660	379	19	and	and	CCONJ
ajmpe-660	379	20	pten	pten	VERB
ajmpe-660	379	21	/	/	SYM
ajmpe-660	379	22	pi3k	pi3k	PROPN
ajmpe-660	379	23	/	/	SYM
ajmpe-660	379	24	akt	akt	PROPN
ajmpe-660	379	25	signaling	signal	VERB
ajmpe-660	379	26	pathway	pathway	NOUN
ajmpe-660	379	27	of	of	ADP
ajmpe-660	379	28	esophageal	esophageal	ADJ
ajmpe-660	379	29	cancer	cancer	NOUN
ajmpe-660	379	30	ec109	ec109	PROPN
ajmpe-660	379	31	cells	cell	NOUN
ajmpe-660	380	1	[	[	X
ajmpe-660	380	2	j	j	X
ajmpe-660	380	3	]	]	X
ajmpe-660	380	4	.	.	PUNCT
ajmpe-660	381	1	chin	chin	PROPN
ajmpe-660	381	2	j	j	PROPN
ajmpe-660	381	3	applied	apply	VERB
ajmpe-660	381	4	physiology	physiology	NOUN
ajmpe-660	381	5	,	,	PUNCT
ajmpe-660	381	6	2015	2015	NUM
ajmpe-660	381	7	,	,	PUNCT
ajmpe-660	381	8	31(05	31(05	NUM
ajmpe-660	381	9	):	):	PUNCT
ajmpe-660	381	10	465	465	NUM
ajmpe-660	381	11	-	-	SYM
ajmpe-660	381	12	8	8	NUM
ajmpe-660	381	13	.	.	PUNCT
ajmpe-660	382	1	lin	lin	PROPN
ajmpe-660	382	2	m	m	PROPN
ajmpe-660	382	3	l	l	PROPN
ajmpe-660	382	4	,	,	PUNCT
ajmpe-660	382	5	lu	lu	PROPN
ajmpe-660	382	6	y	y	PROPN
ajmpe-660	382	7	c	c	PROPN
ajmpe-660	382	8	,	,	PUNCT
ajmpe-660	382	9	chen	chen	PROPN
ajmpe-660	382	10	h	h	PROPN
ajmpe-660	382	11	y	y	PROPN
ajmpe-660	382	12	,	,	PUNCT
ajmpe-660	382	13	et	et	PROPN
ajmpe-660	382	14	al	al	PROPN
ajmpe-660	382	15	.	.	PUNCT
ajmpe-660	382	16	suppressing	suppress	VERB
ajmpe-660	382	17	the	the	DET
ajmpe-660	382	18	formation	formation	NOUN
ajmpe-660	382	19	of	of	ADP
ajmpe-660	382	20	lipid	lipid	ADJ
ajmpe-660	382	21	raft	raft	NOUN
ajmpe-660	382	22	-	-	PUNCT
ajmpe-660	382	23	associated	associate	VERB
ajmpe-660	382	24	rac1	rac1	NOUN
ajmpe-660	382	25	/	/	SYM
ajmpe-660	382	26	pi3k	pi3k	PROPN
ajmpe-660	382	27	/	/	SYM
ajmpe-660	382	28	akt	akt	PROPN
ajmpe-660	382	29	signaling	signal	VERB
ajmpe-660	382	30	complexes	complex	NOUN
ajmpe-660	382	31	by	by	ADP
ajmpe-660	382	32	curcumin	curcumin	NOUN
ajmpe-660	382	33	inhibits	inhibit	VERB
ajmpe-660	382	34	sdf-1α	sdf-1α	NOUN
ajmpe-660	382	35	-	-	PUNCT
ajmpe-660	382	36	induced	induce	VERB
ajmpe-660	382	37	invasion	invasion	NOUN
ajmpe-660	382	38	of	of	ADP
ajmpe-660	382	39	human	human	ADJ
ajmpe-660	382	40	esophageal	esophageal	ADJ
ajmpe-660	382	41	carcinoma	carcinoma	NOUN
ajmpe-660	382	42	cells	cell	NOUN
ajmpe-660	382	43	[	[	X
ajmpe-660	382	44	j	j	X
ajmpe-660	382	45	]	]	X
ajmpe-660	382	46	.	.	PUNCT
ajmpe-660	383	1	mol	mol	PROPN
ajmpe-660	383	2	carcinog	carcinog	PROPN
ajmpe-660	383	3	,	,	PUNCT
ajmpe-660	383	4	2014	2014	NUM
ajmpe-660	383	5	,	,	PUNCT
ajmpe-660	383	6	53(5	53(5	NUM
ajmpe-660	383	7	):	):	PUNCT
ajmpe-660	383	8	360	360	NUM
ajmpe-660	383	9	-	-	SYM
ajmpe-660	383	10	79	79	NUM
ajmpe-660	383	11	.	.	PUNCT
ajmpe-660	384	1	chen	chen	PROPN
ajmpe-660	384	2	jianhua	jianhua	PROPN
ajmpe-660	384	3	.	.	PUNCT
ajmpe-660	385	1	the	the	DET
ajmpe-660	385	2	effect	effect	NOUN
ajmpe-660	385	3	of	of	ADP
ajmpe-660	385	4	curcumin	curcumin	NOUN
ajmpe-660	385	5	on	on	ADP
ajmpe-660	385	6	the	the	DET
ajmpe-660	385	7	proliferation	proliferation	NOUN
ajmpe-660	385	8	and	and	CCONJ
ajmpe-660	385	9	wnt	wnt	NOUN
ajmpe-660	385	10	signaling	signal	VERB
ajmpe-660	385	11	pathway	pathway	NOUN
ajmpe-660	385	12	of	of	ADP
ajmpe-660	385	13	esophageal	esophageal	ADJ
ajmpe-660	385	14	cancer	cancer	NOUN
ajmpe-660	385	15	cell	cell	NOUN
ajmpe-660	385	16	line	line	NOUN
ajmpe-660	385	17	eca-109	eca-109	VERB
ajmpe-660	386	1	[	[	X
ajmpe-660	386	2	d	d	X
ajmpe-660	386	3	]	]	X
ajmpe-660	386	4	;	;	PUNCT
ajmpe-660	386	5	hebei	hebei	PROPN
ajmpe-660	386	6	medical	medical	PROPN
ajmpe-660	386	7	university	university	PROPN
ajmpe-660	386	8	,	,	PUNCT
ajmpe-660	386	9	2015	2015	NUM
ajmpe-660	386	10	.	.	PUNCT
ajmpe-660	387	1	zhao	zhao	PROPN
ajmpe-660	387	2	w	w	PROPN
ajmpe-660	387	3	,	,	PUNCT
ajmpe-660	387	4	zhou	zhou	PROPN
ajmpe-660	387	5	x	x	PROPN
ajmpe-660	387	6	,	,	PUNCT
ajmpe-660	387	7	qi	qi	PROPN
ajmpe-660	387	8	g	g	PROPN
ajmpe-660	387	9	,	,	PUNCT
ajmpe-660	387	10	et	et	PROPN
ajmpe-660	387	11	al	al	PROPN
ajmpe-660	387	12	.	.	PROPN
ajmpe-660	387	13	curcumin	curcumin	PROPN
ajmpe-660	387	14	suppressed	suppress	VERB
ajmpe-660	387	15	the	the	DET
ajmpe-660	387	16	prostate	prostate	NOUN
ajmpe-660	387	17	cancer	cancer	NOUN
ajmpe-660	387	18	by	by	ADP
ajmpe-660	387	19	inhibiting	inhibit	VERB
ajmpe-660	387	20	jnk	jnk	PROPN
ajmpe-660	387	21	pathways	pathway	NOUN
ajmpe-660	387	22	via	via	ADP
ajmpe-660	387	23	epigenetic	epigenetic	ADJ
ajmpe-660	387	24	regulation	regulation	NOUN
ajmpe-660	387	25	[	[	X
ajmpe-660	387	26	j	j	X
ajmpe-660	387	27	]	]	X
ajmpe-660	387	28	.	.	PUNCT
ajmpe-660	388	1	j	j	PROPN
ajmpe-660	388	2	biochem	biochem	PROPN
ajmpe-660	388	3	mol	mol	ADP
ajmpe-660	388	4	toxicol	toxicol	PROPN
ajmpe-660	388	5	,	,	PUNCT
ajmpe-660	388	6	2018	2018	NUM
ajmpe-660	388	7	,	,	PUNCT
ajmpe-660	388	8	32(5	32(5	NOUN
ajmpe-660	388	9	):	):	PUNCT
ajmpe-660	388	10	e22049	e22049	PROPN
ajmpe-660	388	11	.	.	PUNCT
ajmpe-660	388	12	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-660	388	13	american	american	PROPN
ajmpe-660	388	14	journal	journal	PROPN
ajmpe-660	388	15	of	of	ADP
ajmpe-660	388	16	medical	medical	ADJ
ajmpe-660	388	17	and	and	CCONJ
ajmpe-660	388	18	physical	physical	ADJ
ajmpe-660	388	19	education	education	PROPN
ajmpe-660	388	20	vol.8	vol.8	PROPN
ajmpe-660	388	21	,	,	PUNCT
ajmpe-660	388	22	issue	issue	NOUN
ajmpe-660	388	23	5	5	NUM
ajmpe-660	388	24	;	;	PUNCT
ajmpe-660	388	25	september	september	PROPN
ajmpe-660	388	26	-	-	PUNCT
ajmpe-660	388	27	october	october	PROPN
ajmpe-660	388	28	2023	2023	NUM
ajmpe-660	388	29	;	;	PUNCT
ajmpe-660	388	30	issn	issn	PROPN
ajmpe-660	388	31	:	:	PUNCT
ajmpe-660	388	32	2994	2994	NUM
ajmpe-660	388	33	-	-	SYM
ajmpe-660	388	34	0524	0524	NUM
ajmpe-660	388	35	impact	impact	NOUN
ajmpe-660	388	36	factor	factor	NOUN
ajmpe-660	388	37	:	:	PUNCT
ajmpe-660	388	38	6.14	6.14	NUM
ajmpe-660	388	39	1252	1252	NUM
ajmpe-660	388	40	columbia	columbia	PROPN
ajmpe-660	388	41	rd	rd	PROPN
ajmpe-660	388	42	nw	nw	PROPN
ajmpe-660	388	43	,	,	PUNCT
ajmpe-660	388	44	washington	washington	PROPN
ajmpe-660	388	45	dc	dc	PROPN
ajmpe-660	388	46	,	,	PUNCT
ajmpe-660	388	47	united	united	PROPN
ajmpe-660	388	48	states	states	PROPN
ajmpe-660	388	49	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-660	388	50	;	;	PUNCT
ajmpe-660	388	51	mail	mail	NOUN
ajmpe-660	388	52	:	:	PUNCT
ajmpe-660	388	53	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-660	389	1	20	20	NUM
ajmpe-660	390	1	|	|	ADV
ajmpe-660	390	2	a	a	DET
ajmpe-660	390	3	m	m	NOUN
ajmpe-660	390	4	e	e	NOUN
ajmpe-660	390	5	r	r	NOUN
ajmpe-660	390	6	i	i	NOUN
ajmpe-660	390	7	c	c	VERB
ajmpe-660	390	8	a	a	DET
ajmpe-660	390	9	n	n	NOUN
ajmpe-660	391	1	j	j	NOUN
ajmpe-660	391	2	o	o	X
ajmpe-660	391	3	u	u	NOUN
ajmpe-660	391	4	r	r	NOUN
ajmpe-660	391	5	n	n	NOUN
ajmpe-660	391	6	a	a	DET
ajmpe-660	391	7	l	l	NOUN
ajmpe-660	391	8	o	o	X
ajmpe-660	392	1	f	f	X
ajmpe-660	392	2	m	m	NOUN
ajmpe-660	392	3	e	e	NOUN
ajmpe-660	393	1	d	d	NOUN
ajmpe-660	393	2	i	i	PRON
ajmpe-660	393	3	c	c	VERB
ajmpe-660	393	4	a	a	DET
ajmpe-660	393	5	l	l	NOUN
ajmpe-660	393	6	a	a	X
ajmpe-660	393	7	n	n	NOUN
ajmpe-660	394	1	d	d	NOUN
ajmpe-660	394	2	p	p	NOUN
ajmpe-660	394	3	h	h	NOUN
ajmpe-660	394	4	y	y	NOUN
ajmpe-660	394	5	s	s	VERB
ajmpe-660	395	1	i	i	INTJ
ajmpe-660	395	2	c	c	VERB
ajmpe-660	395	3	a	a	DET
ajmpe-660	395	4	l	l	NOUN
ajmpe-660	395	5	e	e	NOUN
ajmpe-660	395	6	d	d	X
ajmpe-660	395	7	u	u	X
ajmpe-660	395	8	c	c	PROPN
ajmpe-660	396	1	a	a	DET
ajmpe-660	396	2	t	t	NOUN
ajmpe-660	397	1	i	i	PRON
ajmpe-660	397	2	o	o	VERB
ajmpe-660	398	1	n	n	CCONJ
ajmpe-660	398	2	|	|	ADV
ajmpe-660	398	3	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-660	398	4	liu	liu	PROPN
ajmpe-660	398	5	t	t	PROPN
ajmpe-660	398	6	,	,	PUNCT
ajmpe-660	398	7	chi	chi	PROPN
ajmpe-660	398	8	h	h	PROPN
ajmpe-660	398	9	,	,	PUNCT
ajmpe-660	398	10	chen	chen	PROPN
ajmpe-660	398	11	j	j	PROPN
ajmpe-660	398	12	,	,	PUNCT
ajmpe-660	398	13	et	et	PROPN
ajmpe-660	398	14	al	al	PROPN
ajmpe-660	398	15	.	.	PUNCT
ajmpe-660	398	16	curcumin	curcumin	PROPN
ajmpe-660	398	17	suppresses	suppress	VERB
ajmpe-660	398	18	proliferation	proliferation	NOUN
ajmpe-660	398	19	and	and	CCONJ
ajmpe-660	398	20	in	in	ADP
ajmpe-660	398	21	vitro	vitro	X
ajmpe-660	398	22	invasion	invasion	NOUN
ajmpe-660	398	23	of	of	ADP
ajmpe-660	398	24	human	human	ADJ
ajmpe-660	398	25	prostate	prostate	NOUN
ajmpe-660	398	26	cancer	cancer	NOUN
ajmpe-660	398	27	stem	stem	NOUN
ajmpe-660	398	28	cells	cell	NOUN
ajmpe-660	398	29	by	by	ADP
ajmpe-660	398	30	cerna	cerna	NOUN
ajmpe-660	398	31	effect	effect	NOUN
ajmpe-660	398	32	of	of	ADP
ajmpe-660	398	33	mir-145	mir-145	NOUN
ajmpe-660	398	34	and	and	CCONJ
ajmpe-660	398	35	lncrna	lncrna	NOUN
ajmpe-660	398	36	-	-	PUNCT
ajmpe-660	398	37	ror	ror	NOUN
ajmpe-660	398	38	[	[	X
ajmpe-660	398	39	j	j	X
ajmpe-660	398	40	]	]	X
ajmpe-660	398	41	.	.	PUNCT
ajmpe-660	399	1	gene	gene	NOUN
ajmpe-660	399	2	,	,	PUNCT
ajmpe-660	399	3	2017	2017	NUM
ajmpe-660	399	4	,	,	PUNCT
ajmpe-660	399	5	63(1	63(1	NUM
ajmpe-660	399	6	):	):	PUNCT
ajmpe-660	399	7	29	29	NUM
ajmpe-660	399	8	-	-	SYM
ajmpe-660	399	9	38	38	NUM
ajmpe-660	399	10	.	.	PUNCT
ajmpe-660	400	1	[	[	X
ajmpe-660	400	2	49	49	NUM
ajmpe-660	400	3	]	]	X
ajmpe-660	400	4	gong	gong	NOUN
ajmpe-660	400	5	x	x	PROPN
ajmpe-660	400	6	,	,	PUNCT
ajmpe-660	400	7	jiang	jiang	PROPN
ajmpe-660	400	8	l	l	PROPN
ajmpe-660	400	9	,	,	PUNCT
ajmpe-660	400	10	li	li	PROPN
ajmpe-660	400	11	w	w	PROPN
ajmpe-660	400	12	,	,	PUNCT
ajmpe-660	400	13	et	et	PROPN
ajmpe-660	400	14	al	al	PROPN
ajmpe-660	400	15	.	.	PUNCT
ajmpe-660	401	1	curcumin	curcumin	PROPN
ajmpe-660	401	2	induces	induce	VERB
ajmpe-660	401	3	apoptosis	apoptosis	NOUN
ajmpe-660	401	4	and	and	CCONJ
ajmpe-660	401	5	autophagy	autophagy	ADJ
ajmpe-660	401	6	inhuman	inhuman	ADJ
ajmpe-660	401	7	renal	renal	ADJ
ajmpe-660	401	8	cell	cell	NOUN
ajmpe-660	401	9	carcinoma	carcinoma	NOUN
ajmpe-660	401	10	cells	cell	NOUN
ajmpe-660	401	11	via	via	ADP
ajmpe-660	401	12	akt	akt	PROPN
ajmpe-660	401	13	/	/	SYM
ajmpe-660	401	14	mtor	mtor	PROPN
ajmpe-660	401	15	suppression	suppression	NOUN
ajmpe-660	402	1	[	[	X
ajmpe-660	402	2	j	j	X
ajmpe-660	402	3	]	]	X
ajmpe-660	402	4	.	.	PUNCT
ajmpe-660	403	1	bioengineered	bioengineere	VERB
ajmpe-660	403	2	,	,	PUNCT
ajmpe-660	403	3	2021	2021	NUM
ajmpe-660	403	4	,	,	PUNCT
ajmpe-660	403	5	12(1	12(1	NUM
ajmpe-660	403	6	):	):	PUNCT
ajmpe-660	403	7	5017	5017	NUM
ajmpe-660	403	8	-	-	SYM
ajmpe-660	403	9	27	27	NUM
ajmpe-660	403	10	.	.	PUNCT
ajmpe-660	404	1	zhou	zhou	PROPN
ajmpe-660	404	2	h	h	PROPN
ajmpe-660	404	3	,	,	PUNCT
ajmpe-660	404	4	ning	ning	PROPN
ajmpe-660	404	5	y	y	PROPN
ajmpe-660	404	6	,	,	PUNCT
ajmpe-660	404	7	zeng	zeng	PROPN
ajmpe-660	404	8	g	g	PROPN
ajmpe-660	404	9	,	,	PUNCT
ajmpe-660	404	10	et	et	PROPN
ajmpe-660	404	11	al	al	PROPN
ajmpe-660	404	12	.	.	PUNCT
ajmpe-660	404	13	curcumin	curcumin	PROPN
ajmpe-660	404	14	promotes	promote	VERB
ajmpe-660	404	15	cell	cell	NOUN
ajmpe-660	404	16	cycle	cycle	NOUN
ajmpe-660	404	17	arrest	arrest	NOUN
ajmpe-660	404	18	and	and	CCONJ
ajmpe-660	404	19	apoptosis	apoptosis	NOUN
ajmpe-660	404	20	of	of	ADP
ajmpe-660	404	21	acute	acute	ADJ
ajmpe-660	404	22	myeloid	myeloid	NOUN
ajmpe-660	404	23	leukemia	leukemia	NOUN
ajmpe-660	404	24	cells	cell	NOUN
ajmpe-660	404	25	by	by	ADP
ajmpe-660	404	26	inactivating	inactivate	VERB
ajmpe-660	404	27	akt	akt	PROPN
ajmpe-660	405	1	[	[	X
ajmpe-660	405	2	j	j	X
ajmpe-660	405	3	]	]	X
ajmpe-660	405	4	.	.	PUNCT
ajmpe-660	406	1	oncol	oncol	PROPN
ajmpe-660	406	2	rep	rep	PROPN
ajmpe-660	406	3	,	,	PUNCT
ajmpe-660	406	4	2021	2021	NUM
ajmpe-660	406	5	,	,	PUNCT
ajmpe-660	406	6	45(4	45(4	NUM
ajmpe-660	406	7	)	)	PUNCT
ajmpe-660	406	8	.	.	PUNCT
ajmpe-660	407	1	79	79	NUM
ajmpe-660	407	2	-	-	SYM
ajmpe-660	407	3	62	62	NUM
ajmpe-660	407	4	.	.	PUNCT
ajmpe-660	408	1	hu	hu	PROPN
ajmpe-660	409	1	c	c	PROPN
ajmpe-660	409	2	,	,	PUNCT
ajmpe-660	409	3	li	li	PROPN
ajmpe-660	409	4	m	m	PROPN
ajmpe-660	409	5	,	,	PUNCT
ajmpe-660	409	6	guo	guo	PROPN
ajmpe-660	409	7	t	t	PROPN
ajmpe-660	409	8	,	,	PUNCT
ajmpe-660	409	9	et	et	PROPN
ajmpe-660	409	10	al	al	PROPN
ajmpe-660	409	11	.	.	PUNCT
ajmpe-660	409	12	anti	anti	ADJ
ajmpe-660	409	13	-	-	ADJ
ajmpe-660	409	14	metastasis	metastasis	ADJ
ajmpe-660	409	15	activity	activity	NOUN
ajmpe-660	409	16	of	of	ADP
ajmpe-660	409	17	curcumin	curcumin	NOUN
ajmpe-660	409	18	against	against	ADP
ajmpe-660	409	19	breast	breast	NOUN
ajmpe-660	409	20	cancer	cancer	NOUN
ajmpe-660	409	21	via	via	ADP
ajmpe-660	409	22	the	the	DET
ajmpe-660	409	23	inhibition	inhibition	NOUN
ajmpe-660	409	24	of	of	ADP
ajmpe-660	409	25	stem	stem	NOUN
ajmpe-660	409	26	cell	cell	NOUN
ajmpe-660	409	27	-	-	PUNCT
ajmpe-660	409	28	like	like	ADJ
ajmpe-660	409	29	properties	property	NOUN
ajmpe-660	409	30	and	and	CCONJ
ajmpe-660	409	31	emt	emt	PROPN
ajmpe-660	410	1	[	[	X
ajmpe-660	410	2	j	j	X
ajmpe-660	410	3	]	]	X
ajmpe-660	410	4	.	.	PUNCT
ajmpe-660	411	1	phytomedicine	phytomedicine	PROPN
ajmpe-660	411	2	,	,	PUNCT
ajmpe-660	411	3	2019	2019	NUM
ajmpe-660	411	4	,	,	PUNCT
ajmpe-660	411	5	58(12	58(12	NUM
ajmpe-660	411	6	):	):	PUNCT
ajmpe-660	411	7	1527	1527	NUM
ajmpe-660	411	8	-	-	SYM
ajmpe-660	411	9	40	40	NUM
ajmpe-660	411	10	.	.	PUNCT
ajmpe-660	412	1	shi	shi	PROPN
ajmpe-660	412	2	j	j	PROPN
ajmpe-660	412	3	,	,	PUNCT
ajmpe-660	412	4	wang	wang	PROPN
ajmpe-660	412	5	y	y	PROPN
ajmpe-660	412	6	,	,	PUNCT
ajmpe-660	412	7	jia	jia	PROPN
ajmpe-660	412	8	z	z	PROPN
ajmpe-660	412	9	,	,	PUNCT
ajmpe-660	412	10	et	et	PROPN
ajmpe-660	412	11	al	al	PROPN
ajmpe-660	412	12	.	.	PUNCT
ajmpe-660	412	13	curcumin	curcumin	PROPN
ajmpe-660	412	14	inhibits	inhibit	VERB
ajmpe-660	412	15	bladder	bladder	NOUN
ajmpe-660	412	16	cancer	cancer	NOUN
ajmpe-660	412	17	progression	progression	NOUN
ajmpe-660	412	18	via	via	ADP
ajmpe-660	412	19	regulation	regulation	NOUN
ajmpe-660	412	20	of	of	ADP
ajmpe-660	412	21	β	β	NOUN
ajmpe-660	412	22	-	-	ADJ
ajmpe-660	412	23	catenin	catenin	ADJ
ajmpe-660	412	24	expression	expression	NOUN
ajmpe-660	413	1	[	[	X
ajmpe-660	413	2	j	j	X
ajmpe-660	413	3	]	]	X
ajmpe-660	413	4	.	.	PUNCT
ajmpe-660	414	1	tumour	tumour	PROPN
ajmpe-660	414	2	biol	biol	PROPN
ajmpe-660	414	3	,	,	PUNCT
ajmpe-660	414	4	2017	2017	NUM
ajmpe-660	414	5	,	,	PUNCT
ajmpe-660	414	6	39(7	39(7	NUM
ajmpe-660	414	7	):	):	PUNCT
ajmpe-660	414	8	1770	1770	NUM
ajmpe-660	414	9	-	-	SYM
ajmpe-660	414	10	2548	2548	NUM
ajmpe-660	414	11	.	.	PUNCT
ajmpe-660	415	1	bharti	bharti	PROPN
ajmpe-660	415	2	a	a	DET
ajmpe-660	415	3	c	c	PROPN
ajmpe-660	415	4	,	,	PUNCT
ajmpe-660	415	5	donato	donato	NOUN
ajmpe-660	415	6	n	n	CCONJ
ajmpe-660	415	7	,	,	PUNCT
ajmpe-660	415	8	singh	singh	PROPN
ajmpe-660	415	9	s	s	PROPN
ajmpe-660	415	10	,	,	PUNCT
ajmpe-660	415	11	et	et	PROPN
ajmpe-660	415	12	al	al	PROPN
ajmpe-660	415	13	.	.	PUNCT
ajmpe-660	415	14	curcumin	curcumin	PROPN
ajmpe-660	415	15	(	(	PUNCT
ajmpe-660	415	16	diferuloylmethane	diferuloylmethane	NOUN
ajmpe-660	415	17	)	)	PUNCT
ajmpe-660	415	18	down	down	ADV
ajmpe-660	415	19	-	-	PUNCT
ajmpe-660	415	20	regulates	regulate	VERB
ajmpe-660	415	21	the	the	DET
ajmpe-660	415	22	constitutive	constitutive	ADJ
ajmpe-660	415	23	activation	activation	NOUN
ajmpe-660	415	24	of	of	ADP
ajmpe-660	415	25	nuclear	nuclear	ADJ
ajmpe-660	415	26	factor	factor	NOUN
ajmpe-660	415	27	-	-	PUNCT
ajmpe-660	415	28	kappa	kappa	PROPN
ajmpe-660	415	29	b	b	PROPN
ajmpe-660	415	30	and	and	CCONJ
ajmpe-660	415	31	ikappabalpha	ikappabalpha	PROPN
ajmpe-660	415	32	kinase	kinase	PROPN
ajmpe-660	415	33	in	in	ADP
ajmpe-660	415	34	human	human	ADJ
ajmpe-660	415	35	multiple	multiple	ADJ
ajmpe-660	415	36	myeloma	myeloma	NOUN
ajmpe-660	415	37	cells	cell	NOUN
ajmpe-660	415	38	,	,	PUNCT
ajmpe-660	415	39	leading	lead	VERB
ajmpe-660	415	40	to	to	ADP
ajmpe-660	415	41	suppression	suppression	NOUN
ajmpe-660	415	42	of	of	ADP
ajmpe-660	415	43	proliferation	proliferation	NOUN
ajmpe-660	415	44	and	and	CCONJ
ajmpe-660	415	45	induction	induction	NOUN
ajmpe-660	415	46	of	of	ADP
ajmpe-660	415	47	apoptosis	apoptosis	NOUN
ajmpe-660	415	48	[	[	X
ajmpe-660	415	49	j	j	X
ajmpe-660	415	50	]	]	X
ajmpe-660	415	51	.	.	PUNCT
ajmpe-660	416	1	blood	blood	NOUN
ajmpe-660	416	2	,	,	PUNCT
ajmpe-660	416	3	2003	2003	NUM
ajmpe-660	416	4	,	,	PUNCT
ajmpe-660	416	5	101(3	101(3	NUM
ajmpe-660	416	6	):	):	PUNCT
ajmpe-660	416	7	1053	1053	NUM
ajmpe-660	416	8	-	-	SYM
ajmpe-660	416	9	62	62	NUM
ajmpe-660	416	10	.	.	PUNCT
ajmpe-660	417	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	X